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Twice Touched
A method passing, an idea Living},
The details pu t into a line.
The thoughts too busy, nothing thinking, 
A  journey prepared detached, sublime.
goodbyes and promises, you  follow with me, 
we take the road, to stop at the cross.
Too Long to look, too Long to think,
The final start and. then be lost.
^top and turn, a profound goodbye 
The rush, the loss, the crying pain.
Not to Look and then, to see i t  all 
Never, always, different again
t>eeply touched, / shake your hand,
A gentle nod, you shaked mine.
A  chasru. o f  sorrow, always carved,
To guide a tear with passing time.
you continued on, / couldn't move, 
Confusion, Loss, i had to leave, 
you slowed and stopped to look and wave. 
The road was blurred, felt, believed.
to remember is beauty, caught in  tears,
To forget impossible, a desperate fear.
'Brian 72. £>uffy 
i s  December
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ABSTRACT
The clinical use of any drug requires a complete understanding of its biotransformation 
properties. The drug coumarin has for years been used in clinical applications. High 
performance liquid chromatography (HPLC) and capillary electrophoresis (CE) were applied 
to the study of coumarin metabolism, in particular the phase I and phase II metabolites, 7- 
hydroxycoumarin and 7-hydroxycoumarin glucuronide. Glucuronidation is the principal 
pathway for detoxification of many drugs and is catalysed by the enzyme uridine diphosphate 
glucuronyl transferase (UDPGT). Both chromatographic methods were applied to the 
analysis of the UDPGT activity in rabbit tissue samples. CE was applied to the study of [3- 
glucuronidase activity for the same samples.
Microchip-based capillary electrophoresis with laser induced fluorescence detection was used 
to investigate antibody based detection methods for the anticoagulant, warfarin, and the 
pesticide parathion. A novel approach for the assay used an easily labelled drug-protein 
conjugate as tracer, rather than the conventional free drug with fluorescent tag. However, 
problems associated with heterogeneity of the antibody preparation and also with the labelled 
drug protein, did not allow complete resolution of antibody-drug-protein from free drug- 
protein to be effected.
Knowledge of what happens on a sub-cellular level is also required for a complete 
understanding of drug disposition. The use of capillary electrophoresis for the analysis of cell 
organelles was examined. Liposomes were chosen as a model as they could be tailored to 
mimic certain characteristics o f different organelles (size, membrane composition), and are 
also manufactured industrially for use in drug delivery/targeting. The method developed 
provides critical information on size and membrane composition on a single liposome basis 
that can be used to monitor liposome preparations for use in clinical applications. Having 
successfully established this method, CE was then applied to the analysis of mitochondria, 
isolated from Chinese ham ster ovary cells. Two specific organelle probes were used, i.e. 
nonyl acridine orange (NAO) for mitochondrial mass analysis, and rhodamine 123 (R hl23)
iv
for membrane potential studies. NAO is a membrane specific probe and its uptake is 
independent on the energetic stale of the mitochondria, binding to the cardiolipin content in a 
2:1 ratio, while rhodam ine 123 requires a membrane potential for its uptake. Measurement of 
fluorophore content of each individual mitochondrion gives information on membrane size 
and activity. A preliminary analysis of the mitochondrial proteome was carricd out by 
capillary gel electrophoresis following the purification of protein from isolated mitochondria 
and labelling with a fluorescent tag.
v
ABBREVIATIONS
AAP Acryloyl amino propanol
Ab Antibody
Ag Antigen
ATP Adenosine triphosphate
APS Adenosine-5-phosphosulphate
BSA Bovine serum albumin
CE Capillary electrophoresis
CGE Capillary gel electrophoresis
CMC Critical micelle concentration
DMSO Dimethyl sulphoxide
DNA Deoxyribonucleic acid
ER Endoplasmic reticulum
FACS Fluorescence activated cell sorter
FFE Free flow electrophoresis
FITC Flourescein isothiocyanate
FID Flame ionisation detection
FTTR Fourier transform infra-red
GC Gas chromatography
GLC Gas liquid chromatography
GSC Gas solid chromatography
2HPAA 2-Hydroxyphenylacetic acid
7-HC 7-Hydroxycoumarin
7-HCG 7-Hydroxycoumarin glucuronide
7-HS 7-Hydroxycoumarin sulphate
cITP Capillary isotachophoresis
cIEF Capillary isoelectric focusing
JC-1 5,5’,6 ,6 -te trach lo ro -l,r,3 ,3 ’tetraethylbenzimidazolylcarbocyanine iodide
vi
LIF Laser-induced fluorescence
MECC M icellar electrokinetic capillary chromatography
MMP M itochondrial membrane potential
MS Mass spectrometry
NA Numerical aperture
NAO Nonyl acridine orange
NCI National Cancer Institute
NMDA N-methyl-D-aspartate
OA Osteoarthritis
OHP Outer Helmholtz Plane
PAPS 3’-Phosphoadenosine-5-phosphosulphate
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate-buffered saline
PC Phosphatidyl choline
PEA Phosphatidyl ethanolamine
PS Phosphatidyl serine
PMT Photomultiplier tube
PNS Postnuclear supernatant
PUVA Psoralen ultraviolet A
PSI Pounds per square inch
ROS Reactive oxygen species
R hl23 Rhodamine 123
mRNA M essenger ribonucleic acid
SDS Sodium dodecyl sulphate
SIC Sample introduction channel
hSI Human sterol isomerase
ST Sulphotransferase
THF Tetrahydrofuran
TMRM Tetramethylrhodamine methylester perchlorate
TMRE Tetramethylrhodamine ethylester perchlorate
UDP Uridine diphosphate
UDPGT Uridine diphosphate glucuronyl transferase
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10. A p p e n d i x
1 INTRODUCTION
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1.1 Chromatographic analysis in biotechnology
The last half of this century has seen an exponential growth in the development of 
technology, from landing on the moon and putting robots on mars to cloning the human 
genome and nano-technology. In the area of biotechnology, a wide diversity of techniques is 
being developed to help researchers probe into ever smaller and intricate areas.
In order to make these new discoveries the instrumentation used must also advance. At 
present there exists a huge arsenal o f equipm ent for scientists to investigate new ideas. 
Instruments are applied to many applications as researchers look for better ways to 
investigate and understand the life sciences. An example is chromatography. Since its 
beginnings it has branched into many areas, including thin layer chromatography (TLC), high 
performance chromatography (HPLC), gas chromatography (GC), and capillary 
electrophoresis (CE). W ith attention now focusing on “Total Chemical Analysis Systems” -  
devices capable of performing all handling and analysis steps all in one go (van den Berg and 
Lammerick, 1998) the drive to a universal instrum ent capable of analysis seems set to unfold 
as analytical scientists search to reduce the size and complexity of current methods of 
analysis. Perhaps a single instrument with interchangeable chips/compartments for different 
applications will be the way in the future.
The work presented in this thesis examines chromatographic analysis in biotechnology -  high 
performance chromatography (HPLC) (chapter 3), and capillary electrophoresis (CE) 
(chapters 4, 5, 6  and 7). The technique o f CE has proven to be more adaptable and is 
examined in different formats. These include microchip with laser-induced fluorescence 
(LIF) detection (chapter 5) and different conventional narrow bore capillary formats, i.e. zone 
electrophoresis with on-column UV-Vis/LIF detection and zone and gel electrophoresis with 
post column LIF detection. W hile HPLC is one o f the most common chromatographic 
method of analysis in use today, it has proven not to be as flexible as CE. M icro LC in both 
open tubular and packed formats (Ishii, 1978; Hirata, 1979) showed promise, but technical 
difficulties in the design of high pressure-low volume solvent delivery systems and in the 
operational challenges in handling the severe pressure drop in packed column 
chromatography deterred commercial development. To examine if CE could be applied 
across a broad spectrum, two models were chosen, the first, analysis o f the metabolites of the 
drug coumarin, providing a look at CE in the analysis of small molecules, and the second, 
analysis of cellular organelles, which w ould present CE with the challenge of large biological
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particles. For micro CE studies it was necessary to devise a format that could be applied on- 
chip. For this reason and also due to the limitations in detection schemes available, an 
immunoassay for a member of the coumarin family, warfarin, and the insecticide, parathion 
was investigated. As the analysis of cellular organelles was a new area for CE, it was 
necessary to examine the validity of the method with the use of liposomes, membrane-bound 
vesicles, as models for organelles, and in particular for the analysis of mitochondria.
Section 1.2 investigates the coumarins and gives a brief background on the compound 
including its occurrence, clinical applications and toxicology, before examining some of the 
different methods used for its identification and analysis. W hile there are no reported 
applications of analysis of coumarins using microchip technology, section 1.3 gives an 
introduction to microchip technology and introduces some of the work already carried out. 
Section 1.4 examines cellular organelles, giving an outline of each and the various methods 
of analysis applied including gradients, flow cytometry, and free flow electrophoresis. For 
organelle analysis by CE the mitochondrion was chosen, as it has attracted a lot of attention 
for its role in a num ber of diseases (section 7.1.6) and there are no reported methods for its 
analysis using CE to date. For this reason it would also be an excellent candidate for analysis. 
In order to give a more complete analysis, a brief look at a new area of biotechnology and the 
use of CE was investigated -  proteomics - with the analysis of the mitochondrial proteome by 
CE, introduced in section 1.4.3.
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1.2 Coumarins and analysis
1.2.1 Coumarin
Coumarin, a white crystalline solid, mol. wt. 146.15, mp 68-70°C, bp 297-299°C, belongs to a 
group of compounds known as the benzopyrones, all of which contain the same backbone 
structure, consisting of a benzene ring joined to a pyrone -  a six membered heterocyclic ring 
containing one oxygen atom and five sp2-hybridised carbons. Coumarin is freely soluble in 
ethanol, chloroform, diethyl ether and oils and is slightly soluble in water.
The coumarin family is large with two main branches, the benzopyrones, containing the a- 
pyrone group, and the flavanoids, containing the y-pyrone group. Figure 1.1 shows the 
structure of coumarin, one of its primary metabolites, 7-hydroxycoumarin, and secondary 
metabolites 7-hydroxycoumarin glucuronide and 7-hydroxycoumarin sulphate along with the 
names of the catalysing enzymes for the sequence o f metabolic reactions examined in 
chapters 3 and 4.
1.2.2 Occurrence
Coumarins are found in many dicotyledonous plant families. Many monocotyledonous plants 
are also known to contain large amounts of coumarins (W einmann, 1997). The compounds 
are found in various parts of plants including the trunk, stem, foliage, flowers, fruits and 
seeds and can be isolated by extraction with suitable solvents. Coumarin is also found in 
various fruits, bilberry, cloudberry, and in green tea (Lake, 1999). The first isolation of 
coumarins was from Tonka beans in 1822, and the first published record of its synthesis was 
in 1868. The presence of coumarin in various plants seems to be linked with the ability to 
inhibit the growth and sporulation o f fungal pathogens and other ailments (Weinmann, 1997).
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F igure  1.1 Reaction scheme showing the structures o f  the parent drug coumarin, 7- 
hydroxycoumarin, 7-hydroxycoumarin glucuronide, 7-hydroxycoumarin sulphate and the 
production o f  7-hydroxycoumarin glucuronide by uridine diphosphate glucuronyl transferase 
enzymes and 7-hydroxycoumarin sulphate by sulphotransferase enzymes.
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1.2.3 Human exposure
Coumarin is listed as an “active principle” by the Council of Europe and there are maximum 
allowed concentrations for in foodstuffs, 2  mg/kg for food and non alcoholic beverages and 
10 mg/kg for alcoholic beverages (Annex II of European Directive, 88/388/EEC). Lake 
(1999) in a review, details areas where human exposure to coumarin is increased. Examples 
include exposure to coumarin from various foods and beverages, where it can be assumed 
that over a long period of time, less than 5% of solid food w ould be flavoured with cinnamon 
or other ingredients capable of imparting the 2  mg/kg maxim um concentration of coumarin. 
This would take the daily dose of coumarin to around 1.235 mg/day. Lake also lists areas of 
coumarin exposure from fragrant cosmetic products containing coumarins (shampoos, shower 
gels, antiperspirant and bath products) where the dermal absorption of coumarin in human 
subjects has been shown to be 60%. This value was obtained in a simulated study where 2 mg 
of coumarin, in 70% aqueous solution, was applied to a 100 cm skin area for 6  hours 
(Huntingdon Life Sciences, 1996).
1.2.4 Metabolism of coumarin
The work presented in this thesis is not intended to be an investigation into the metabolism of 
coumarin and while chapters 3 and 4 examine the metabolism of 7-hydroxycoumarin in the 
various tissues of New Zealand W hite rabbit, the focus is on the chromatographic methods of 
analysis used. For a more detailed review on coumarin metabolism the reader is referred to 
Pelkonen et al. (1997) and Egan et al. (1990). Coumarin and its derivatives are metabolised 
in a num ber of ways, all of which are influenced by the substrate, species, and the presence of 
other drugs (Casley-Smith and Casley-Smith, 1986). In humans the major metabolic pathway 
is via 7-hydroxylation, catalysed by the P450 enzyme CYP2A6. Bogan et al. (1996b) looked 
at the interspecies differences in coumarin metabolism, showing that human liver microsomes 
have the highest level of 7-hydroxylation, with rat, pig and dog having undetectable levels. 
The second major metabolic pathway in man is via 3-hydroxylation. Only between 1 and 6 % 
of an oral dose is excreted in this form in man, compared to 80% via 7-hydroxylation 
(Casley-Smith and Casley-Smith, 1986). Figure 1.1 shows the sequence of reactions studied 
in chapters 3 and 4 following on from 7-hydroxylation, with the formation of the glucuronide
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via the enzyme uridine diphosphate glucuronyl transferase (UDPGT) and the sulphate 
conjugate via sulphotransferase. W hile glucuronidation is known to be the m ajor pathway for 
7-hydroxycoumarin in humans (Egan et a l, 1990), sulphation is reported to occur in the 
perfused rat liver as a high affinity, low capacity pathway (Zimmerman et al., 1991).
1.2.4.1 Glucuronidation of coumarins
Glucuronidation has its primary role as a m ajor detoxification pathway for drugs in 
vertebrates and accounts for most of the detoxified material in bile and urine (Dutton, 1991). 
The process is carried out by a family of enzymes known as Uridine Diphoshate 
Glucuronyltransferases (UDPGTs) and involves the coupling of the sugar acid, D-glucuronic 
acid, to the compound in question. In the case of the studies carried out in chapters 3 and 4 
this compound is 7-hydroxycoumarin (Fig 1.1). It is well established that the liver is the 
major site for glucuronidation, and also the major source of D-glucuronic acid (Dutton, 1991). 
Studies carried out on rabbit tissues in this thesis, by both high performance liquid 
chromatography and capillary electrophoresis, also confirm this to be the case. The next 
major site was found to be the kidney. W ithin the tissues, the UDTGP enzymes are located 
primarily in the endoplasmic reticulum of both hepatic and extra-hepatic tissues (Roy 
Chowdhury et a l,  1985).
1.2.4.2 Sulphation of coumarins
Sulphate conjugation is another important step in the biotransformation of many drugs and 
other compounds. Although the process of sulphation is not as clearly understood as 
glucuronidation, it is carried out by the sulphotransferase (ST) enzymes (W einshilboum, 
1994). Like glucuronidation, sulphation increases the water solubility of most compounds 
and, therefore, their excretion, as well as causing a general decrease in biological activity. 
However, for certain compounds sulphate conjugation is required for activation o f enzymes 
(W einshilboum, 1994). For coumarin, Figure 1.1 shows the metabolic pathway with the 
substrate 7-hydroxycoumarin being sulphated at the same position as for glucuronidation. A
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CE method for analysis of the sulphation of 7-hydroxycoumarin using liver slice incubates is 
developed in chapter 4. The co-substrate for the reaction is 3’-phosphoadenosine-5’- 
phosphosulphate (PAPS) which is synthesised from inorganic sulphate and adenosine 
triphosphate (ATP). For generation of the sulphate conjugate of 7-hydroxycoumarin, 
magnesium sulphate was used as the source of inorganic sulphate. The process involves two 
enzymatic steps with sulphate adenylyltransferase catalysing the formation of adenosine-5- 
phospho sulphate (APS) from ATP and inorganic sulphate, and adenylylsulphate kinase 
catalysing the formation of PAPS from APS and a second molecule of ATP.
1.2.4.3 De-conjugation of glucuronide and sulphate conjugates
Conjugation of drugs in liver and extrahepatic tissues is a complicated process involving the 
availability of substrates (D-glucuronic acid and PAPS) (Reinke et al., 1986), the uptake of 
substances across cellular membranes and the formation and release of conjugated products 
(DeVries et al., 1986). Generated conjugates are involved in “futile cycling” via specific 
transferases and hydrolases located within the same or adjacent subcellular compartments. 
The process is termed “futile” as conjugates may undergo successive cycles of synthesis to 
the conjugate and hydrolysis back to the free metabolite. This cycling is potentially an 
important site of regulation since factors affecting the activity of a transferase or associated 
hydrolase will ultimately affect the net conjugate production and utilisation in cells 
(Kauffmann, 1994). Following conjugation by UDPGT enzymes, glucuronides are 
hydrolysed by an enzyme known as p-glucuronidase (EC 3.2.1.21, (3-D-glucuronide 
glucuronohydrolase). The enzyme is a glycoprotein, consisting of several complexes, M i to 
M 4  (Dutton, 1991). Glucuronidase is an unusual enzyme in that 30 -  50% of total liver 
enzyme is actually located in the microsomal fraction (Brown et a l,  1987). Studies have 
reported the liver and kidney to have relatively high concentrations of ER glucuronidase 
(Lusis and Paigen, 1977), while no glucuronidase complex has been detected in spleen, brain, 
heart or fat (Swank et al., 1994). Chapter 4 examines various rabbit tissues for P- 
glucuronidase activity towards 7-hydroxycoumarin-glucuronide.
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1.2.5 Clinical applications of coumarins
The introduction of coumarin for clinical use required testing of its biopharmaceutical 
properties. Pharmacokinetic data in humans indicates a wide-spread distribution within the 
body (Ritschel, 1981). Intestinal and renal adsorption are not influenced by varying 
gastrointestinal or urinary pH because coumarin is non-charged and 7-hydroxycoumarin has a 
pKa of 7.77. The extent of protein binding is well below the critical value of >80% (being 
35% and 47% for coumarin and 7-hydroxycoumarin, respectively). In animal and human 
organisms, central effects, for example, sedative, hypnotic and antipyretic have been shown 
(Kitagawa, 1963). The various effects of coumarin and derivatives have been well 
documented over the past few years, and a detailed list of the range o f physiological effects, 
both in plants and animals can be found in a num ber of areas (Saoine, 1964; Nakajima and 
Kawazu, 1980; Egan et al., 1990).
The interest in coumarin as an investigator drug is still valid, though the parent drug has 
being submitted to a thorough derivatisation and screening o f the derivatives between 1950 
and 1970. Except for the group o f anticoagulants derived from 4-hydroxycoumarin, other 
coumarin derivatives such as the antibiotic novobiocin (complex coumarin from two 
Streptomyces species) or hymecromen, a spasmolytic agent for bilious affections and 
complaints, did not attain clinical use or a true medical importance. The furanocoumarins are 
playing a role in the treatment or psoriasis and other dermatological diseases (PUVA -  
psoralen ultraviolet A range therapy).
Coumarin and 7-hydroxycoumarin have been patented in Australia (Casely-Smith and 
Casely-Smith, 1986). Patents cover applications related to the resolution of high-protein 
oedemas. Promising findings in m ore than 700 patients suffering from  renal cell carcinoma 
have been available for at least eight years. Cancers of the prostate were treated after primary 
therapy by tumour resection and/or nephrectomy with varying doses of coumarin or 7- 
hydroxycoumarin (sustained release tablets) over different periods of time or until regression 
of the disease (Weinmann, 1997). Y am ada et al. (1999) reported on the inhibition of matrix 
metalloproteinases (MMP) in cartilage explants by esculetin (6,7-dihydroxycoumarin). 
Studies were carried out on rabbit articular cartilage explants. Also investigated were the 
effects of oral administration of its prodrug, CPA-926, which was reported to reduce the 
effects of induced osteoarthritis (OA) at doses of 200 mg/kg and 400 mg/kg. The report
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concluded that esculetin inhibits matrix degradation in rabbit jo in t cartilage explants through 
suppression of M M P systhesis, secretion or activity, and that prophylactic administration of 
its prodrug, CPA-926, appears to provide some protection against cartilage destruction in a 
short term rabbit experimental OA model.
1.2.6 Toxicology
Coumarin exhibits a very species-dependent metabolism (Ritschel, 1981) and, therefore, the 
procedure of extrapolation from animal studies to the human situation requires great care. A 
number of studies have examined the acute, chronic and carcinogenic effects of coumarin in 
the rat and mouse. These studies, carried out at the maxim ally tolerated doses, revealed that a 
threshold does exist for coumarin toxicity, and below these levels, such effects are not 
observed. In the case of various rat strains the acute oral LD 50 was reported to range from 
290mg to 680mg/kg (Egan et a l,  1990). Effects observed in the rat include increase in 
relative liver weight, and changes in various hepatic biochemical parameters, and reduction 
of microsomal glucose-6 -phosphate activity, depending on the dose. Observations made on 
liver sections of coumarin-treated rats dependent on dose magnitude and duration of 
treatment, include necrosis, apoptosis, vaccuolation, and fatty acid and bile duct hyperplasia 
(Lake, 1999). In plant cells, coumarin can cause chromosome and DNA breakage (Grigg, 
1977). It also exhibits antimutagenic effects against genotoxicity generated by 4-nitro- 
quinoline-1-oxide or UV radiation in E. coli (Ohta et a l,  1983).
Due to differences in metabolism between the species, some alternative methods have been 
tried to extrapolate from animal to human. These include the use of liver preparations 
(cryopreserved hepatocytes, liver microsomes of precision cut liver slices), liver, lung and 
kidney slices (De Kanter et a l, 1999) and have shown promising results. Specimens of 
human liver have been tested and compared with preparations from monkey, rat, mouse, 
hamster, guinea pig and other mammals. However, the great differences in the patterns of 
coumarin metabolites in humans and animals clearly indicate the polymorphism of the 
metabolising enzymes activity (Pearce et a l,  1992).
Page 10 of 243
1.2.7 Coumarin analysis
Since its first isolation in 1822, coumarin and its many derivatives have been the subject of 
many rigorous tests and analysis. To date, many methods of analysis have been developed. High 
performance liquid chromatography has seen many applications in both identification and 
studies of metabolism and gas chromatography coupled to mass spectrometry has been used to 
identify coumarin structures following separation. More traditional methods like thin layer 
chromatography have also been used as quantitative methods in coumarin analysis. For a 
detailed review on the analysis of coumarins the reader is referred to Bogan et al. (1997). The 
following section reviews some of these methods, concentrating mostly on chromatographic 
methods, and the results, following analysis.
1.2.7.1 Thin layer chromatography
Separation and identification o f  coum arins: A thin layer chromatographic method
was developed to determine the authenticity of natural vanilla extracts (Poole et al., 1993). 
The method looked for the presence of compounds used in the production of counterfeit 
vanilla products. These compounds include coumarin, piperonal and ethyl vanillin. 
Separations were carried out on Whatman HP-K high performance silica gel plates. The 
solvents found to be most suitable for the separation were chloroform - ethyl acetate -  
propan-l-ol, 92 + 2 + 2 v/v). The presence of coumarin was confirmed by a second solvent 
system consisting o f a l x l 0  + l x l 2  minute development with hexane-methyl f-butyl ether 
(4 + 1 v/v) on the silica gel plates. Selective visualisation was achieved by 
postchromatographic application of 2,4-dinitrophenylhydrazine reagent. The plate was dipped 
into this solution for about 5 seconds and allowed to drain on a paper towel. The reaction was 
virtually instantaneous and the plate was scanned a few minutes after application of the 
reagent. Harmala et al. (1992) examined the retention behaviour of fourteen closely related 
coumarins in normal phase thin layer chromatography and high performance liquid 
chromatography. TLC separations were carried out on alufoil, silica gel 60 F 254 TLC plates 
(average particle size - 10 (im). Ethyl acetate (St (solvent strength) = 4.4), chloroform (St  = 4.1), 
and tetrahydrofuran (ST = 4.0) in hexane (ST = 0) gave the best separation of the fourteen
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coumarin compounds. The migration distances and solvent fronts were measured with a 
densitometer at 320 nm. The report concluded that a change in solvent strength caused a 
different response in TLC than in HPLC, although it is possible to evaluate the effect on 
HPLC of solvent change from TLC runs. Overall the selectivity in HPLC can be described by 
experiments in TLC, however, when transferring the mobile phase, the fact that the elution 
process is different in TLC and HPLC must be taken into account.
Metabolic studies: Cholerton et al. (1992) com pared the use of a thin layer
chromatographic fluorescence detection method to a spectrofluormetric method for the 
determination of 7-hydroxycoumarin in human urine. Precoated high performance glass 
backed silica TLC plates were used. Chromatography was carried out in a Camag horizontal 
developing chamber in the saturation configuration using the lower phase of chloroform -  
water - ethyl acetate - acetic acid as mobile phase. Detection and quantitation of 7- 
hydroxycoumarin was carried out using a Camag TLC scanner II connected to a Camag 
SP4290 TLC integrator. The lanes were scanned at a wavelength of 313 nm using the 
mercury lamp in the reflection mode. For analysis of conjugated 7-hydroxycoumarin, 
samples were treated with ^-glucuronidase (4000 units) for 16 hours at 37°C. The lim it of 
quantitation was 1 ng/ml, with a linear calibration curve up to 4 (ig/ml. Indahl and Scheline 
(1971) reported the use o f TLC for analysis of the m etabolism of umbelliferone and hemiaren 
in rats and in the rat intestine microflora after oral and intraperitoneal administration. 
Separation was performed on thin layer cellulose plates, with observation under UV light at 
254 nm and by spraying with fast blue B salt. The mobile phase used was benzene - glacial 
acetic acid -  water (6:7:3 v/v) and potassium chloride -  glacial acetic acid (100:1 v/v).
1.2.7.2 High performance liquid chromatography
Separation and identification o f  coum arins: High performance liquid chromatography
was used to identify coumarin as an adulterant in vanilla-based liquid flavourings of M exican 
origin (Thompson, 1988). In total 40 samples representing fourteen different brands were 
assayed for coumarin, vanillin, and ethyl vanillin. Separation was carried out on a 30 cm x
3.9 mm ID (iBondapak Q g  column with a 40:60 methanol water mobile phase (flow rate
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lm l/m in) with detection at 275 nm. Coumarin was reported to be present in 27 (67.5%) of the 
products examined, with a concentration range of 0.2 -  2.56 mg/ml, with a mean of 1.17 
mg/ml. Vanillin was present in 38 (95%) and ethyl vanillin was present in 11 (27.5%) of the 
products. Gamache et al. (1993) reported on the analysis o f phenolic and flavanoid 
compounds in juice beverages using HPLC with coulometric array detection. In total 27 
components were separated in a 16 channel chromatogram including 4-hydroxycoumarin, 7- 
hydroxycoumarin, coumaric acid, and 7-methoxycoumarin (analysis time 45 minutes). The 
method was demonstrated to be applicable to the analysis of orange, apple and grapefruit 
juices.
Metabolic studies: An automated high performance liquid chromatographic assay using
fluorescent detection for the determination of 7-ethoxycoumarin and umbelliferone from 
microsomal incubations was reported by Evans (1992). Following a 30 minute incubation, 7- 
ethoxycoumarin, 4-methylumbelliferone (internal standard) and the metabolite umbelliferone 
were extracted by chloroform and separated using an isocratic mobile phase (methanol : 
0.05M acetate buffer, pH 4.7, 55:45 v/v). Separation was carried out on a (xBondapak phenyl 
(300 mm x  3.9 mm ID) analytical column. The eluent was monitored with an excitation 
wavelength of 360 nm and an emission wavelength of 470 nm. A detection limit of 
0.07(ig/ml was reported, with the extraction recovery of umbelliferone ranging from 91% to 
98% over the concentrations in the standard curve.
Egan (1992) demonstrated the use of HPLC for the determination of coumarin, 7- 
hydroxycoumarin and its glucuronide conjugate in urine and plasma. Samples were extracted 
using 3 ml of diethyl ether following mixing for 3 min. The mixture was centrifuged for 10 
minutes at 600g before removal o f the organic layer, evaporation to dryness and 
reconstitution in 200|jl of methanol. Conjugated 7-hydroxycoumarin was determined after 
treatment of 1 ml of the sample with 1 m l of (3-glucuronidase at a concentration of 5000 
units/ml, incubation for 30 minutes and extracted as before. Lamiable et al. (1993) used 
HPLC for the determination o f coumarin in plasma at low concentrations. The method 
involved a single step extraction o f the alkalinised sample with hexane and subsequent 
evaporation of the organic phase in the presence of hydrochloric acid to collect and 
concentrate the coumarin. Analysis was performed on a Cg column with detection by UV 
absorbance at 275 nm. The assay was used to study the evolutions of concentrations of
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coumarins in one volunteer after oral administration of a single 10 mg dose. Results showed 
the maximum concentration to be found with 5 minutes after a single oral administration, 
reaching 5.81 mg/ml, falling beneath the limit o f detection after 240 minutes.
Runkel et al. (1996) describe the combined use of HPLC and TLC for the examination of the 
metabolic and analytical interactions of grapefruit juice and coumarin in man. The study 
investigated the influence of the juice on the fate of coumarin m etabolised by CYP2A6 in 
man. Analysis was carried out on samples collected up to 24 hours after dosing. After in vitro 
hydrolysis samples were analysed fluorimetrically for 7-hydroxycoumarin. HPLC and TLC 
identified the fluorescent metabolites from the juice. The study concluded if coumarin is 
administered in water its excretion is completed after 6  hours and 70% of the dose is 
recovered, while up to a litre of juice is required to enhance the delay of metabolism and 
bring coumarin recovery up to nearly 1 0 0 %.
Genetic variation among mice in the metabolism of coumarin was reported recently by Lovell 
et al. (1999). In all strains the major metabolic pathway was the 3,4-epoxidation with o- 
hydroxyphenylacetaldehyde as the major metabolite. M ajor variations were discovered in 
female mice in relation to coumarin 7-hydroxylase activity ranging from  high to very low 
levels metabolised. The difference between the strains in the male mice was much less 
pronounced. Analysis by HPLC also revealed evidence for strain variation in the metabolism 
of a number of other coumarin metabolites. A significant discovery was made regarding the 
DBA/2 mouse, which has been suggested as a model for coumarin metabolism for humans in 
that the profile of 7-hydroxylation differed considerably from humans as well as other 
species.
Killard et al. (1996) looked at the glucuronidation of 7-hydroxycoumarin in bovine liver 
homogenate using HPLC. The method separated coumarin, 7-hydroxycoumarin, 7- 
hydroxycoumarin-glucuronide and an internal standard, 4-hydroxycoumarin. Samples were 
separated by reverse-phase HPLC on a C ] 8 column with detection at 320 nm. The limit of 
detection was 1.47fiM for the glucuronide with a linear range from 0 -  295.7p,M. Several 
researchers have investigated coumarin metabolism using liver slices. H iller and Cole (1995) 
and Walsh et al. (1995) both examined 7-ethoxycoumarin metabolism in liver slice incubates. 
The method of W alsh et al. looked at the m etabolism  in both rat and human liver slices. 
Separation was carried out on a Cg Hypersil BDS column using ion pairing conditions for 
separation of 7-ethoxycoumarin, 7-hydroxycoumarin and the glucuronide and sulphate 
conjugates. H iller and Cole improved upon the analysis time for this method, using short
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column gradient elution with a total assay run time of 1 0  minutes using liver slices from 
mice. A 33 mm x  4.6 mm ID, 3 pm particle size LC - 8  column was used with a flow rate of 
1.5ml/min. Solvent A was composed of 90% acetic acid (0.25%), 50% acetonitrile and 
0.17% tetrabutyl ammonium phosphate (w/v), solvent B composed of 50% acetic acid 
(0.25%), 50% acetonitrile and 0.17% tetrabutyl ammonium phosphate (w/v), detection with a 
variable wavelength absorbance detector. A recent method for looking at coumarin 7- 
hydroxylation and 7-ethoxycoumarin o-deethylation by human liver cytochrome P450 
enzymes claims 1 0 0 -fold improvement in sensitivity over previous spectrofluormetric 
methods in detecting the metabolite, 7-hydroxycoumarin (Yamazaki et a l,  1999). Using 36 
different concentrations of coumarin between 0.17 pM  and 100 pM, 7-hydroxylation was 
monitored via the single enzyme CYP2A6 (Km: 0.4pM , Vmax: 0.56 nmol/min/mg/protein). 7- 
Ethoxycoumarin oxidation was monitored using 100 different substrate concentrations 
between 7.5 pM  and 1 mM  by several enzymes, CYP2E1, CYP3A4, CYP2B6 and CYP1A2. 
Of the enzymes monitored, CYP2E1 demonstrated the highest activity with a Km value of 
109 pM , and a Vraax value of 1.8 nmol/min/nmol P450). Incubation mixtures consisted of 
human liver microsomes (0.025 mg protein/ml) or recombinant P450 (10 pmol/ml) with 
several concentrations of coumarin or 7-ethoxycoumarin in a final volume of 0.20 ml of 100 
mM potassium phosphate buffer, pH 7.4, containing a NADPH generating system. 
Incubations were carried out at 37°C for 10 min and terminated by adding 10 pi of 60% 
HCIO4 . (w/v) for the HPLC method, or 10 pi of CI3CCO 2H (w/v) for the spectrofluorimetric 
method. M obile phase for the HPLC separation consisted of 45% CH 3CN (v/v) containing 20 
mM NaC 1 0 4 , pH 2.5, at a flow rate of 1.2 ml/min with separation carried out on a Cig 5 pm 
analytical column (Mightsil RP-18, 150 x  4.6 mm ID, Kanto, Tokyo, Japan). Fluorimetric 
detection for the HPLC method was done at an excitation wavelength of 338 nm and an 
emission wavelength of 458 nm. For the spectrofluorimetric assay, formation of 7- 
hydroxycoumarin was determined at similar ex/em wavelengths with a Shimadzu RF-5000 
spectrofluorimeter (Shimadzu, Koyoto).
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1.2.7.3 Gas chromatography
Separation and  identification o f  coum arins: A method involving solvent extraction
and gas chromatography coupled to mass spectrometry was reported by W einberg et al. 
(1993) for the identification and quantification of coumarin, phthalide, and Sequiterpene 
Compliance markers in an umbelliferous vegetable mix. Analysis was carried out on a 25 m, 
0.32 mm ID HP-5 gas chromatographic capillary column coated with a 0.52 |im  bonded- 
phase film of methyl silicone with helium as the carrier gas. Column temperature was 
maintained at 45°C for 3 min and then heated to 300°C at 8 °C/min. The mass spectrometer 
transfer line was operated at 300°C, the ion source at 260°C and the electron voltage was 
70eV. The magnet was scanned from mass 300 to 350 at 1 s/decade, with a rest time of 0.5 s. 
Nominal resolution was 1000. Large quantities of carrot and celery juice were extracted with 
methylene chloride. Among the many components identified were umbelliferone and 
psoralen, although at extremely low concentrations, so low that no further attempt was made 
to quantify them. Hawthorn et al. (1988) demonstrated the use of GC with flame ionisation 
detection and GC-MS for analysis of spices for the presence of flavour and fragrance 
compounds. Analysis was carried out on capillary fused silica DB-5 columns. For GC-FTD, 
the earner gas was hydrogen, and for GC-M S, helium gas with electron impact ionisation 
(70eV) detection was used. Supercritical fluid extractions were preformed by using an SFT 
Model 250-TMP supercritical fluid pumping system. O f the spices examined, cinnamon was 
the only one with coumarin shown to be present, although coumarin spiked into Rosemary at 
a concentration of 1.14 mg/g showed an average percentage recovery of 105% with a RSD of 
1 2 % for the method.
M etabolic studies: Determination of 2-hydroxyphenylacetic acid (2HPAA) in urine
after oral and parentemal administration of coumarin by gas-liquid chromatography with 
flame ionisation detection was reported by M eineke et al. (1998). Prior to analysis the 
samples were extracted into ethyl ether and the analytes were derivatized with 
trimethylphenylammonium hydroxide. 3-Hydroxyphenyl acetic acid was used as an internal 
standard to establish a calibration range from 0.3 to 150 |Xg/ml. It was concluded from the 
study that, on average, less than 1 0 % of the coumarin administered was excreted in the form 
of 2HPAA. Jirovetz et al. (1992) analysed blood samples of mice following inhalation of
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coumarin (3.0 g) placed in the mice cage. The air concentration o f the coumarin was 
measured to be in the range of 50 -  108 m g/m 3, (8.4 1 cage). For GC-FED a 25 m HP-5 fused 
silica column, 0.32 mm ID, film thickness 0.17 pm  with hydrogen carrier gas. For GC-MS 
and GC-FITR helium carrier gas was used with the same conditions. For GC-MS the 
interface heating was 280°C. Following identification of coumarin in the blood serum of 
mice, quantification was carried out using tiglinic acid benzyl ester as an internal standard. 
Coumarin concentration in the blood serum  was measured at a concentration of 7.7 ng/ml.
1.2.7.4 Voltametric and polarographic methods
Separation and  identification o f  coum arins: Carrazon et al. (1989) reported the use of
voltammetric techniques for the determination of coumarins in m icellar and emulsified 
media. The apparatus consisted of an electrochemical cell comprising a M etrohm  6.1204.000 
glassy carbon rotating disc electrode, an Ingold 10-303-3000 saturated calomel reference 
electrode and a platinum wire counter electrode in a double wall M etrohm  EA867-20 vessel. 
Differential pulse voltammetry at the stationary electrode gave a lim it of determination for 
umbelliferone at 2.9x 10 6 mol I '1, and a lim it of detection of 8.7 x  10 ' 7 mol I ' 1 for the 
micellar solution with similar results for the emulsified media (%RSD = 3.5). Linear sweep 
voltammetry with the stationary electrode gave a limit of determination o f 1 . 8  x  1 0 ‘5 mol I ’1, 
and a limit o f detection of 4.9 x  10 6 mol I ' 1 (%RSD = 3.0). Orlov (1988) demonstrated the 
use of polarography for the determination o f coumarin percentage in yellow and white sweet 
clovers. Measurements were carried out on an LP-7 polarograph with dropping mercury 
electrode. Using this procedure, 0.54% of coumarin was found in the herbage of yellow sweet 
clover (five samples) and 0.34% in that o f white sweet clover (five samples).
M etabolic studies: Dem psey et al. (1993) reported on the use of differential pulse
voltammetry for the determination o f 7-hydroxycoumarin in urine. A  conventional three 
electrode system was used (platinum gauze as counter, glassy carbon as working and 
saturated calomel as reference. Analysis o f urine samples from a human volunteer before and 
after drug administration (100 mg) was carried out. The concentration of free 7-HC excreted 
was determined at regular time intervals (0 -  24 hr). The free 7-HC excreted over the period
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studied was found to be 5.07 mM. The amount of 7-HC conjugated was determined after 
treatment with (3-glucuronidase (10,000 units/ml). Total 7-HC was calculated as 5.67 mM, 
0.6 mM conjugated 7-HC.
1.2.7.5 Capillary electrophoresis
Several researchers (Bogan et al., 1995a; Bogan et al., 1996; Cole et al., 1996) have applied 
this tool to the separation of coumarin metabolites in a variety of matrices for in vitro and in vivo 
studies. The number of applications has increased sharply, most notably in the last four years.
M e t a b o l i c  s t u d i e s :  Bogan et al. (1995a) reported on the analysis o f 7-hydroxycoumarin
and coumarin in urine and serum. Samples were prepared by extraction o f the analyte into 
diethyl ether, and reconstitution into electrolyte buffer, 25 mM  phosphate, pH 7.5. Separation 
was performed on untreated fused silica capillaries with detection at 210 nm. The method had 
a linear range between 0 and 50 pg/ml with a lim it of detection of 1 |J.g/ml. Separation and 
detection of 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide in urine was 
demonstrated by Bogan et al. (1996a). The separation was carried out on an untreated silica 
capillary with a phosphate buffer / deoxycholic acid / acetonitrile electrolyte solution with 
detection was at 320 nm. While 214 is a more sensitive wavelength, absorbance from species 
present in the matrix prevents the use of this wavelength for detection. At 320 nm  it was 
possible to analyse for 7-HC and 7-HCG without absorbance from interfering species. The 
linear range o f the assay is 0-100 pg/ml, with a lim it of detection of 2 |ig/m l. (%RSD from 1 
-  10%). Separation of 7-HC and 7-HCG is achieved in under 7.5 min. This method 
represented a major improvement over previous methods for analysis of free and conjugated 
7-HC as the glucuronide can be measured directly with minimal sample clean up and hence 
no need for deconjugation, extraction, and evaporation steps. Bogan et al. (1996b) and Deasy 
et al. (1995) reported on the applications of capillary electrophoresis to the in vitro study of 
coumarin and 7-hydroxycoumarin metabolism. Liver microsomal preparations from a 
variety of sources (human, rabbit, bovine, porcine and murine) containing cytochrome 
P4502A6 were prepared. A reaction mixture consisting of coumarin, the microsomal 
preparation and an NADPH regeneration system in phosphate buffer was prepared and 
sampled periodically. The production of 7-hydroxycoumarin was monitored over time. The
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methods reported on the cytochrome P4502A6 activity in the different species (Bogan et a l, 
1996) and the method of Deasy et al. (1995) assessed interindividual differences within a 
species. The limit of detection was 1 (ig/ml. with a linear detection range 0 - 5 0  pg/ml. The 
study demonstrated highest 7-hydroxycoumarin production in human liver microsomal 
preparations with no detectable levels of 7-hydroxycoumarin produced in rat, pig, or dog.
Bogan et al. (1995) reported on the use of CE to m onitor the in vitro production of 7- 
hydroxycoumarin glucuronide from a crude preparation of bovine liver uridine diphosphate 
(UDP) glucuronyl transferase. Separation was carried out using a phosphate 
buffer:deoxycholic acid:acetonitrile electrolyte solution on an untreated fused silica capillary. 
The reaction was incubated at 37 °C and samples were rem oved periodically and analysed 
directly with no sample preparation. The rate o f reaction reported for the bovine liver for the 
first 70 min was 3.1 ± 0.13 nmol of 7-hydroxycoumarin glucuronide produced per minute per 
mg of protein. Cole et al. (1996) while evaluating extended light paths in capillaries for use in 
CE with laser induced fluorescent detection, looked at the detection of 7-ethoxycoumarin (7- 
EC) and its metabolites in liver slice incubates. Samples were incubated 4-6 hr with 7-EC 
prior to reaction termination and analysis. Excitation was 325 nm and emission at 540 nm. 
W hile the use of extended light paths for the capillaries showed a marked improvement in 
detection limits over conventional capillaries (ca. five-fold), only the parent compound, 7- 
EC, and 7-hydroxycoumarin were detected. The glucuronide and sulphate conjugates, due to 
their significantly different ex/em wavelengths could not be detected.
M ethod/ A pplication Detection LO D Reference
T L C  -  Vanilla extract analysis UV Absorbance 500ng Poole et al. (1993)
T LC  -  Analysis of urine Fluorescence 1 ng/ml Cholerton et al. (1992)
H PL C  -  Coumarin metabolism UV Absorbance Thompson et al. (1988)
H PLC  -  7-HC detection UV Absorbance 500 ng/ml Egan et al. (1992)
G C -  Coumarin identification Mass spec. Weinberg et al. (1993)
CE -  Coumarin metabolism UV Absorbance 1  p,g/ml Bogan etal. (1996a)
T able 1.1 Limits o f  detection and detection modes fo r  some methods o f  analysis fo r
coumarins
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1.3 Chip-Based microcolumn separation systems
The use of modem micromechanical fabrication technology for analytical chemical 
applications has created a rapidly advancing interdisciplinary field of research (Effenhauser, 
1998). For some time researchers have looked for ways to miniaturise analysis systems. This 
knowledge has lead to the development of small diameter packing materials and open-tubular 
microcolumn separation techniques such as microbore HPLC (Knox, 1980) and capillary 
electrophoresis (Jorgenson et al., 1981). Regarding CE, column diameters ranging from 10 -  
1 0 0  pm internal diameter provided a feature that was easily accessible by micromachining 
technology. In addition to just small bore separation channels, microfabrication technology 
offers features such as networks of channels, flow restrictors, reagent compartments, etc. of 
virtually any shape. Most importantly, this can be done without introducing significant dead 
volume into the system, which w ould be detrimental to the precise handling of pico- and 
nano-litre sample volumes. There are many incentives of chip-based integrated chemical 
separation of which the following are perhaps uppermost:
>  Reduced consumption of sample reagents and mobile phase.
>  Improved analytical performance in terms of resolution power per time unit.
>  Multifunctional, interconnected channel networks with negligible dead volumes.
>  Suitability for inexpensive mass fabrication.
W hile all of these are advantages, the benefit of a reduction in the consumption of sample, 
reagents, and mobile phase can present problems regarding detection, hence the use of
extremely sensitive laser-induced fluorescence (LIF) as the choice mode of detection for most
chip based systems to date. Although microfabrication has its basis in microelectronics and 
most research in microfabrication has being focused on microelectronic devices (Moreau, 
1988), applications in other areas is rapidly appearing. These include systems for 
microanalysis (Jacobson, 1994; Bratten, 1997), micro volume reactors (Sond, 1994), 
combinatorial synthesis (Briceno, 1995), and now in the area of separation and analysis of 
chemical and biological substances (Jacobson, 1994a; Chiem and Harrison, 1997). The past 
few years have seen the development of miniaturised total chemical analysis systems (p-
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TAS) capable of performing all sampling steps in an integrated fashion (van der Bery, 1995). 
Systems for free flow electrophoresis (Raymond, 1994), gas chromatography (Terry, 1979), 
capillary electrochromatography (Jacobson, 1994b), and m icellar electrokinetic capillary 
chromatography (MECC) (Heeren, 1996), have been developed. Rapid and efficient capillary 
zone electrophoresis electrophoretic separations in micromachined channels (open, gel filled 
or polyacrylamide coated) on quartz substrates have also being demonstrated (Effenhauser 
1993; Jacobson, 1994; Effenhauser, 1994). Devices for performing not only analysis, but also 
chemical synthesis are also being developed. An array of chemical tools on a chip makes it 
possible to synthesise, analyse and characterise extremely small amounts of product. 
Examples include DNA chips for high speed DNA sequencing (Goffeau, 1997) and 
microchips for carrying out the polymerase chain reaction (PCR), (Fodor, 1991).
1.3.1 Immunoassays on-chip
Applications of microchip CE to immunoassays as investigated in chapter 5 for warfarin and 
parathion have also been reported. Koutny et al. (1996) performed the first microchip 
electrophoretic immunoassay in serum by adapting to chip format a cortisol assay performed 
earlier using conventional CE. A calibration curve for cortisol in serum over the range of 
clinical importance was established with the device, the peak area of free labelled cortisol 
was measured. Two different assays perform ed on-chip were reported by Chiem and Harrison 
(1997). The injection volume was 100 pi and the channels were uncoated. Injector to detector 
distance was 5 cm. The assays were for BSA, in direct format, and the drug theophylline, in 
competitive format. For theophylline the reported separation time was -4 0  seconds, and a 
calibration curve covering the clinically relevant range of 1 0 - 2 0  pg/dl for serum samples 
was shown.
1.4 Organelles and Chromatographic analysis
There is very little reported on the analysis of cell organelles using chromatographic 
techniques, although a recent publication of the Journal of Chromatography (Vol. 722, 
February, 1999) devoted the entire journal to articles on the analysis of cells, functional
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aggregates and their components. This is an indication that the use of chromatographic 
methods for analysis of small particles is becoming more popular in an effort to understand 
more about cells and their organelles. W hile none of the articles reported on the analysis of 
the organelle analysed in chapter 7 (mitochondria), a review on the analysis of subcellular 
particles reported on the current developments on liposome analysis. The results, however, 
showed exactly the same format as the few earlier publications (see chapter 6 ) for liposome 
analysis by CE and are very far from the quality and precision discovered for the first time in 
this thesis and reported in chapter 6 . As the work in chapters 6  and 7 is intended to lead to 
methods capable of analysing all organelles by CE, a general review of organelles is given in 
this section, before examining the various methods currently used for their analysis.
1.4.1 Analysis of cell organelles
The majority of work on the analysis of cellular organelles, has focused on populations of 
organelles, either inside cells or isolated, with few cases looking at the single organelle level 
(Cossarizza, 1996). Classical methods of analysis have revolved around subcellular 
fractionation using gradients for separation following homogenisation. Perhaps the biggest 
stumbling block in the analysis of subcellular particles has been the homogenisation step. The 
production of an “ideal homogenate” (release of functional, intact organelles as a free 
suspension) is difficult to obtain. Problems involve the formation of cytoplasmic aggregates 
which can clump organelles together and precipitate, and damage to organelles during 
homogenisation. As the cytoplasmic and cytoskeletal organisation o f different tissue culture 
cells differ enormously, a homogenisation procedure for every case must be developed 
separately, with monitoring by morphological means (phase contrast microscopy). The 
following five sections (1.4.2.1 -1 .4 .2 .5) examine methods used for analysis of subcellular 
components, giving examples o f the various applications.
1.4.1.1 Gradients
To date, centrifugation has proven to be the m ost effective method of organelle isolation and 
purification. Isolation of subcellular particles by density gradient methods is achieved by the
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different positions taken up by particles following centrifugation. The position of the particle 
is determined mainly by their lipid to protein ratios. The higher the protein content of the 
membrane, the higher the density. The content of the vesicles will also influence the density, 
as will the presence of attached components, for example ribosom e’s on the surface of rough 
endoplasmic membranes. One o f the other factors responsible for separation is the choice of 
separation medium. Sucrose is most commonly used along with M etrizamide, Percoll, Ficoll 
or Nycodenz (Pasquali et al., 1999). The use of discontinuous gradients has also been applied 
successfully for separation of various organelles. M adden and Storrie (1987) used 
discontinuous gradient ultracentrifugation for isolation o f mitochondria from Chinese 
ham ster cells. The gradient used 6 % (v/v) Percoll overlaid on 17% (w/v) Metrizamide in turn 
overlaid on 35% (w/v) M etrizamide (all in 250mM sucrose), and centrifuged for 15 minutes 
at 50,000g. M itochondria were localised at the Percoll/M etrizamide interface and at the 
17/35% (w/v) Metrizamide interface, with the 17/35% (w/v) providing the most pure fraction. 
Separation by gradients can be achieved by two different centrifugation methods. The first 
method uses velocity, in which particles move in the direction of the centrifugal force, and 
separate based on size and density, this method is time-dependant, as eventually everything 
will pellet, or by equilibrium, in which particles move to a position in the gradient which 
matches their density. W alm sley et al. (1999) used a combination of cross linking and 
sucrose gradient analysis to examine intracellular retention of proteins within the 
endoplasmic reticulum (ER). The ability of the ER to retain unassembled or malfolded 
proteins was investigated using procollagen as a model. The accumulation of these partially 
folded intermediates occurs during vitamin C deficiency due to incomplete proline 
hydroxylation, as vitamin C is an essential co-factor o f the enzyme prolyl 4-hydroxylase. It 
was demonstrated that the retention is tightly regulated with little or no secretion from the ER 
under conditions preventing proline hydroxylation.
1.4.1.2 Immunoisolation
Im munoisolation techniques differ from those of gradients in that they exploit biological 
properties of organelles rather than physical aspects. The high specificity of antibodies is 
utilised to locate organelles containing the antigen of interest. This method is more 
complicated and requires more time and skill than gradient analysis. A prerequisite for
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immunoisolation is the identification of a suitable antigen on the organelle and the generation 
of a high affinity antibody to this antigen. Often this technique will be preceded by a gradient 
step to provide a more pure homogenate. Solid supports such as cellulose fibres, 
monodisperse magnetic beads and Eupergit particles have been used to immobilise the 
antibody (Pasquali et a l,  1999). Salamero et a l  (1990) used magnetic beads with an 
immobilised antibody against the cytoplasmic domain of the polymeric IgA receptor to 
isolate golgi fractions. The method was used to generate a cell-free assay that reproduced 
vesicular budding during exit from the golgi complex by incubation of the stacked golgi 
fraction under conditions to sustain vesicular transport. From  the total population of budded 
vesicles those destined to the basolateral plasm a membrane were immunoisolated and 
characterised.
1.4.1.3 Free flow electrophoresis
The technique of free flow electrophoresis (FFE) separates subcellular particles based on 
their unique charge properties. Again the method relies on the production of a homogenate of 
organelles, which are loaded onto a liquid buffer that flows between two electrodes. The 
electrophoretic mobility is independent on the size and shape of the particles. In fact, the 
particles with the greatest mobility were found to be those with the ability to acidify their 
interiors, (Pasquali et al., 1999), such as lysosomes and trans-golgi network vesicles, thus 
generating a membrane potential with negative charge outside. W hile the normal conditions 
of FFE works best for these organelles with the main peak of a free flow electropherogram 
composed mostly of lysosomes and endocytotic vesicles, there is also cross contamination 
from smooth and rough endoplasmic reticulum, and light mitochondria. Among the 
advantages of FFE are the speed o f purification and the amount of sample that can be 
processed. However, it is unlikely that FFE will ever be a one step separation procedure, but 
used in conjunction with other steps can yield good results.
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1.4.1.4 Flow cytometry and organelle analysis
Perhaps by far the majority of work on organelle analysis was performed by flow cytometry. 
Flow cytometry can be used as an analytical tool as well as for sorting cells and other smaller 
particles. One example is a fluorescence activated cell sorter (FACS), consisting of two main 
parts, the sample flow and data analysis system, which are connected by optical devices. A 
continuously flowing buffer stream carried the particles from a sample tube through a light 
beam at a measuring point. Light signals from an individual particle are obtained by an array 
of light detectors. Particle size is measured by forward scatter of light, and light deflected 
sideways (90°) relative to the incident laser light (side scatter) is proportional to the quantity 
of granular structure in the particle. The particles can also generate light at different 
wavelengths as a result of fluorescence from specifically bound probes. In an ideal situation, 
the amount of fluorescence is proportional to the num ber of dye molecules. The most 
commonly used system for sorting of fluorescent particles is the ‘stream in a ir’ system, in 
which the particles, embedded in a stream of flow buffer, exit from a nozzle tip after which 
the stream is broken up into defined droplets containing single particles by mechanical 
vibration of the nozzle. Droplets containing particles to be purified (depending on their size 
and/or fluorescence intensity) are charged, separated from  other droplets during passage 
through a strong electric field and collected in separate tubes.
The technique of flow cytometry has been used extensively for the analysis of many 
organelles. Cossarizza (1996) examined the heterogeneity among individual mitochondria 
membrane potentials isolated from rat liver with the fluorescent probe 5,5',6,6'-tetrachloro- 
1,1',3,3' tetraethylbenzimidazolylcarbocyanine iodide, JC-1. Highest heterogeneity was found 
in de-energised mitochondria, while the highest homogeneity was observed during the first 
phase of the phosphorylative process. The effect of cryopreservation of bovine sperm 
organelle function was examined by (Thomas et al., 1998), in which the plasmalemma, 
acrosome and mitochondria were analysed. Results showed that these organelles in unfrozen 
spermatozoa varied as to their functional status, while the cryopreservation process resulted 
in a more uniform status. M acouillard-Poulletier de Gannes et al. (1998) dem onstrated that 
mitochondrial volume changes can be followed by flow cytometry when exam ining changes 
in the mitochondrial matrix volume using multiparametric flow cytometric analysis. The use 
of specific effectors of mitochondrial activity (oligomycin and KCN) showed mitochondrial
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swelling to produce a concomitant increase in forward scattering and decrease in side 
scattering of the cell population.
Mitochondrial membrane potential (MMP) in dissociated rat cerebellar neurons was 
measured using rhodamine 123 (Rhl23) (Sureda et a l,  1995). Dye distribution was studied 
by confocal scanning microscopy, while Rh 123 fluorescence following exposure of cell 
populations to various agents was monitored by flow cytometry. Results showed that 
exposure of cell populations to the mitochondrial specific uncoupling agent and impairment 
of glucose bioavailability caused a decrease in fluorescence, while oxidative stress induced 
by H 2O2 did not affect fluorescence. It was also dem onstrated that application of L-glutamate 
and N-methyl-D-aspartate (NMDA), the excitatory amino acids, decreased Rh 123 uptake, 
suggesting that the measurement of MMP by flow cytometry in dissociated cerebellar 
neurons can be used to m onitor the activity of drugs acting on glutamate receptors.
M itochondria dysfunction is considered to be a m ajor cause of the modifications that occur 
during cell ageing. To examine this further, cardiolipin, a suitable marker of the chondriome, 
as well as the mitochondrial transmembrane potential were examined in keratinocytes from 9- 
to 75 year old women (Maftah et a l,  1994). Using the dyes nonyl acridine orange (specific 
for cardiolipin) and rhodamine 123, results showed a 57% drop in cardiolipin levels in cells 
from the elderly donors compared to the children, although the membrane potential remained 
the same. The stability of the membrane potential was proposed to come about by either the 
same pool of organelles able to maintain membrane potential even when cardiolipin levels 
decrease, or mitochondria membrane potential does indeed decrease with age, but is 
compensated by energy production involving glycolysis.
Peroxisome induction and degradation was monitored by flow cytometric analysis of 
Hansenula polymorpha (yeast) cells grown in methanol and glucose media. Cell volume, 
refractive index and fluorescein isothiocyanate (FTTC) retention were monitored (Smeraldi et 
a l, 1994). Peroxisomes are inducible organelles which may occupy a large fraction of the 
cell volume when yeast cells are growing in methanol media, and undergo a degradation 
process mediated by vacuoles (monitored by F1TC retention) whenever they and their 
enzymes become metabolically redundant (when grown on glucose). Results showed the 
peroxisome development in the cells to be substrate-dependent and demonstrated the 
dynamics of peroxisome proliferation and degradation in response to environmental factors.
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Another investigation used analysis of peroxisome proliferation and the effects of humic acid 
as a possible method for studying the molecular control of determination and differentiation 
of mesodermal cell lineages (Lee et a l,  1999). The use of fluorescent lectin binding in 
conjunction with flow cytometry for analysis of surface carbohydrates on the golgi apparatus 
was reported by Guasch et al. (1995). Several fluorescein isothiocyanate-conjugated lectins 
were used to detect and quantify specific surface sugars on isolated elements from purified 
cis- and trans-golgi fractions from rat liver. It was suggested that the method may be used to 
study golgi composition and function, since it was possible to reveal the intensity of specific 
binding of different lectins to each golgi fraction and the percentage of elements binding the 
lectins specifically. Reported were that cis-golgi elements appear homogenous in mannose 
and fructose, whereas galactose and N-acetyl-glucosamine residues are more abundant in 
trans-golgi elements.
Analysis of nuclei by flow cytometry has been reported in a num ber of cases. Sabe et al. 
(1999) demonstrated its use for the analysis of estrogen receptor expression in isolated nuclei 
and cells, while Gschwendtner et al. (1999) used high resolution image cytometry for 
quantitative assessment of bladder cancer by nuclear texture analysis.
1.4.1.5 Microscopy
SR31747A is a sigma ligand previously described as having immunosuppressive properties. 
Two of its receptors were recently identified and termed sigmai and human sterol isomerase 
(hSI). Dussossoy et a l  (1999) reported on the co-localisation of sterol isomerase and sigmai 
receptor at endoplasmic reticulum and nuclear envelope level using confocal and electron 
microscopy. W estern-blotting techniques with polyclonal antibodies raised against hSI 
(human sterol isomerase) were first used to demonstrate the presence of the protein in B- and 
T-cell lines. The use of both confocal microscopy and electron microscopy enabled the 
subcellular localisation within the ER and with the outer and inner membranes of the nuclear 
envelope. Electron microscopy was used to examine the mitochondrial pathology in human 
schizophrenic striatum, (Kung and Roberts, 1999), to investigate the possibility that 
abnormalities in schizophrenia brain might be due, in part, to pathology in mitochondria. 
Results showed significantly fewer (-26% ) mitochondrial profiles throughout the neurophil 
of the schizophrenic samples than controls, although the structural integrity of the
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mitochondria did not seem to differ significantly between either control or schizophrenic 
sample. Also reported were the numbers of mitochondrial profiles per axon terminal which 
appeared lower in the subset of schizophrenics off drugs as compared to either the 
schizophrenics on-drugs or the controls.
1.4.2 Limitations involved in analysis of whole cells and organelles
W hile the above methods have provided valuable information and yielded many ways to 
probe and analyse both cells and organelles, there exist limitations among them, furthering 
the need for methods of analysis for organelles to be performed on an individual basis for 
clear-cut unambiguous results.
F l o w  c y t o m e t r y :  In the case of mitochondria] analysis one of the most important
limitations of flow cytometry is that it does not permit a direct discrimination between 
respective probe responses to plasma and mitochondrial membrane potentials. For this 
reason, it is limited in the choice of dyes that can be used. For example, if membrane 
potential studies on whole cells are required, then anionic oxanols and bis-oxanols are more 
suitable for cells abundant in mitochondria, as these negatively charged dyes are strongly 
repelled from mitochondria.
C o n v e n t i o n a l  f l u o r e s c e n c e  m i c r o s c o p e s :  An important problem with the use of
conventional fluorescence microscopes concerns the resolution obtained. As fluorescence 
comes from above and below the plane observed by the microscope, results will be marred 
due to this. This effect can be partially overcome by the use of correction factors (Ehrenberg 
et al., 1988).
L a s e r  s c a n n i n g  c o n f o c a l  f l u o r e s c e n c e  m i c r o s c o p y :  The use of this technique overcomes,
to some extent, the problem described above, with fluorescence from  layers about 0.4-0.6 |xm 
thick capable of being measured. However, the use of a focused laser beam to obtain the 
unique vertical resolution of confocal microscopy brings with it the side effect of
Page 28 of 243
fluorescence photobleaching. Some dyes are more resistant to this than others, for example, 
(tetramethylrhodamine methylester perchlorate, TM RM, and tetramethylrhodamine ethylester 
perchlorate, TM RE). However, caution is needed even for these cases to avoid errors in 
membrane potential (Ehrenberg et al., 1988). For very small objects such as mitochondria, 
even confocal microscopy fails to provide enough space resolution to determine reliably the 
intensity of fluorescence from its interior. To overcome this, the use of a com puter aided 
digital image restoration, which is based on a 3D deconvolution of a series of object images 
acquired with a conventional microscope at a vertical spacing of 0.3p,m, can provide enough 
space resolution for a reliable determination of mitochondrial membrane potential in situ, 
(Loew, 1993).
The above methods describe the analysis of organelles on the basis of size, morphological 
parameters, activity and levels of particular constituents (lipid components etc). There is 
another avenue open to exploration, not only for organelles, but any tissue or organism, and it 
involves the analysis of the protein content (the proteome). This is a new area developing in 
biology and gathering momentum fast as biologists seek to understand more about the 
complex proceedings inside and between organelles, cells and whole organisms. The term 
associated with this new field is proteomics.
1.4.3 Proteomics
The term “proteome” is a relatively new concept in biology, first appearing in late 1994 at the 
Siena 2-D Electrophoresis meeting, and in 1997 was the subject of a num ber of conferences. 
Proteome indicates the PROTEins expressed by the genOME or tissue at any given time. 
Embarking on the analysis of the proteome will perhaps lead biology into a new era of 
completeness, similar to when the periodic table was defined for chemistry. The proteome, 
unlike the genome, is not a fixed feature of an organism, continuously changing as the state 
of development of the tissue and the environm ent changes. It was this understanding that put 
paid to one o f the old dogmas of biology, the one-gene-one-enzyme theory, as there are far 
more proteins in a proteome of an organism than genes in the genome. This comes about 
from the many changes that can occur between the DNA translation stage to final protein
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expression, from the many ways a gene can by spliced in forming mRNA, to the multitude of 
ways the same protein can by post-transitionally modified.
In the search to understand and find cures for the many diseases, the race to sequence DNA 
and use differential display o f mRNA to search for key molecules involved in both normal 
physiological pathways and in disease is continuously driven by industry. For example, in the 
occurrence of cancer there appears to be several genetic alterations needed. The short cut to 
understanding these protein networks is to study them directly. This is proteomics. Currently 
the only separation technology that provides highly purified proteins separated in a simple 
parallel process is 2-D gel electrophoresis. Although electrophoresis was first used in 1909 by 
Michaelis, and again by Tiselius in 1937. In the early 1970’s two dimensional electrophoresis 
was described by Dale and Latner (1969) and M acko and Stegemann (1969) through the 
combination of IEF followed by PAGE. Stegemann (1970) introduced IEF in polyacrylamide 
gels followed by SDS-PAGE. However, it was not until 1975 that the method most 
separations are based on today was developed (O ’Farrell, 1975). Other methods such as serial 
liquid chromatography and capillary electrophoresis methods are currently being evaluated, 
however, to date, none are able to come near 2-D electrophoresis for resolution.
Proteome projects, which aim to identify and characterise all proteins expressed by an 
organism or tissue, provide information which is detailed in many ways. Identification gives 
a name or database accession code to a protein (or spot on a gel if 2-D electrophoresis is used 
to identify the protein), linking the amino acid sequences o f proteins to DNA sequences of 
genes, thereby linking genomes to proteomes. This information also provides us with a first 
step towards analysing co- and post-translational modification of proteins, which will lead 
ultimately to a greater understanding of function. The ability to create reference maps for 
individual organisms is possible, and hence discover which proteins are “common”, and 
which ones are unique to a particular tissue. As detection methods for proteins on gels 
improve, identification will also provide quantitative data on the amount of protein expressed 
which could ultimately be used in conjunction with data from mRNA microarray analysis 
(Schena, 1996). This will allow a better understanding not only of when and where a protein 
is expressed, but also information on the numbers per cell, pool size and half-life.
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1.4.3.1 2-D gel electrophoresis
As an analytical technique, 2-D gel electrophoresis is the proven leader when it comes to the 
power to resolve hundreds of proteins on the one single gel. Separation is based by exploiting 
two physical properties of the proteins, molecular weight and isoelectric point. Data on 
relative abundance and electrophoretic pattern as well as those properties mentioned above is 
collected. The num ber of investigators that have reported on the use of 2-D gel 
electrophoresis for identification o f various proteins is vast, and to try and review even a 
small amount would be a major task. However, in recent times, within the new world of 
proteomics, 2-D gel electrophoresis has been applied to the analysis and identification of the 
proteome. Sazuka et al. (1999) reported proteomic studies on the cyanobacterium 
Synechocystis (sp. strain PCC6803) and updating the 2D protein-gene linkage database with 
the further identification of 97 proteins and their genes, to total 277 the num ber of proteins 
identified and linked to their genes for this organism. Perrot et al.(1999) identified 92 novel 
protein spots on the yeast protein 2-D map, extending to 401 the num ber of proteins 
identified on their yeast 2-D reference map. These spots correspond to 279 different genes 
and were identified by three different methods -  gene overexpression, amino acid 
composition and mass spectrometry.
2-D gel electrophoresis has been used in functional proteomic studies and applied to the 
investigation of signal transduction systems involving platelet-derived growth factor (PDGF), 
endothelin and bradykinin. Following the stimulation of mouse fibroblast cells, 
phosphorylation/dephosphorylation of several hundred proteins was followed as a function of 
time using 2-D gel electrophoresis (Godovac-Zimmermann et al., 1999). Up to 100 proteins 
showed changes in phosphorylation within minutes of receptor stimulation. Using matrix- 
assisted laser desorption/ionisation -  tim e of flight (MALDI-TOF) mass spectrometry, new 
proteins not previously know to be associated with signal transduction were identified. 
Hermann et al. (1998) used 2-D gel electrophoresis as the first step in proteome analysis of 
Corybacterium glutamicum. The map revealed over 1000 silver stained spots for cytoplasmic 
proteins and approximately 700 silver stained spots for the membrane fraction. 10 proteins 
were identified using N-terminal sequencing, the 35kDa antigen, antigen 84, ATP synthase 
subunits a, y  and 5, cysteine synthase, elongation factor G and Ts, enolase, and rotamase.
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Although 2-D gel electrophoresis is used almost exclusively as the precursor step to proteome 
analysis of any organism, a study carried out by W ilkins demonstrates it is not without its 
short comings and limitations. The effects of protein hydrophobicity and cellular protein copy 
number on a proteins absence or presence on a 2-D gel was investigated. (W ilkins et a l, 
1998) By calculating the average hydropathy of all known proteins from Bacillus subtilis, 
Escherichia coli and Saccharomyces cerevisiae, and defining the range o f hydrophobicity and 
hydrophilicity in these organisms, the average hydropathy values were calculated for a total 
of 427 proteins from these species, which had being identified by 2-D gels on previous 
occasions. It was shown that there have been no highly hydrophobic proteins identified by 2- 
D gel separations to the date of the publication (1998). A clear hydrophodicity cut off point 
was seen, above which the authors concluded, that 2-D gel electrophoresis did not appear to 
be useful for protein separation. On investigating the effect of a proteins cellular copy 
number on its presence on the gel, use of a graphical model showed that variations in loading 
and copy number per cell interact to determine the quantity o f protein that will be present on 
a gel. Considering the current loading capacity, the authors concluded that 2-D probably 
could not visualise or produce analytical quantities of proteins present at less than 1 0 0 0  
copies per cell. From these conclusions, it is clear that improvements are needed to 2-D gel 
technology to enable the visualisation and analysis of all proteins expressed by a cell or 
tissue. Chapter 7 takes a look at the use o f CE for analysis of the mitochondrial proteome. 
The work presented marks the beginning investigations towards the use of capillary gel 
electrophoresis in analysing fluorescently labelled proteins extracted from isolated 
mitochondria.
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2 M ATERIALS AND METHODS
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2.1 Materials
Unless otherwise stated, all standard laboratory reagents were purchased from Sigma 
Chemical Co., Poole, Dorset, England and St. Louis, MO, USA.
HPLC grade solvents were purchased from Labscan, U nit T26, Stillorgan Industrial Park, Co. 
Dublin.
Warfarin polyclonal antibodies and W arfarin-BSA conjugate were a gift of Brian Fitzpatrick, 
Dublin City University.
Parathion polyclonal antibodies and BSA-Parathion conjugate were a gift of Paul Dillon, 
Dublin City university
Enzyme-labelled antibodies for ELISA were purchased from Sigma Chemical Co.
Chinese Hamster Ovary and Hybridoma cells were kindly donated by Dr. W ei-Shu Hu, 
University of Minnesota.
Fluorescent stains (nonyl acridine orange, NAO, Rhodamine 123, Rh 123), labels 
(fluorescein isothiocyanate, FTTC, fluorescein and 3,(2-furoyl) quinoline-2-carboxaldehyde, 
FQ, 5,5’,6,6’-te trach lo ro -l,l’3 ,3 ’ tetraethylbenzimidazolylcarbocyanine iodide, JC-1) and 
fluorescein loaded 6  |_im diameter polystyrene beads were purchased from M olecular Probes, 
Eugene, Oregon, USA.
Protein determinations were made using a Bicinchoninic acid (BCA) assay kit (Pierce, 
Illinois, USA) on microtitre plates.
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Rabbits used for organ donation were kept at 16-18°C at DCU animal house.
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2.2 Equipment
Untreated fused silica columns used for capillary electrophoresis were supplied by Polymicro 
Technologies, Phoenix, Arizona, USA.
HPLC columns were supplied by Phenomenex, M elville House, Queens Avenue, Hurdsfield 
Industrial Estate, Macclesfield, Cheshire, England.
High performance liquid chromatographic (HPLC) analysis was performed using Beckman 
System Gold 507 Autosampler, 126 pump, 166 UV detector and 168 photo diode array 
detector, all controlled using Beckman System Gold software.
Capillary Electrophoresis was carried out on the following instruments: Beckman System 
5500 P/ACE (UV and i IF  detection) instruments, an ‘in-house’ constructed CE instrument 
with post-column LIF detector, University of Minnesota, parts supplied by M elles Griot, 
USA, University of Alberta machine shop, Edmonton, Canada, and University of M innesota 
Electronics shop. Microchip capillary electrophoresis was carried out on an ‘in-house’ 
constructed instrument, University of Alberta, parts and equipment supplied by Melles Griot, 
and University of Alberta machine shop.
Microchip substrates were part made in the Alberta Microelectronic Corporation (AMC) and 
assembled in-house, Alberta Microelectronic Corporation, #318, 11315 - 87 Avenue 
Edmonton, Alberta, Canada, T6G 2T9
pH measurements were made using Jenway 3015 pH meter (Jenway Ltd., Gransmore Green, 
Felsted, Dunmow, Essex CM6 3LB, England.
Standard photometric measurements were made using a Shimadzu UV160A, Shimadzu 
Corp., 1 Nishinokyo-Kwabaracho, Nakagyo-Ku, Kyoto 604, Japan.
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Bench centrifugation was performed using a Heraeus Sepatech (Heraeus Instruments Inc., 
111-A Corporate Blvd, South Plainsfield, NJ 07080, USA). Ultracentrifugation was 
performed on a Beckman J2-21 using a JA-20 rotor, Beckman Industries Inc., Bioindustrial 
Business Unit, Fullerton, CA, 92634-3100, USA.
Incubations for coumarin metabolism studies were carried out in 10ml blood tubes (Medical 
Supply Co., Dublin, Ireland).
Nuclear magnetic resonance (NMR) analysis was carried out on a 400MHz AC NMR 
Spectrophotometer, Brucker, Banor Lane, Coventry, England.
Infra red (IR) analysis was carried out on a Nicollet Spectrophotometer, Nicollet Instrument 
Corporation, 5225-1, Verona Road, M adison, WI, USA.
Analysis of microtitre immunoplates was carried out using a Titretek Multiscan Twinreader, 
Flow Laboratories Ltd., W oodcock Hill, Harefield Road, Rickmansworth, Hertfordshire, 
England.
Enzyme immunoassay microtitre plates were purchased from Nunc, PO Box 280, Kamstrip, 
Roskilde, Denmark.
Fluorescent microscopy was carried out on a Nikon Eclipse TE300 fluorescent microscope. 
Samples were visualised with an FTTC cube under magnifications of 20x, 40x and a 60x, N. 
A. 1.3, oil immersion lens.
Homogenisation o f Chinese ham ster ovary cells was carried out using a 1 ml Potter-Elvehjem 
glass tissue homogeniser (clearance 0.1mm).
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2.3 Methods
2.3.1 General methods
Phosphate-buffered saline: All phosphate-buffered saline (pH 7.4) used was according to 
Dulbecco ‘A ’ formulation (Oxoid), as shown in Table 2.1.
Sodium  chloride 8.0g/l
Potassium  chloride 0.2g/l
D isodium  hydrogen phosphate 1-15 g/1
Potassium dihydrogen phosphate 0.2g/l
pH 7.4
T ab le  2.1 Composition o f  PBS used on all occasions.
2.3.1.1 Bicinchoninic acid (BCA) assay
10 [xl of protein (tissue) sample to be assayed were placed in wells of a 96 well microtitre 
plate (Nunc). 190|xl o f BCA reagent (Pierce) (50 parts reagent A to 1 part reagent B) were 
added and incubated at 37°C for 1 hour. The absorbance was read on a Titretek Twin reader 
Plus at 562nm and com pared to a set of protein standards from 0 to 2 mg/ml.
2.3.1.2 Preparation of buffers for capillary electrophoresis
Phosphate buffers: Phosphate buffers were made by making an appropriate amount of
each acid (NaH2P 0 4) and base (Na2HPC>4) component, and titrating against each other until 
the desired pH was obtained.
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B o r a t e  b u f f e r s :  M ade by dissolving a measured amount o f sodium tetraborate in ultra-
pure water for the desired molarity, and adjusted to the correct pH  using NaOH.
S u c r o s e / H E P E S  b u f f e r s :  These were prepared from stock solutions of both lOOmM
HEPES and 250mM Sucrose using the formula (1) to determine the required volumes to 
obtain the final concentrations desired. pH adjustments were made using NaOH.
V,C , = V2C2 (1)
T r i s / B o r a t e  b u f f e r s :  M ade by dissolving the correct amount o f Tris-HCl and sodium 
tetraborate in ultra-pure water to achieve the desired molarity. pH adjustments were made 
with NaOH.
G l y c i n e  b u f f e r :  For affinity purification of FlTC-labelled antibodies, glycine buffer,
pH 2.8, was prepared by addition of 1.6 ml of 12 molar HC1 to 190 ml ultra-pure water. This 
was then adjusted to pH 2.8 by addition of solid glycine, and the final solution made up to 
200 ml.
2.3.1.3 Preparation of mobile phases for HPLC
H P L C  m o b i l e  p h a s e s :  For analysis by HPLC, mobile phases were made by mixing the 
relevant solvents (HPLC grade methanol and acetic acid, and water) thoroughly in a 11 Duran 
bottle and degassing prior to use. All mobile phases were used within 6 hours of preparation.
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2.3.2 Determination by HPLC of the UDP-Giucuronyl transferase activity for 7- 
hydroxycoumarin in rabbit tissue samples
2.3.2.1 Tissue preparation
Organs were obtained from a New Zealand W hite Rabbit and stored at -20°C until required. 
The tissues prepared were from the liver, kidney, bladder, large intestine, lung, spleen, heart 
and fat. Table 2.2 shows the reaction m ixture used for the assay. A 1 g sample o f each organ 
was weighed and homogenised in 10 ml o f 50mM  Tris-HCl, pH 7.4. The protein 
concentration in each organ was determined by Bicinchoninic acid (BCA) assay. A reaction 
mixture was set up and incubated at 37°C. Samples were taken every 15 mins from time 0 to 
120 minutes. The reaction was terminated by addition of 200 (il of reaction m ixture to 40 (J.1 
of 20% (w/v) trichloroacetic acid. This m ixture was centrifuged in a benchtop centrifuge at 
8000g for 5 minutes prior to analysis to remove the protein.
C o m p o n e n t S t o c k  s o l u t i o n  
c o n c e n t r a t i o n
V o l u m e  ( ¡ A ) F i n a l
c o n c e n t r a t i o n
7-hydroxycoumarin 6.17mM 500 0.77 Im M
Enzyme prep. lOmg/ml 1000 2.5mg/ml
D-Saccharic acid- 
1,4-lactone
50mM 500 6.25mM
UDPGA 50mM 25 1.25mM
Absolute ethanol — 100 —
M gCl2 Im M 125 6 .2 5 x l0 'bM
Tris-HCl (pH 7.4) 1M 500 125mM
Ultrapure W ater — 1250 —
T able 2.2 Reaction mixture used fo r  the uridine diphosphate glucuronyl transferase 
( U D P G T )  assay.
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«2.3.2.2 Preparation of Standards for HPLC UDPGTassay
A 1 mg/ml stock solution of 7-hydroxycoumarin was prepared in 10% methanol /  90% water 
and the 1 mg/ml stock solution of 7-hydroxycoumarin-glucuronide was prepared in ultra pure 
water. The internal standard used was 4-hydroxycoumarin and was prepared in methanol. The 
standards used for determining concentration of analytes were 0, 1, 5, 10, 20, 50, 80, 100 and 
200 |ig/ml.
2.3.2.3 HPLC Separation
Gradient elution was used for analysis. The solvents employed were A, water-methanol- 
acetic acid (950:50:2, v/v) and B, 100% methanol. The eluent was m onitored at 320 nm. 
Sample (20 |ol) was injected onto the column using the autosampler. The 1 ml/min gradient 
was as follows: 0-5 min 100% A —» 50% A : 50% B ; 5-14 min 50% A : 50% B ; 14-15 min 
50% A : 50% B 100% A.
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2.3.3 In vitro glucuronidation of 7-hydroxycoumarin and determination of 7- 
hydroxycoumarin and 7-hydroxycoumarin glucuronide by capillary 
electrophoresis.
2.3.3.1 Uridine diphosphate glucuronyl transferase (UDPGT) assay
Seven organs (liver, kidney, large intestine, lung, spleen, heart and fat) were obtained from 
New Zealand W hite Rabbit and stored at -20°C until required. A lg  sample of each organ 
was weighed and homogenised in 10 ml of 50 m M  Tris-HCl, pH 7.4. The resulting 
homogenate was adjusted to lOmg/ml (mg wet weight of organ/ml of buffer). This 
constituted the protein solution to be used in the reaction solution. The protein concentration 
in each was determined by Bicinchonnic acid (BCA) assay, after dialysis of an aliquot of 
protein solution in 50 volumes of phosphate buffered saline solution (PBS) overnight at 4°C. 
A standard curve was constructed from a range of standards, 0 - 2  mg/ml, bovine serum 
albumin (BSA), prepared in PBS.
Table 2.2 shows the eight components necessary for the reaction, along with the respective 
volumes. A 1 mg/ml solution of 7-hydroxycoumarin was prepared in 10% ethanol : 90% 
ultra-pure water. All other solutions were prepared in ultra-pure water. Reactions were 
carried out in 10 ml blood tubes. The reaction was initiated by addition of 1ml of the protein 
solution, to make a final reaction volume of 4 ml. The reaction was incubated in a dark oven 
at 37°C, and terminated by adding 50 pi of acetonitrile (Analar grade) to 150 pi of reaction 
mixture. This was then centrifuged at 8000g to remove the protein and any other material that 
might interfere with analysis. The supernatant was then immediately analysed.
2.3.3.2 /3-Glucuronidase assay
A lg  sample of each organ assayed for presence of P-glucuronidase activity was weighed out 
and homogenised in 10 ml of 100 m M  acetate buffer, pH 4.3. This constituted the protein 
solution to be used in the reaction. Protein determinations were made as for the UDPGT
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assays, using the BCA kit (section 2.3.2.1). Table 2.3 outlines the reaction components 
necessary for the (3-glucuronidase assay.
C om ponent Stock solution 
concentra tion
Volum e (jil) F inal
concentration
7-hydroxycoumarin 6.17 mM 40 1.76 mM
Enzyme prep. 10 mg/ml 40 2.86 mg/ml
Acetate buffer, (pH 4.3) 100 mM 60 42.86 mM
T able 2.3 Reaction components and concentrations fo r  the ¡3- glucuronidase assay.
2.3.3.3 Reaction solution for /^-glucuronidase assay.
Table 2.3 lists the components used. The reaction was prepared to a final volume of 140 J.U 
and allowed to continue for 30 minutes at 37°C in a dark oven until it was stopped by the 
addition of 50 jxl of 50mM D-saccharic acid-1,4-lactone ((3-glucuronidase inhibitor). 50 |J,1 of 
acetonitrile was then added and the solution centrifuged at 8000g for 5 mins. The supernatant 
was immediately analysed.
2.3.3.4 Controls
For the (3-glucuronidase assay control a reaction solution sim ilar to each of the tissue 
preparations was made with the addition o f 50|il of D-saccharic acid-1,4-lactone to the 
reaction before the addition o f 7-HCG (to prevent 7-HCG breakdown) and the reaction 
monitored after 30 minutes. In the case of all controls monitored, there was no breakdown to 
7-HC observed. A similar control was prepared for the UDPGT assay. A reaction solution
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was prepared with the protein precipitated out of solution by acetonitrile before addition of 
the UDPGA with monitoring for glucuronide after 30 minutes. There was no detectable 
production of the glucuronide in each of the controls monitored.
2.3.3.5 Standard curve preparation.
UDPGT assay: A range of standards were prepared consisting of 0 - 200 Jlg/ml of 7-
hydroxycoumarin, prepared in 10% ethanol : 90% ultra pure w ater (v/v), and 7- 
hydroxycoumarin glucuronide prepared in ultra-pure water. 20 (il of each were spiked into 40 
(j.1 of 1M Tris-HCl, pH  7.4, 50 (il o f acetonitrile and 40 ]il of each protein solution. The 
resulting mixture was vortexed and centrifuged to remove the protein. Previous CE studies 
have used denaturation of protein solution by boiling to remove any interference due to 
endogenous P-glucuronidasc present. However, in this case it was decided to remove the 
protein as this avoids any further reaction of any type in the mixture prior to analysis which 
might otherwise affect the results. The amount of 7-HCG produced was calculated from a 
plot of 7-HCG concentration standards versus absorbance (peak height).
f3-,glucuronidase study: The standard curve for the P-glucuronidase study was prepared
from solutions that consisted of 40 |xl of 7-hydroxycoumarin and 7-hydroxycoumarin 
glucuronide standards, 60^1 of lOOmM acetate buffer, pH 4.3, 50 |ll of D-saccharic acid-1,4- 
lactone and 100 fil of enzyme solution, (either P-glucuronidase or homogenate). Immediately, 
50 |xl o f acetonitrile was added to precipitate out the protein which was then centrifuged and 
removed as before. Concentrations of 7-HC and 7-HCG were calculated from plots of 
concentration versus absorbance (peak height).
For calculation o f P-Glucuronidase activity in units/g wet mass of whole organ, the activity 
for each organ was compared to that of P-glucuronidase obtained from Sigma and from this 
the activity in units/g wet weight of organ could be determined. A standard curve with 0 -  
10,000 units of P-glucuronidase incubated for 30 minutes with 200 (ig/ml 7-HCG was 
prepared and used to calculate activities.
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2.3.3.6 C E  separation
Separation was carried out on a P/ACE System 5500 CE instrument, with detection by a 
P/ACE UV absorbance detector using a 27 cm untreated fused silica capillary, 50 ¡.im ID, 375 
fim OD, (19.3 cm capillary inlet to detector distance). Prior to running samples, the capillary 
was conditioned with 0.1M HC1 for 10 minutes, 0 .1M NaOH for 10 minutes and finally 
lOOmM phosphate buffer, pH 7.0, for 10 minutes. The capillary was conditioned between 
each run by a 3 minute rinse with 100 mM phosphate buffer. Samples were applied by 8- 
second pressurised injection at 0.5 psi. Separation was achieved at 17.5 kV, 25°C, with 
detection at 320 nm. Typical running current was 150 |aA.
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2.3.4 Determination of 7-hydroxycoumarin and its glucuronide and sulphate 
conjugates in liver slice incubates by capillary zone electrophoresis
2.3.4.1 Synthesis of 7-hydroxycoumarin sulphate
7-hydroxycoumarin (200mg, 1.23 mmol), tetra-n-butylammonium hydrogen sulphate 
(627mg, 1.85 mmol), and dicyclohexylcarbodiimide (2.5g, 12.1 mmol) were combined in dry 
pyridine (15 ml), stirred to effect solubilisation, and the reaction left at 5°C for 5 days. The 
reaction mixture was then diluted with an equal volume of methanol and filtered. The filtrate 
was evaporated to give an oil that was treated with methanol (20 ml). This was concentrated 
to -1 0  ml and filtered again. The methanol filtrate was then applied to a lipophilic Sephadex 
LH-20 column (2.5 x 18 cm) equilibrated in methanol. The column was eluted with 
methanol, and after collecting 40 ml of eluant the sulphate was collected over the next 30 ml. 
This latter fraction was concentrated to 5-10 ml, and 1M potassium  hydroxide in methanol 
(1.1 ml) was then added. After cooling in an ice bath, the crystals were filtered off, washed 
with cold methanol and dried under vacuum.
2.3.4.2 NMR analysis of 7-hydroxycoumarin sulphate
For NMR analysis 20 mg of 7-hydroxycoumarin sulphate was dissolved in D 2O and analysed 
using a 400MHz AC NMR Spectrophotometer.
2.3.4.3 IR analysis of 7-hydroxycoumarin sulphate
For IR analysis, 15 mg was m ixed with potassium bromide (KBr), pressed between KBr 
plates and analysed using a Nicollet Infra Red Spectrophotometer.
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2.3.4.4 Liver slice preparation and incubation
Liver was obtained from Balb\C mice and stored at -20°C until required. Liver slices were 
prepared using an ‘in-house’ made razor-bladed instrument based on that described by 
Krumdieck et al. (1980) (section 4.3.2.1), ensuring that the slices were submerged in buffer at 
all times during preparation. Incubations were carried out in blood tubes at 37°C. Tissue 
slices were pre-incubated for 90 minutes at 37°C in a warm room  using a blood tube m ixer 
with the revolving face of the m ixer horizontal to ensure gentle m ixing of the buffer. The 
slices were then incubated with 100 |aM 7-hydroxycoumarin for 6-10 hours prior to analysis.
2.3.4.5 Preparation of Krebs-Henseleit buffer
Krebs-Henseleit buffer (pH 7.4) was made by addition of the ingredients listed in Table 2.4 to 
250 ml of ultra-pure water. 0.42 m l of gentamycin sulphate (from a stock solution of 50 
mg/ml) was added to the final solution to complete the buffer com position prior to use.
C om pound W eight (g)
Sodium chloride 1.725
Potassium chloride 0.090
Magnesium sulphate anhydrous 0.064
Monosodium phosphate anhydrous 0.036
d-Glucose 1.125
HEPES* 1.486
Calcium chloride dihydrate 0.425
*(N-[2-Hydroxyethyl]piperazine-N-[ethanesulphonic acid])
T able 2.4 Composition o f  Krebs-Henseleit buffer fo r  liver slice incubations.
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2.3.4.6 Preparation of standards
7-HC standards were prepared from a lm g/m l stock solution prepared in ethanol and ultra 
pure water (10 +  90%, v/v). Both 7-HCG and 7-HS standards were prepared from  a 1 mg/ml 
stock prepared in ultra pure water. All standards were diluted with Krebs-Henseleit buffer.
2.3.4.7 Capillary Electrophoresis separation
Separation conditions were as outlined in section 2.3.4.6.
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2.3.5 Microchip capillary electrophoresis - Immunoassays for Warfarin and 
Parathion
2.3.5.1 Confirmation of antibody activity by ELISA
Nunc maxisorp immunoplates were coated with 100 |J.l of 50 (ig/ml conjugate 
(warfarin/parathion-BSA) in PBS and allowed to coat overnight at room temperature. The 
wells were then washed with 5 x  200 |Lil of wash buffer (PBS-Tween) and the wells blocked 
with the addition of 100 |il of 5% (v/v) foetal calf serum in PBS. This was incubated for 90 
minutes at 37°C and then washed (5 x  200 (il of wash buffer). Different concentrations of 
warfarin/parathion) (24 -  790 ng/ml) and primary antibody (FITC-labelled/unlabelled), 
constant concentration, were added to each well and incubated for 90 minutes at 37°C. The 
plate was then washed (5 x  200 (il of wash buffer), secondary antibody added (anti-rabbit 
labelled with alkaline phosphatase), and allowed to incubate for 90 minutes at 37°C. The 
plate was washed again (5 x  200 fxl of wash buffer) and the substrate added (para-nitrophenyl 
phosphate). The substrate was provided in tablet form and diluted in the required volume of 
ultra pure water prior to use. The plate was allowed to develop for 60 minutes at room 
temperature before reading the absorbance at 405 nm using a titretek plate reader.
2.3.5.2 Fluorescein isothiocyanate (FITC) labelling of Anti-Warfarin and Anti- 
Parathion antibodies.
The concentration o f antibody solution was adjusted by the addition of BSA to give a final 
protein concentration of 4 mg/ml in 0.1M  sodium carbonate buffer, pH 9.0. BSA was added 
as the labelling conditions used were optimised for 4 mg/ml solutions of protein. Labelling 
was carried out by mixing of antibody (in 0.1M  carbonate buffer, pH  9.0) in an eppendorf 
tube with FITC (25.7 mM  in DMSO) in 5 |J.I aliquots with vigorous vortexing between 
additions (giving a final concentration of 50 (ig FITC added per mg of protein). The solution 
was then left in the dark at room  temperature for three hours, before being dialysed against 
1000 volumes PBS, pH  7.4, with 0.02% (w/v) sodium azide to remove any unreacted FITC.
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2.3.5.3 Affinity purification of FITC-labelled antibodies
The antibody was purified from solution, which also contained labelled BSA, by protein G 
affinity purification (protein G immobilised on Sepharose 4B). The column was equilibrated 
with 20 ml of PBS (pH 7.4). 1 ml of antibody solution was added to the column, let run 
through, and the eluate collected. 1 ml of PBS was then added to the eluate and this was run 
through the column again until just above the level of the solid support. This was repeated 
with another 4 ml of PBS added to the elute, followed by 25 ml of PBS only. The column 
was washed with 0.1M Tris-HCl buffer, pH 8.7, and eluted with 0.1M  glycine buffer, pH 2.8, 
followed by dialysis into PBS. The column was equilibrated with PBS containing 20% (v/v) 
ethanol and stored at 4°C.
2.3.5.4 Capillary Electrophoresis analysis of FITC-labelled antibodies
On-colum n C E -LIF  analysis: Separation was carried out in a fused untreated silica
capillary (27 cm x 50 p,m ID x  375 ^m  OD, 19.3 cm to detector window). The samples were 
analysed on a Beckman CE P/ACE 5500 instrument with detection by a P/ACE LIF detector. 
Borate buffer, pH 9.0, was used as electrolyte buffer. All components were controlled by 
System Gold™ software. Separations were carried out at 16kV, 25°C, using an argon-ion 
laser for detection with excitation at 488nm, and emission at 520nm. Typical running current 
was 6.1 piA
M icrochip analysis: Both antibodies were analysed on chip. Analysis conditions were
5mM borate buffer, pH 9.0, as electrolyte. Injections were made for 10 seconds at 1.5kV, 
with a separation voltage of 6kV.
2.3.5.5 Labelling of BSA Conjugates.
The labelling of the BSA-parathion and warfarin conjugates was carried out in the same 
manner as the labelling o f the antibodies as outlined in section 2.3.5.2, with the only change
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being the protein concentration for the warfarin conjugate was 3 .0 3 x l0 '6M, and 1 .9x10 'SM 
for parathion conjugate. The concentration of FITC used was a five-fold excess of the 
relevant conjugate concentration. Following labelling, the reaction was dialysed overnight in 
1000 fold PBS to remove unreacted dye. The resulting solution was stored at 4°C.
2.3.5.6 Microchip immunoassay
For both parathion and warfarin on-chip immunoassay trials, 50 mM Tris/borate buffer, pH
8.5, was used with an injection time of 2.7kV and a separation voltage of 7.3kV.
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2.3.6 Single liposome analysis using CE with post column LIF
2.3.6.1 Preparation of liposomes
Liposomes with lipid membrane compositions similar to the outer mitochondrial membrane 
were prepared. Stock solutions of each phospholipid and cholesterol were prepared in 
chloroform: 1.23xlO‘2M phosphotidyl serine (PS); 1.3xlO"2M  phosphotidyl ethanolamine 
(PEA); 1.29x10'2M  phosphotidyl choline (PC) and 2.5xlO '2M  Cholesterol. The phospholipids 
PC, PS, PEA and cholesterol were combined in a ratio of 39:2:35:3 respectively in a 5 ml 
round bottom flask (total volume 790 fil each) and mixed thoroughly. The chloroform was 
evaporated under a stream of argon at room temperature. W hen all solvent was evaporated, 
1ml of 10‘6M  fluorescein in lOmM borate, pH 9.3, (for flourescently labelled liposomes), and 
lm l of lOmM borate for blank liposomes was added to each respective flask, vortexed until 
all lipid components were in solution and then placed at 4°C for 2 hours to swell. The 
liposomes were then washed by centrifuging at 13,800g for 5 minutes in a benchtop 
centrifuge, followed by removal of the supernatant and addition of an equal volume of milli- 
Q water. This wash step was repeated four times. The resulting liposom e preparation was 
stored at 4°C in the dark until needed. Stability of preparations was monitored by microscopy 
on a daily basis.
2.3.6.2 Grignard coating of capillaries for C E  analysis
Day 1: Approximately 5 m of capillary was cut, wrapped around a water bottle,
leaving about 15 cm at either end, taped together (ensuring that the tape is folded onto itself 
so that it can be removed following baking). The oven was set to 120°C and one end of the 
capillary was placed into the adapter attached to the nitrogen (N2), placing the other end in 
water. The capillary was then rinsed as outlined in Table 2.5. W hen the rinses were finished, 
the outlet end of the capillary was put into the oven, keeping the nitrogen flowing through at 
5 psi overnight.
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Solution Time (hours) Pressure (psi)
IM N aO H 3 20
ddH20 1 20
M eOH 1 20
T able 2.5 Sequence fo r  rinsing o f  fu sed  silica capillary prior to coating.
Day 2: The oven temperature was reduced to 65°C with the capillary still inside it, the
capillary was then rem oved from the oven, each end trimmed about 1 cm and the outlet end 
placed in water. The capillary was rinsed with SOCl2 (in a glass vial) for 30 minutes at 20 psi. 
When completed, both ends o f the capillary were capped with pieces of GC septum, placed 
into the oven and baked for 6-8 hours (or overnight). This step was repeated 6 hours after the 
initial run in order to ensure removal of all SiOH groups.
Day 3: To ensure all glassware was dry it was placed in a warm oven before use (2
glass vials, a 5 ml volumetric flask and stopper, and a glass syringe with needle). 1 ml of 1M 
vinylmagnesium bromide was placed in a 5 ml volumetric flask and the flask filled to 5 ml 
with dry tetrahydrofuran (THF). The syringe was rinsed with THF, and a glass vial of dry 
THF for the outlet end of the capillary was also filled. The capillary was rem oved from the 
oven, about 1 cm was snipped from each end of the capillary and the outlet end put back in 
the oven (to prevent it from becoming blocked in the rinse step). The capillary was rinsed 
with the THF/vinylmagnesium bromide solution (in a glass vial) for 30 minutes at 20 psi - 
keeping the outlet end in the oven until the solution was observed exiting the capillary. The 
outlet end was then removed from the oven and placed in a vial of THF. Both ends o f the 
capillary were capped with a GC septum and placed in the oven overnight.
Day 4: All glassware required was dried again as on day three. The glass vial was
filled with dry THF, the capillary removed from the oven, and about 1 cm snipped from each 
end, placing the outlet end back in the oven. The capillary was rinsed with dry THF (in a 
glass vial) for 30 m inutes at 25 psi, and the outlet end removed from the oven when liquid 
was seen exiting the end of the capillary. The entire portion of the capillary spool that
Page 53 of 243
remained outside the oven during the procedure was cut off and discarded. The capillary was 
cut into the sizes required and flushed with water for 10 minutes at 20 psi.
3% acryloyl amino propanol (AAP) was polymerized by adding I |il TEM ED, 4 p.1 o f 10% 
(w/v) APS (must be fresh) and stirring. This pAAP solution was flushed through the 
capillaries for 10 minutes at 25 psi, then the N 2 flow was stopped, the pAAP vial switched to 
water and the capillaries feft to sit in water for 30 minutes. The N2 was then turned on for a 
few minutes, flushing the capillaries with water. The capillaries’ ends were stored in water 
until required.
2.3.6.3 CE-LIF analysis of liposomes
The post column detection CE-LIF used was constructed ‘in-house’ as outlined in section 
6.1.2. Separations were carried out in a coated fused silica capillary, 50(im ID, 150 |im  OD at 
200Vcm"\ Injections were performed at 50Vcm_1 for 5 seconds. Excitation was at 488nm 
with detection at 535DF35nm.
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2.3.7 Mitochondrial analysis using CE-LIF
2.3.7.1 Labelling of mitochondria in whole cells
The mitochondria used in this study were isolated from Chinese Ham ster Ovary (CHO) cells. 
A stock solution of 1 mM  nonyl acridine orange (NAO) fluorescent dye (used to measure 
mitochondrial mass), 10 mM  Rhodamine 123 and lOmM 5 ,5 \6 ,6 ’-tetrach loro-l,r,3 ,3 ' 
tetraethylbenzimidazolylcarbocyanine iodide, JC-1, (used to measure mitochondrial activity) 
prepared in 100% DMSO were used to label the mitochondria in whole cells. CH O ’s were 
labelled at a final concentration of 10 ^iM NAO and JC-1, and 1 |iM  for Rhodamine 123, for 
5 minutes at room temperature in cell growth medium.
2.3.7.2 Fluorescence microscopy analysis of stained cells
Following staining of whole cells as outlined above, the uptake and fluorescence of dye was 
monitored by fluorescence microscopy. 5 (xl o f stained cells was taken, placed on a glass 
slide, covered with a cover slip and analysed by light and fluorescence microscopy (FITC 
cube) prior to homogenisation.
2.3.7.3 Isolation of mitochondria from Chinese hamster ovary cells
Following labelling the mitochondria, 2 ml o f cells [1 x 106 cells/ml] were homogenised on 
ice using a Potter-Elvehjem tissue homogeniser. Homogenisation was closely monitored by 
light microscopy to ensure minimal strokes for membrane disruption. The homogenate was 
centrifuged at 1300g for 5 minutes to remove nuclear and membranous material. The pellet 
was resuspended in ice cold 250mM sucrose and recentrifuged. Both supernatant fractions 
were combined to give a total post-nuclear supernatant (PNS) which was then centrifuged 
using differential gradient ultracentrifugation.
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2.3.7.4 Differential gradient ultracentrifugation
A hybrid percoll/metrizamide discontinuous gradient was prepared in 250mM  sucrose, pH
7.5. 2 ml of 35% (w/v) metrizamide (p = 1.1907) was overlaid with 2 ml o f 17% (w/v) 
metrizamide (p = 1.1079) which in turn was overlaid with 5 ml of 6% (v/v) percoll (p = 
1.0406). Gradients were prepared in Labcor 16 ml ultracentrifugation tubes. The PNS was 
gently overlaid on top. Centrifugation was carried out at 50,000g for 15 minutes 4°C with the 
brake setting at zero. Following centrifugation, the required fraction area/interface was 
carefully removed using a blunt ended needle and stored at 4°C in the dark prior to analysis.
2.3.7.5 Analysis of mitochondria by C E
Analysis was carried out on an in-house built instrument with post column laser-induced 
fluorescence detection. Injections were performed electrokinetically and hydrodynamically. 
Hydrodynamic injections were performed by raising the sample vial to a height above the 
waste (outlet) reservoir until a background identical to that for an electrokinetic injection was 
obtained (i.e. the bulk flow from the capillary was identical for both injection modes). Both 
coated and uncoated capillaries were used for analysis.
2.3.8 Mitochondrial protein analysis
2.3.8.1 3,(2-furoyl)-quinoline-2-carboxaldehyde, FQ, labelling of molecular weight 
markers and protein samples
To label the molecular weight markers, 3,(2-furoyl) quinoline-2-carboxaldehyde, (FQ), was 
dissolved in methanol at a concentration of 10 mM  and lyophilised in 10 |xl aliquots in 500 (xl 
vials. 9 |il of protein standard (10'3M) was added to one of these vials and placed in a bath at 
65°C. The reaction was initiated by addition o f 1 |.U of 25 mM  potassium cyanide (KCN) (in 
water). Protein samples isolated from mitochondria were labelled in the same manner.
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2.3.8.2 Isolation of mitochondria from Chinese Hamster Ovary Cells
M itochondria were prepared in the same manner as detailed in section 2.3.7.3 and 2 3 .1  A, 
without the addition of fluorescent stain to the washed cells.
2.3.8.3 Purification of protein from mitochondria
Protein was purified from isolated mitochondria as follows: 0.1 ml of sample was treated 
with 0.4 ml of methanol and vortexed. This was then centrifuged for 10 min at 9000g. 0.1 ml 
of chloroform was added, vortexed and centrifuged at 9000g for 10 min. 0.3 ml of water was 
then added, the solution vortexed, centrifuged for 1 min at 9000g and the upper phase 
removed. 0.8 ml of methanol was added, vortexed, and centrifuged again for 2 min at 9000g, 
The supernatant was removed and the pellet dried under a stream of air. The final protein 
pellet was lyophilised and stored at -20°C  until required.
2.3.8.4 Capillary gel electrophoresis of mitochondrial protein
For analysis of mitochondrial protein the coated capillary was filled with 5% (w/v) dextran 
(Mol. Wt. 185,000), 6.7mM  SDS and 5mM HEPES, pH 7.50. All samples were denatured at 
95°C for 5-mins prior to analysis. Injections were made for 20 seconds at SOVcm'1 and 
separations were performed at 400V c m 1.
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3 HIGH PERFORMANCE LIQUID 
CHROMATOGRAPHY APPLIED TO THE
ANALYSIS OF COUMARIN
METABOLISM
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3.1 Introduction
Liquid chromatography is the generic name used to describe any chromatographic procedure 
in which the mobile phase is a liquid. It includes thin layer chromatography (TLC), paper 
chromatography and the various types of column chromatography involving gravity fed 
columns. The beginnings of chromatography are attributed to Tswett, who in 1903 reported 
on the separation of chloroplast pigments into a series of coloured bands on a packed column 
(Bidlingmeyer, 1992). Bidlingmeyer (1992) gives a table outlining the important advances in 
chromatography from 1903 until the appearance of the first commercial instrument in 1969. It 
was in the late 1960s and early 1970s that high performance liquid chromatography (HPLC) 
became well established as developments and refinements to the instrumentation took place 
as well as an increase in applications (Brown, 1989). Today most biochemical and 
biomedical laboratories use HPLC routinely for analysis of a wide variety of analytes, with 
molecule sizes varying from the very small (MW 100) to hundreds of thousands. A major 
step in the development of HPLC came with its automation enabling the generation of a 
large amount of very reproducible data in a relatively short time.
3.1.1 Instrumentation
Although there are now a variety o f manufactures producing HPLC systems, the basic layout 
is mostly the same. M ost instruments produced incorporate the following components; one or 
more solvent reservoirs, a pumping mechanism to deliver the mobile phase, valves or loops 
for sample injection, a separation column, a guard column to prevent contamination of the 
separation column by small particles and finally a detector unit. A schematic of a basic HPLC 
unit is shown in Figure 3.1. A sim ilar configuration was used for the work described later in 
the chapter
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Figure 3.1 Schematic ofHPLC used for analysis o f rabbit tissue samples
3.1.1.1 Mobile phase delivery systems
The mobile phase must be delivered to the column over a wide range of flow rates and 
pressures. To permit the use of a wide range of inorganic and organic solvents, the pump, its 
seals and all connections must be made of materials chemically resistant to the mobile phase. 
Of the many types of pump design currently in use (syringe type, constant pressure), the 
reciprocating piston type is the most popular, involving a small motor driven piston which 
moves rapidly back and forth in a hydraulic chamber that may vary in capacity from 35 to 
400(0.1 in capacity (Knox, 1982). This type of pumping induces pulses, which are damped out 
using a flexible bellows or a compressible gas in the capped upright porting of a T-tube to 
take up some of the pulsation energy. When the pump refills, this energy is released to help 
smooth the pressure pulsations. Pressures in excess of lOOOpsi are required for effective 
operation. Pulse dampers that use a compressible fluid separated from the mobile phase by a 
flexible inert diaphragm offer several advantages including easy mobile phase changeover, 
effectiveness at low system pressure, wide dynamic range, and minimal dead volume. In this 
type of pulse damper, the compressible fluid expands when the pump system retracts, 
maintaining system pressure and constant solvent flow (Willard et al., 1988).
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3.1.1.2 Sample injection
Insertion of the sample onto the pressurised column m ust be as a narrow plug so that the peak 
broadening attributable to this step is negligible. The injection system itself should have no 
dead (void) volume. M ost systems today are automated and sample injection onto the column 
is achieved without the use of syringes. Loop or valve injection is very rapid and can operate 
at pressures up to 470 atm with less than 0.2% error (W illard et a l,  1988). The system can be 
located within a tem perature-controlled environment for systems that require handling at 
elevated temperatures. The method of injection for the work presented in this chapter used an 
autosampler with needle uptake into a 20 jxl sample loop.
3.1.1.3 Separation column
Columns for HPLC are constructed of heavy wall, glass lined metal tubing, or stainless steel 
tubing to withstand high pressures (up to 680 atm) and the chemical action of the mobile 
phase. Column end fittings and connectors must be designed with zero void volume to avoid 
contributing to band broadening. M ost column lengths range from  10 -  30 cm long, short, 
fast columns are 3 -  8 cm long. For the work described in this chapter column length was 30 
cm constructed from stainless steel tubing. Many HPLC separations are done on columns 
with an internal diameter of 4 -  5 mm providing a good compromise between efficiency, 
sample capacity and the amount o f packing and solvent required. Column packings feature 
particles that are uniformly sized and mechanically stable with diameters in the range o f 3 -5  
(im, occasionally up to 10 |lm  or larger for preparative chromatography (Snyder et al., 1988).
3.1.1.4 Detection
Today there are a num ber of different detection formats available for HPLC including ultra 
violet-visible (UV-Vis) and fluorescence. Optical detectors based on UV-Vis adsorption are 
by far the most common form at in use (W illard et al., 1988). Basically three types of 
absorbance detectors are available: a fixed-wavelength detector, a variable-wavelength
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detector, and a scanning ( ‘real-tim e’) detector. These systems have become so refined that 
fundamental noise limitations now originate from thermal instabilities in flow cells and in the 
optical and electrical components (Skoog et al., 1998). Detector cell volumes on the order of 
8 fil per centimetre of optical path length are acceptable for conventional-diam eter separation 
columns. The detector used in the work presented in this chapter is the UV-Vis type with 
variable wavelength detection.
3.1.2 Optimisation of HPL C separations
Before analysis, in order for the best resolution to be achieved, the instrument must first be 
optimised for the separation being undertaken. W hile almost every separation reported in the 
literature lists conditions that require optimisation specific for the application, there are a 
number of precautions and steps that apply to all situations. These include temperature 
effects, viscosity and extra column band broadening, all of which were optimised for the 
system used in this chapter prior to analysis of samples.
3.1.2.1 Temperature effects
In many HPLC analysis, variations in temperature can cause significant changes in retention 
times, making qualitative analysis difficult and affecting the precision of quantitative 
measurements. Elevated temperatures are advantageous because of decreased mobile phase 
viscosity, increased mass transfer, and increased sample solubility result in either better 
resolution or faster analysis.
3.1.2.2 Viscosity
A solvent with low viscosity is always preferred in HPLC (Braithwaite and Smith, 1985). 
While maintaining constant pressure drop across the column, an increase in the viscosity of 
the solvent always decreases the flowrate of the mobile phase. To overcome this application 
of more pressure to maintain the flow rate is required, which can produce heat, and may have
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a detrimental effect on the separation. There is also a practical lim it to the pressure that can 
be applied to maintain flow rates determined by the packing material and column 
construction. The diffusion coefficients of solutes are also affected by the viscosity o f the 
mobile phase. For the mobile phase used in this chapter the use o f m ethanol ensured low 
viscosity, making the desired flow rate (1 ml/min) easily achievable without the need to 
lower the viscosity further.
3.1.2.3 Extra column band broadening
Extra column band broadening is caused by dilution factor the injector, column (dead) void 
spaces, the volume of connecting tubing before and after the separation column, and the 
detector volume. Any band spreading from these factors is added to the random dispersion 
within the separation column. For symmetrical solute elution bands, these factors are additive 
as variances:
^  tot ~  inj +  O ’ trails ^  d e t)  "I" ^  colum n
W here Otot — total dispersion factor.
CTinj =  dispersion contribution from the injection.
Otrans =  dispersion contribution from the tubing.
O'¿et =  dispersion contribution from the detector,
^column =  dispersion contribution from the column.
In order to neglect the variances from the term s within the parentheses, they m ust collectively 
amount to less than half the column variance at the flow velocities needed for HPLC (1 
ml/min in this application). W ith the use of narrow bore columns, the detector volume must 
be 2 - 3(xl to ensure the separations achieved within the separation are not lost through band 
spreading within the detector (Willard et al., 1988). For the instrument used in this chapter all
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tubing length before and after the separation column was minimised, the column set vertical 
and all connections carefully checked for correct fit and seal.
3.1.3 Solvent programming
A separation using a single solvent o f constant composition is termed an isocratic elution 
(Skoog et al., 1998). However, for the work carried out in this chapter a gradient profile was 
used. This technique involves the use of two solvents differing significantly in polarity and in 
the course of the separation the ratio of the two solvents combining to make up the mobile 
phase is varied according to a profile entered by the operator. This can be carried out by 
introducing both solvents into a mixing chamber at varying rates (Fig 3.1). Section 2.3.2.3 
details the gradient profile used for analysis of coumarin metabolism in section 3.2. The 
optimum gradient for a particular separation is selected by trial and error, following selection 
of the solvents based on theory, as the case with the work presented later in this chapter. The 
use of gradient elution means it is possible to obtain both maximum resolution and sensitivity 
for every solute in the sample (W illard et al., 1988).
3.1.4 Reverse phase chromatography
Reverse phase is one type o f the many formats of chromatography available to HPLC. 
Reverse phase chromatography, as used for this work, uses a hydrophobic bonded packing, 
usually with an octadecyl (C-18) or octyl (C-8) functional group and a polar m obile phase, 
often a partially or fully aqueous mobile phase. Polar substances prefer the mobile phase and 
elute first. As the hydrophobic character of the solute increases, retention increases. 
Generally the lower the polarity o f the mobile phase, the higher is its elution strength (Synder 
et al., 1988). Hydrocarbons are retained more strongly than alcohols, thus w ater is the 
weakest eluent. M ethanol and acetonitrile are popular solvents because they have low 
viscosity and are readily available with excellent purity (Biblingmeyer, 1992). Eluents 
intermediate in strength in between these solvents and water are obtained by preparing 
mixtures. Since the optimum composition of the mobile phase must generally be found by 
trial and error, it is sometimes convenient to start with a 1:1 water methanol mixture. If the
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sample components elutes at or near the transit time o f a non-retained solute, tM, a lower 
concentration of methanol is indicated. Changing to acetonitrile, dioxane, or mixtures of 1,4- 
dioxane/methanol or acetonitrile/2-propanol can also improve selectivity (Skoog et a l,  1998). 
In reverse phase chromatography, solvent gradients are generated by a continuous decrease in 
the polarity of the eluent during the separation -  for example by gradually increasing the 
organic solvent content in water/methanol or water/acetonitrile mixtures.
3.1.4.1 Mechanism of reverse-phase chromatography
When a solute dissolves in water, the strong attractive forces between water molecules get 
distorted or disrupted. These attractive forces arise from the three dimensional network of 
intermolecular hydrogen bonds. Only highly polar or ionic solutes can interact with the water 
network (Biblingmeyer, 1992). Nonpolar solutes are “squeezed out” of the mobile phase but 
bind with the hydrocarbon moieties of the stationary phase. In reverse-phase chromatography 
the driving force for retention is not the favourable interaction of the solute with the 
stationary phase, but rather the effect of the mobile-phase solvent in forcing the solute onto 
the hydrocarbonaceous bonded layer (Skoog et a l,  1998). In opposition is the interaction of 
the solutes polar groups with the mobile phase. As a result, hydrophobic retention involves 
mainly nonpolar substances or the nonpolar portion of molecules. Hydrophobic retention can 
be lessened by adding to water any organic solvent that is m iscible with water. The less polar 
the added solvent the greater the effect.
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3.2 Determination by reverse-phase HPLC of the UDP-glucuronyl 
transferase activity for 7-hydroxycoumarin in rabbit tissue samples
3.2.1 Coumarin metabolism
Section 1.2.4 outlined the metabolism of coumarin and the major phase I pathway in humans. 
In this chapter HPLC is used to examine the metabolic fate of the phase I metabolite, 7- 
hydroxycoumarin (7-HC) in various rabbit tissue samples, and to examine the rate of its 
metabolism. Analysis of these samples would provide information on inter-organ differences 
in the metabolism of 7-HC. The results would also provide a comparison for the CE method 
applied to a similar study (except for the bladder) in chapter 4.
3.2.2 Sample preparation
Eight different rabbit organs were chosen including liver, kidney, heart, lung, spleen bladder, 
large intestine, and fat. Samples were prepared from each organ as outlined in section 2.3.2.1 
and incubations set up for metabolism of 7-HC. The protein concentration for each organ 
sample was calculated as outlined in section 2.3.1.1. The values obtained are shown in Table
Organ Protein concentration (m g/m l) used in 
incubations
Liver 0.77
Kidney 1.10
Heart 1.04
Lung 1.76
Spleen 1.66
Large intestine 1.35
Fat 0.00
Bladder 0.35
T able  3.1 Protein concentrations fo r  each o f  the organs analysed fo r  uridine diphosphate 
glucuronyl transferase UDPGT activity
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3.2.3 Development of HPLC Separation
3.2.3.1 Separation column
For the separation of polar molecules, reverse phase chromatography (section 3.1.4) with the 
use o f a non-polar stationary phase is the method of choice. For the application here a Ci8 
column was used as it had been reported with success in the method of K illard et al. (1996) 
for separation o f the same compounds.
3.2.3.2 Mobile phase and gradient profile
Section 3.1.2 outlines the preliminary checks made to the instrument prior to development of 
the method. A reverse-phase gradient FEPLC method was adapted from that o f Killard et al., 
(1996). Development of the gradient elution profile was carried out by analysing a series of 
standards under different conditions until the optimum separation of analytes was achieved. 
Using a gradient profile has the effect of increasing the retention time of the glucuronide, 
moving it away from the void volume. Figure 3.2 shows the resolution obtained with the 
glucuronide (7-HCG) eluting at 8.3, 7-hydroxycoumarin (7-HC) at 10.4, and internal standard 
(4-hydroxycoumarin, 4-HC) at 12.2 minutes, respectively.
The choice of solvents used for the separation was selected because they had been 
successfully used previously by Egan and O ’Kennedy (1992) and Sharifi et al. (1993). The 
composition of the mobile phase was Methanol: Water: Acetic Acid (950: 50: 2 v/v). The 
gradient profile was as follows: 0.5 min 100% A —> 50% A: 50% B, 5 -  14 min 50% A: 50% 
B, 14 -  15 min 50% A: 50% B —» 100% A. This profile represents a decrease in retention 
time by more than 8 minutes for the internal standard, 4-HC, and a 4 and 6 minute decrease 
for 7-HCG and 7-HC, respectively, over the method of Killard et al. (1996). Baseline 
resolution is still maintained between each peak (Fig 3.2)
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3.2.3.3 Detection
Previous HPLC methods for analysis of coumarins used 320 nm as the detection wavelength 
of choice (Killard et a l,  1996). W hile the coumarins will absorb more strongly at lower 
wavelengths in the spectrum, detection at these wavelengths (214 nm) is hampered by 
absorbance from other species present in the matrix, making the lower wavelengths only 
suitable for analysis of pure samples of coumarins. Hence 320 nm  was used here as the 
detection wavelength.
Time (min)
F igure 3.2 Chromatogram showing separation o f  standards, 7-hydroxycoumarin, 7- 
hydroxycoumarin glucuronide and the internal standard, 4-hydroxycoumarin, in incubation 
medium, using reverse phase gradient elution chromatography (1 ml/min flow  rate) with 
detection at 320 nm.
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3.2.4 Glucuronidation of 7-hydroxycoumarin by UDPGT
Section 1.2.4.1 outlined the metabolism involved in glucuronidation of 7-hydroxycoumarin 
(7-HC) with the enzyme UDPGT. There are few methods that allow the direct determination 
of 7-hydroxycoumarin-glucuronide (7-HCG) without deconjugation (Sharifi et a l,  1993; 
Killard et a l,  1996). However, with the method applied here the metabolite o f 7- 
hydroxycoumarin, 7-hydroxycoumarin glucuronide, was m onitored over time and its increase 
could be seen clearly (Fig. 3.3). The determination of 7-hydroxycoumarin (7-HC) or its 
metabolite allows a calculation of the metabolic rate of the reaction for the tissue in question. 
The pathway by which 7-HC is metabolised to 7-HCG is shown in Figure 1.1.
Tim e (min)
F igure 3.3 Overlay o f  fo u r  chromatograms o f  kidney reaction mixture showing analysis 
fo r  7-hydroxycoumarin-glucuronide at time 0, 30, 60, and 90-min. H PLC conditions were as 
fo r  Figure 3.1.
Eight organs; liver, kidney, large intestine, bladder, lung, spleen, heart and fat were selected 
for the study. UDPGT activity was not observed in all tissues. The highest activity was 
observed in the liver, followed by the kidney and bladder. A very low level of 7-HCG 
production was observed in the large intestine with trace amounts o f 7-hydroxycoumarin-
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glucuronide observed for the spleen and lung after 90 minutes. The fat and heart tissue 
showed no detectable activity.
3.2.5 Analysis of results
The amount of 7-HCG produced was calculated using peak height ratios (7-HCG over 
internal standard) from a standard curve prepared as outlined in section 2.3.2.2. Tables 3.2 
and 3.3 show the amount of 7-HCG produced at each time interval o f sampling with the 
standard deviation and coefficient of variation (C.V.). C.V. was calculated using the formula:
mean 1
3.2.5.1 Hate of reaction for each organ
A plot of the mean 7-hydroxycoumarin-glucuronide concentration produced (n=3) versus 
time was used to calculate the activity of UDPGT in the tissue (Table 3.4). The rate of 
reaction was calculated from the linear part of the curve (Fig. 3.4) using the formula shown 
below.
Rate o f  reaction = slope -¡- [protein] + molecular weight
W here: slope = slope of the linear portion of the graph
Iprotein] = protein concentration of the organ (Table 3.1)
M olecular w eight = molecular weight o f 7-HCG  (338.14)
The liver and kidney produced appreciable quantities of 7-hydroxycoumarin-glucuronide 
with relative activities o f 2300 and 220 pmol o f 7-hydroxycoumarin-glucuronide produced 
per minute per milligram of protein, respectively. The bladder showed an activity of 140 
pmol of 7-HCG produced per minute per milligram of protein, w ith a very low level of
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activity in the large intestine of 7.8 pmol of 7-HCG produced per minute per milligram of 
protein.
T im e (min) M ean  (n=3) 7-H C G  
concen tra tion  (¡jM ) ± S.D.
c.v.
Kidney Liver Kidney Liver
0 00.00 ± 0.00 00.00 ± 0.00 0.0 0.0
15 02.40 ± 0.09 02.50 ± 0.40 3.7 1.5
30 05.30 ± 0.20 49.60 ± 3 .3 0 4.0 6.6
45 10.30 ± 0 .0 4 81.50 ± 2 .8 0 4.3 3.4
60 12.60 ±  0.60 102.0 ± 3 .4 6 4.9 3.4
75 17.30 ± 0 .48 129.0 ± 3 .8 7 2.7 3.0
90 20.70 ± 1.53 133.0 ± 7 .1 8 7.4 5.4
T able 3.2 Mean concentrations o f  7-hydroxycoumarin-glucuronide (±  the standard  
deviation, S.D.) produced by rabbit kidney and liver UDPGT and the % relative standard  
deviation over time (n=3).
Tim e (m in) M ean (n=3) 7-H C G  
concen tra tion  (fxM) ±  S.D.
C.V.
Lrg. Int. B ladder Lrg. Int. B ladder
0 0.000 ± 0.00 0.000 ± 0.00 0.0 0.0
15 0.100 ± 1.78 0.940 ± 3 .55 2.7 0.9
30 0.213 ± 0 .8 0 1.756 ± 0 .8 8 3.0 4.4
45 0.337 ± 1.37 2.980 ± 0 .58 4.8 6.1
60 0.480 ± 0.95 3.250 ± 0 .98 5.1 2.2
75 0.665 ± 0 .41 3.685 ± 2 .5 4 3.0 3.5
90 0.751 ± 0 .2 2 4.666 ± 1.74 6.6 4.8
T able  3.3 Mean concentrations o f  7-hydroxycoumarin-glucuronide (±  the standard  
deviation, S.D.) produced by rabbit large intestine and bladder UDPGT and the % relative 
standard deviation over time (n=3).
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Time (min)
Figure 3.4 Graph showing rate o f  production o f  7-hydroxycoumarin glucuronide in fo u r  
o f the tissue samples; liver (A), kidney (B), bladder (C), and large intestine (D).
Tissue C on cen tra tio n  o f 7-H C G  p roduced  p e r 
m in  p e r  m illig ram  of p ro te in  (pmol)
Liver 2300
Kidney 220
Bladder 140
Large intestine 7.8
Lung 0.0
Spleen 0.0
Heart 0.0
Fat 0.0
T able  3.4 Table showing the activities o f  the different organs in the production o f  7- 
HCG.
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3.3 Discussion
As discussed in section 1.2.4 glucuronidation of compounds is carried out by the UDPGT 
family of membrane-bound enzymes (Dutton, 1991). Analysis of glucuronidation is of vital 
importance for a number of reasons, primarily because o f its role as the major detoxification 
pathway, accounting for m ost of the detoxified material in the bile and urine. Since the same 
family of enzymes carries out the glucuronidation of many different drugs, use of a model 
drug, while providing important information on that drug also provides the researcher with 
information on glucuronidation sites within an organism. This information helps elucidate the 
drug distribution within the species and, as drugs from almost all therapeutic classes are 
glucuronidated (Clarke and Burchell, 1994), understanding the location and rate at which it 
occurs provides valuable information required for generation of relevant dosage.
Another important feature of understanding glucuronidation is that for most drugs the 
glucuronide conjugate is form ed mostly for the purpose of detoxification and excretion, as in 
the case of bilirubin (Dutton, 1991), and has no pharmacological properties. However, in the 
case of the drug morphine, it was discovered that morphine-6-glucuronide was 650 times 
more potent than the parent drug as an analgesic (W ahlstrom et al., 1989). For this reason the 
development of methods to determine the m ajor sites of glucuronidation and for its detection 
is important. UDTGT activity for 7-hydroxycoumarin is present in many organs of the one 
species, here in the rabbit it has been demonstrated to be present in the liver, kidney and to a 
lesser extent bladder and large intestine. Trace amounts o f the glucuronide were found in the 
spleen and lung, with no detectable activity in the heart and fat tissue. The HPLC method 
used here was adapted from that of Killard et al. (1996) with a significant decrease in total 
analysis time. This was achieved by altering the gradient profile to decrease the retention 
time of all three analytes and internal standard, 4-HC (by up to 8 minutes in the case of the 
internal standard). This is the first time a study on the metabolism of 7-HC with different 
rabbit tissue has been undertaken, with analysis by HPLC. The results will provide 
researchers with information on the presence of the UDPGT enzyme system within the 
different organs of the rabbit as well as respective rates of metabolism of 7-hydroxycoumarin 
to the glucuronide. This information is very useful, not only for the understanding of 
coumarin metabolism, but also in understanding glucuronidation of drugs and for possible 
differences between the pathways used.
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4 CAPILLARY ELECTRO PH O RESIS  
APPLIED TO THE AN ALYSIS OF
COU MARINS
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4.1 Introduction
The term electrophoresis first appeared in 1909 when M ichaelis discovered the separation of 
proteins based on their isoelectric points. The work of Tiselius (1937) gave the first 
indication o f the potential o f electrophoresis for analysis, demonstrating the separation of 
serum proteins, albumin, and the a -, P-, and Y-gl°bulins by “moving boundary 
electrophoresis” . However, this approach to electrophoresis was limited by incomplete 
separation of the proteins, the relatively large sample volume needed, and the necessity of 
relatively low electric fields due to the convection currents generated by Joule heating, 
despite the use of dense sucrose solutions. Consden et al., (1944) and W ieland and Fisher, 
(1948) demonstrated paper electrophoresis to be applicable to a wide variety of molecules, 
while Kolin (1954) tried isoelectric focusing (IEF) but with little success as his pH gradients 
were short and unstable over time. The 1960’s saw m ajor improvements as polyacrylamide 
gels were optimised with stacking and resolving buffer systems for high resolution 
separations of native and sodium dodecyl sulphate (SDS)-complexed proteins (Brishammar et 
al.; 1961, Davis, 1964). The synthesis by Vesterburg (1969) of ampholine mixtures, 
facilitating stable pH gradients in isoelectric focusing gave rise to the use o f this method as a 
routine biochemical method for analysis.
It was against a background of increasing demands for high resolution, quantitative precision 
of bio-pharmaceuticals and control of waste management costs (from HPLC), that capillary 
electrophoresis (CE) was developed. The pioneering work of Hjerten (1967) laid the 
groundwork for the CE analysis of diverse analytes, ranging from small molecules (inorganic 
ions, nucleotides) to macromolecular structures, such as proteins and viruses. Much of this 
work was conducted with a functional CE unit, albeit with 3 mm tubes, that was constructed 
in 1959.Virtanen (1974) followed this work with the use of smaller internal diameter tubes 
(0.2mm), which eliminated convection problems and simplified instrument design. In the late 
1970’s and early 1980’s, CE was shown to be a viable analytical technique by M ikkers et al., 
(1979), and Jorgenson and Lukács, (1981). It was shown that CE had potential for producing 
high-resolution separations of biopolymers, as well as smaller pharmaceutical agents, and 
used minuscule amounts of both sample and reagents. Improvements in sensitivity of 
detectors, advances in automation technology and, most particularly, the widespread
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availability of high quality narrow bore capillary silica tubing has allowed CE to be applied 
to many areas of analysis, several of which are examined in this thesis.
4.1.1 Instrumentation
A diagrammatic representation of a CE instrument is shown in Figure 4.1. The basic 
components include a high voltage power supply (0 -  60kV), a polyimide-coated capillary 
with an internal diameter of <200 |xm, two buffer reservoirs that can accommodate both the 
capillary and the electrodes connected to the power supply, and a detector.
F igure 4.1 General schematic o f a CE instrument.
To perform a separation the capillary is filled with an appropriate separation buffer at the 
desired pH and sample is introduced into the inlet. Both ends of the capillary and the 
electrodes from the high voltage power supply are placed into buffer reservoirs and up to 
30kV applied to the system. The ionic species in the sample plug migrate with an 
electrophoretic mobility (direction and velocity) determined by their charge and mass, and 
eventually pass a detector where information is collected and stored by a data 
acquisition/analysis system.
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4.1.1.1 Capillaries
Separation capillaries are m ostly made of fused silica with an internal diameter between 10 
and 100 nm and a variable length that can be up to 100 cm. Open tubes are used for free zone 
electrophoresis. Surface m odification is necessary if  electroosmotic flow is to be reversed or 
eliminated (section 4.1.2). Since this flow is generated by the silica wall, it is evident that the 
quality of the fused silica may play an important role in the separation process (Carchon and 
Eggermont, 1992)
4.1.1.2 Injection
In order to reduce the dispersion of the separated zones, the sample itself must be loaded onto 
the capillary in a narrow zone. The two most commonly used methods are hydrodynamic 
pressure injections and electrokinetic injections (Skoog et al., 1998). O f the two, the form er is 
the only unbiased method o f injection, as electrokinetic injections have the disadvantage that 
the loading of sample ions onto the capillary depends on their charge and mobility, the faster 
migrating ions entering the capillary in larger numbers. Hydrodynamic injection allows the 
sample to be pressed into the capillary, hence it cannot be used for gel filled capillaries. Care 
must be taken before separation to ensure the capillary is in equilibrium. For both types of 
injection it is necessary to ensure buffer reservoir levels are the same to prevent siphoning in 
either direction which could reduce or increase sample loading. Gravity can also be used to 
introduce sample ions into the capillary. It is a very elegant and highly reproducible 
technique in which one end o f the capillary is dipped into the sample and both are lifted for a 
preset time. Both height and time in combination with the viscosity of the sample determine 
the amount of sample loaded onto the capillary (Carchon and Eggermont, 1992).
4.1.1.3 Detection
The instruments most frequently used and commercially available are optical detectors using
15 13UV or fluorescence with reported representative limits of detection (LODs) of 10‘ to 10' 
for absorbance and down to 10'20 moles for fluorescence. For detection, the most common
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format involves removal of a small section o f the capillary polymer coating so that the 
capillary wall becomes transparent for UV/fluorescence detection. This type of arrangement 
(on-column) is available on most commercial CE instruments, but as seen later in chapter 6, 
even lower LOD’s are obtainable using a post column detection format. Other forms of 
detectors have also been employed. These include Raman spectroscopic detection systems 
and electrical conductivity electrical systems as well as the coupling of CE to mass 
spectrometers. Representative detection limits for mass spectrometry is in the order of 
1 x 10"17 moles with conductivity at 1 x  10"16 moles (Skoog et a l ,  1998).
4.1.2 Electroosmosis in Capillary Electrophoresis
Electrophoretic mobility (|i) of a charged molecular species can be approximated from  the 
Debye-Huckel-Henry theory
= q/6nr]r (1)
where q is the charge on the particle, T) is the viscosity of the buffer and r  is the stokes radius 
of the particle. The mass of the particle may be related to the Stoke’s radius by M  = (4/3) 
7irV  where V  is the partial specific volume of the solute. However, due to the non-spherical 
shape, counter-ion effects, and non-ideal behaviour of proteins and biological molecules 
inside the capillary these conditions are not met (Rickard, 1991). As electrophoresis ensues in 
normal polarity mode from positive to negative, the analytes separate according to their 
individual electrophoretic mobilities and pass the detector as “analyte zones” . Since under the 
appropriate conditions, all species (net positive, negative and neutral) pass the detector 
indicate that a force other than electrophoretic mobility is involved. If the applied electric 
field were the only force acting on the ions, net positively (cationic) substances would pass 
the detector, while neutral components would remain static and net negatively (anionic) 
species would be driven away from the detector. The other force involved is “electroosm osis” 
(Chiari et al., 1996).
Electroosmotic flow was first identified in the late 1800’s when Helmholtz (1879) conducted 
experiments involving the application of an electrical field to a horizontal glass tube
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containing an aqueous salt solution. Helmholtz discovered that the silica im parted a layer of 
negative charge to the inner surface of the tube, which, under an applied electric field, led to 
the net movement of fluid to the cathode. W hat happens is shown in Figure 4.2, the ionised 
silanol groups (SiO‘) of the capillary wall attract cationic species from the buffer. Obviously 
the buffer pH will determine the fraction o f the silanol groups that will be ionised. The ionic 
layer that is formed has a positive charge density that decreased exponentially as the distance 
from the wall increases. The double layer formed closest to the surface is termed the “Inner 
Helmholtz or Stem Layer” and is essentially static. A  more diffuse layer formed distal to the 
Stem Layer is termed the “Outer Helmholtz Plane” (OHP). Under an applied field cations in 
the OHP migrate in the direction of the cathode carrying the waters of hydration with them. 
Because of the cohesive nature of the hydrogen bonding of the waters of hydration to the 
water molecules o f the bulk solution, the entire buffer solution is pulled towards the cathode. 
This EOF or “bulk flow” acts as a pumping mechanism to propel all molecules (cationic, 
neutral and anionic) towards the detector. It is this phenomenon that allows CZE to be a 
widely versatile tool today for analysis. This is the driving force behind all separations 
reported in this chapter.
Stem layer
Outer 
Helmholtz 
plane37 5 u
F igure  4.2 Diagram o f  the capillary and the ionic layers critical in 
generating electroosmotic flow
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4.1.3 Control of electroosmotic flow
There are several ways to partially or fully control EOF (and adsorption). These include the 
use of additives and buffer changes (Bushey and Jorgenson, 1989), organic solvents (Campos 
and Simpson, 1992), adsorption of neutral and/or charged macromolecules (including 
surfactants) to the wall (Chiara et al., 1996) and chemically bonded phases (Nashabeh, 1991). 
A brief outline of some of these measures will be given here.
4.1.3.1 Buffer changes and additives
Buffers cations: To evaluate the effect of the buffers cation on electroosmotic flow
(|xeo), Atamna, (1991), and Issaq, (1991), conducted a series of experiments in 0.1M each of 
Li, Na, K, Rb and Cs acetates. The results showed that the larger the crystal radius, the higher 
the effect of the cation in quenching |ieo. It was hypothesised that the larger cations are more 
strongly adsorbed onto the silica wall, thereby altering its charge and effectively reducing 
EOF.
Zwitterions: Another way to control EOF (without altering the buffer conductivity) is to
add zwitterions to the running buffer. Ideally these zwitterions should have a large ApK, so as 
to be isoelectric over the pH 3 -  10 range. Exam ples are trimethylammonium propyl 
sulphonate, triethylammonium propyl sulphonate, and tripropylammonium propyl sulphonate 
(Bushey and Jorgenson, 1989)
Solvents: Binary mixtures of water and a protic (methanol, ethanol, 2-propanol) or an
aprotic dipolar solvent (acetonitrile, acetone, dimethyl sulphoxide) all in a 1:1 ratio, 
dramatically lower EOF and zeta potential by shifting the pK values of silanols to higher pH 
ranges (Schwer, 1991).
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4.1.3.2 Adsorbed coatings
A number of substances adsorb to the silica wall through electrostatic interactions or 
hydrogen bonding following hydrophobic derivatisation of the capillary. These can be neutral 
molecules, e.g. polyvinal alcohol, or cationic surfactants, e.g. Fluorad FC134 (Chiari et al., 
1996). If the wall adsorbs a neutral polymer, electroosmosis is eliminated and the solutes may 
be sterically prevented from coming into contact with the wall and from being adsorbed. 
When cationic surfactants are added to the separation buffer, the charge on the surface will be 
changed from negative to positive and the EOF direction will be reversed.
4.1.3.3 Chemically bonded phases
The development of coatings covalently bonded to the capillary wall in recent years has led 
to significant improvements in the elution profile and separation efficiencies of biopolymers. 
The chemistry usually involves organosilanisation, a surface modification procedure derived 
from “silane-coupling” methodology, which has being successfully transferred to capillary 
electrophoresis. Fused silica capillaries are typically reacted with organosilanes to yield an 
Si-O-Si (siloxane) linkage.
Capillary
wall Si - OH + R4.nSiXn —>
N
:S i - O X n.iR 4-n + HX
where n = 1 -  3, R is an alkyl or substituted alkyl group and X is an easily hydrolysed group 
such as halide, amine, alkoxy or acyloxy. In an ideal modification procedure the bonded 
phases should completely cover the original silica and the functions introduced should not 
interact with biopolymer solutes over a wide range of conditions. The coating should exhibit 
a defined or reproducible composition and the bonded phases should have high chemical 
stability and resistance in the presence of alkaline and acidic solvents used routinely in CE 
(Chiari et al., 1996)
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4.1.4 Other modes of capillary electrophoresis
W hile capillary zone electrophoresis is perhaps the most common form of CE used today, 
other forms of electrophoresis have been incorporated to the capillary format, including 
micellar electrokinetic capillary chromatography, capillary gel electrophoresis, capillary 
isoelectric focusing, and capillary isotachophoresis. These methods can be carried out with 
the same basic equipment and allow highly efficient separations of neutral species and/or 
ions.
4.1.4.1 Micellar electrokinetic capillary chromatography
M icellar electrokinetic capillary chromatography (MECC) which was first described by 
Terebe (1985), is based on micellar solubilisation and electrokinetic migration. The technique 
involves the addition of a surfactant to the buffer, e.g. deoxycholic acid, at a concentration 
just above its critical micelle concentration (CMC). This allows the formation of micelles 
inside the capillary, a pseudo stationary phase that enhances the separation of sample ions but 
also permits the neutral sample compounds to partition within the interior of the micelle. 
Separation of all sample analytes depends now on the differential partition between the 
hydrophobic interior of the charged micelle and the aqueous phase. Since electroosmotic flow 
still dominates the direction of the flow, all analytes are eluted at the end of the capillary. The 
retention order in MECC is determined by the solubility of the solutes in the aqueous mobile 
phase. The use of surfactants not only improves the separation of ionic compounds, but also 
extends the methods applicability to water-insoluble solutes, whereas the choices of anionic 
or cationic surfactants further increases the diversity of M ECC (M atsubara and Terabe, 
1996).
4.1.4.2 Capillary gel electrophoresis
The technique o f capillary gel electrophoresis (CGE) is almost a direct transfer of 
conventional gel electrophoresis into a capillary. The traditional method, while relatively
simple, is labour intensive involving the preparation of gels, long run times due to low
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voltage applications, because of heat dissipation problems, and slow staining/destaining 
techniques for visualisation. The end result is only qualitative. In CGE the technique is more 
rapid, with tiny (by comparison) volumes of gel required, the ability to apply high voltages 
and hence short analysis times (due to the large surface area and thin walls of the capillary 
resulting in rapid heat dissipation). Since protein zones are registered by either UV adsorption 
or fluorescence (for labelled samples), CGE offer qualitative information. When 
polyacrylamide gels are used, the pore size can be manipulated by altering the ratio of 
monomer to cross linking agent in the polymerisation mixture, and thus the pores of the gel 
can be made comparable to the size o f the molecules to be separated as demonstrated in 
chapter 7. Also the use of different m olecular weight dextrans allows the separation to be 
tailored to the desired molecular weight range. In CGE, factors, including eddy diffusion and 
solute sorption, can influence zone broadening. The efficiency is lower than that obtained in 
open tubular CZE, but the selectivity in increased so that separation is still obtained (Campos 
and Simpson, 1992).
4.1.4.3 Capillary isoelectric focusing
In capillary isoelectric focusing (cIEF), amphoteric analytes such as peptides and proteins are 
separated on the basis of their isoelectric point (Rodriguez-Diaz et al., 1997). Sample ions are 
mixed with the carrier ampholytes that span the desired pH range, and the mixture is loaded 
onto the capillary. W hen an electric field is applied, the ampholytes build up a pH gradient 
and the sample ions focus concurrently. This process can be followed by a current decrease. 
In cIEF resolution strongly depends on the slope of the pH gradient. A fter focusing, sample 
ions are eluted from the capillary by 1) a pressurised flow, 2) lifting one end of the capillary; 
and 3) adding salt (e.g. sodium chloride) to the electrode buffer. As the sodium ions replace 
protons in the capillary, a pH balance gradient is generated and is followed by elution of the 
components. In capillary isoelectric focusing (CIEF), the coating of the capillary is important 
because the electroosmotic flow m ust be eliminated completely (Hjerten, 1987). Since the 
entire capillary is filled with sample ions, larger sample amounts are used for isoelectric 
focusing, i.e., when proteins are focused, care must be taken that precipitation must not occur, 
because o f protein concentration that is excessive. At the same time, the resistance in the
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capillary increases at those sites where proteins are focused, so that heat development at these 
sites may cause protein precipitation.
4.1.4.4 Capillary isotachophoresis
Capillary isotachophoresis is performed in a discontinuous buffer system, as opposed to CZE 
which uses a uniform buffer carrier throughout. The sample is introduced in solution as a 
zone between a leading electrolyte and a terminating electrolyte, each containing only one ion 
species with the same sign as the sample ions to be separated. For the system to work, on 
application of the electric field, the leading electrolyte must have an effective mobility 
higher and the termination electrolyte must have an effective mobility lower than that of the 
sample ions.
When the system has reached equilibrium, all of the ions migrate with the same speed, but are 
separated into a discrete number of zones in immediate contact with each other and arranged 
in order of decreasing mobility. Because of these identical migration velocities, a voltage 
gradient in the consecutive zones occurs so that, by using a potential gradient detector, a 
stepwise pattern is recorded. The electropherogram has always been difficult to inteipret as 
sample compounds are separated but the zones are close to each other. Quantitative 
information is got from the length of a zone as it reflects the amount of the component 
present. This means that the electropherogram may show very different patterns that are 
difficult to recognise. However the problems can be overcome by transforming the 
conductivity signal into a chromatogram like pattern. The electropherogram would then show 
peaks that are located at specific conductivities, and the area under the peak reflecting the 
amount (Carchon and Eggermont, 1989). UV detection can be used only if UV-absorbing 
ions are preceded and followed by non UV absorbing compounds or vice versa.
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4.2 In vitro glucuronidation of 7-hydroxycoumarin and determination of 
7-hydroxycoumarin and 7-hydroxycoumarin-glucuronide by capillary 
electrophoresis
4.2.1 Coumarin metabolism
Section 1.2.4 gave a brief description of coumarin metabolism. The majority of coumarin 
administered in humans is excreted as 7-hydroxycoumarin glucuronide (7-HCG). It is the 
principal phase II metabolite and is produced from the main phase I metabolite, 7- 
hydroxycoumarin (7-HC). Here using CE, various rabbit tissues are analysed for both their 
ability to glucuronidate 7-HC, involving uridine diphosphate glucuronyl transferase 
(UDPGT), and to carry out the reverse reaction, breakdown of 7-HCG to 7-HC, using (3- 
glucuronidase. Figure 1.1 shows the reaction scheme for both UDPGT and (3-glucuronidase.
4.2.2 Sample preparation
Seven rabbit tissue types were selected, consisting of liver, kidney, large intestine, lung, 
spleen, heart and fat. Samples were prepared from each organ and incubations set up as 
outlined in section 2.3.2.1. In order to calculate the rate of reaction for 7-HCG production the 
protein concentration for each organ sample was calculated as outlined in section 2.3.1.1. The 
values obtained are shown in Table 4.1.
4.2.3 Method development
4,2.3.1 Capillaries
Section 4.1.1.1 describes the capillaries used without surface modification, allowing EOF to 
be the overall driving force for all separations. The shortest capillary length allowed by the 
design of the instrument, 27 cm, was chosen to reduce analysis tim e (19.3 cm to detector).
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4.2.3.Z Buffers
Phosphate buffer was chosen as electrolyte due to its buffering capacity within the desired pH 
region for the separations, pH 7.0-7.5. In order to determine m axim um voltages that could be 
used for the separation an O hm ’s Law plot was constructed for lOOmM phosphate buffer (Fig 
4.3). This would give an indication at what voltage joule heating inside the capillary might 
begin to affect the separation (from use of too high voltages). The plot shows a linear range 
up to ~10kV, but application of up to 17kV may be possible without affecting the separation. 
For separations it was found that 17.5kV gave good results in terms of total run time with 
reasonable current and no detrimental effects on the separation over the course of the study.
4.2.3.3 Detection
All analytes absorb at 214 as well as 320 nm. However, due to interferents in the m edia also 
absorbing at 214 nm, it was not possible to analyse at this wavelength. Hence 320nm was 
chosen as the wavelength of detection, despite a slight loss in sensitivity.
Voltage (kV)
F ig ure  4.3 O hm ’s Law p lo t fo r  100 m M  phosphate buffer
Page 86 of 243
4.2.4 UDPGT assay results
Separation of 7-HCG from endogenous species present in the metabolic m ixture and from 7- 
HC is achieved in under 4 minutes. Figure 4.4 shows an electropherogram of the reaction 
mixture for the kidney. It also shows an overlay of electropherograms of samples taken at 
time 0, 40, and 80 mins. The increase in production of 7-HCG with time can be seen.
Organ Protein concentration (m g/m l) used in  
incubations
Liver 0.76
Kidney 1.35
Heart 1.09
Lung 1.65
Spleen 1.68
Large intestine 1.29
Fat 0.00
T able  4.1 Protein concentrations fo r  each o f  the organs analysed fo r  UDPGT activity. 
Protein concentration calculated as outlined in section 2.3.1.1
A graph of mean (n=3) concentration of 7-HCG produced against time (Tables 4.2 and 4.3) 
was plotted for each organ and the slope of the graph used to calculate the reaction rates for 
each organ (Table 4.5). Rate of reaction was given by:
slope + [protein] + molecular weight
Where: slope = slope of the linear portion o f the graph
[protein] = protein concentration from Table 4.1 
M olecular weight in the case o f 7-HCG = 338.14
The rates of reaction calculated for each organ shown in Table 4.4 are expressed as pico 
moles (pmol) of 7-HCG produced per minute per milligram of protein.
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Tim e (mins)
Figure 4.4 CE electropherogram o f the kidney metabolic solution. It shows an 
overlay o f electropherograms o f samples taken at 0, 40 and 80 min, respectively. 
Overlays shown between 3.4 and 5.9 min. Conditions: 27 cm fused silica capillary; 
lOOmM phosphate buffer, pH 7.0; 8 s pressure injection; separation at 17.5kV, with 
detection at 320 nm.
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The mean amount (n=3) of glucuronide produced was calculated for each organ from a 
standard curve (0-200^g/ml) prepared as outlined in section 2.3.3.5. The results obtained 
demonstrate the liver to be the major site of glucuronidation for 7-HC, followed by the 
kidney, and with a small amount produced by the large intestine (Table 4.4).
Percentage relative standard deviation for each peak were all < 9.8%. The concentration of 7- 
HCG produced with time was calculated for the liver, kidney and large intestine along with 
the CV for each time interval using the formula:
C V = Standard Deviation x  100 
Mean
Table 4.2 shows the % RSD for 7-HCG concentrations with time for the large intestine and 
kidney, with the results for the liver shown in table 4.3.
T im e (min) M ean  (n=3) [7-HCG] (|xM) ± SD CV
Lrg. Int. Kidney Lrg. Int. K idney
0 00.00 ± 0.00 00.00 ± 0.00 0.0 0.0
20 00.00 ± 0.00 20.86 ± 0 .8 0 0.0 3.8
40 00.00 ±  0.00 32.66 ±3 .21 0.0 9.8
60 00.00 ± 0.00 70.00 ± 3.60 0.0 5.1
80 00.00 ± 0.00 80.09 ±3 .11 0.0 3.8
100 00.00 ± 0.00 95.89 ± 1.34 0.0 1.4
120 00.00 ± 0.00 118.66 ± 2 .7 2 0.0 2.3
140 0.497 ± 0.04 131.85 ± 2 .0 7 8.0 1.6
160 0.563 ± 0.05 148.77 ± 2 .7 9 8.0 1.8
T able  4.2 M ean (n=3), standard deviation and  % RSD fo r  7-HCG produced with time 
fo r  the kidney and large intestine (Lrg. Int.). Results calculated as outlined in section 4.2.4.
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Tim e (min) M ean (n=3) [7-H CG] (jiM) ±  SD CV
0 00.00 ± 0.00 0.0
20 09.80 ± 0 .5 0 5.0
40 23.66 ± 0 .8 8 3.7
60 37.56 ± 0 .8 3 2.0
80 48.55 ± 0 .6 9 1.4
100 58.11 ± 1.01 1.7
120 63.11 ± 0 .7 6 1.2
140 76.44 ± 1.17 1.5
160 87.11 ± 1.16 1.3
T able  4.3 Mean (n=3), standard deviation and % RSD fo r  7-HCG produced with time 
fo r  the liver. Results calculated as outlined in section 4.2.4.
Tissue M ean (n=3) [7-HCG] p ro du ced  p e r  m in 
p e r m illig ram  of p ro te in  (pmol)
Liver 2100
Kidney 200
Large intestine 7.8
Lung 0.0
Spleen 0.0
Heart 0.0
Fat 0.0
Table 4.4 Table showing the activities o f  the different organs in amount o f  7-HCG  
produced in pmol p er  minute p er  milligram o f  protein.
4.2.5 p-Glucuronidase assay results
The method of Bogan et al. (1995) when applied as a new procedure for the assay o f 13- 
glucuronidase activity proved effective for detection of both 7-HC and 7-HCG. Separation of
Page 90 of 243
both compounds was achieved in less than 4 minutes and the increase in 7-HC concentration 
with time can be seen as shown in Figure 4.5. The same seven organs chosen for the UDPGT 
assay were chosen for this study.
4.2.5.1 /?-Glucuronidase activity calculations
Activity was expressed in the form of (3-Glucuronidase activity units/g wet mass of whole 
organ. The activity for each organ was compared to that of (3-glucuronidase obtained from 
Sigma and from this the activity in units/g wet weight of organ could be determined. A 
standard curve with 0 -  10,000 units o f (3-glucuronidase incubated for 30 minutes with 200 
(ig/ml 7-HCG prepared as outlined in section 2.3.3.5 was used to calculate activities. Figure 
4.5 shows the increase in 7-HC concentration with increase in units of (3-Glucuronidase for a 
30 min incubation. Results show that in excess of 500 units is enough to completely liberate 
102|ig of 7-HC from 200(Ag of 7-HCG in 30 min.
U nits of (3-G lucuronidase
F ig ure  4.5 Table showing amount o f  7-HC produced from  7-HCG with increasing 13- 
Glucuronidase enzyme units (obtained fro m  Sigma) fo r  30 min incubation. Incubation 
conditions were as outlined in section 2.3.3.2.
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Time (min)
Figure 4.6 Portion o f electropherogram from liver incubation showing increase in 
breakdown of7-H CG  to 7-HC with time. Conditions: 27 cm fused silica capillary; lOOmM 
phosphate buffer, pH  7.0; 8 s pressure injection; separation at 17.5kV, with detection at 320
As in the case of the UDPGT assay the liver proved to be the most active site for 
deconjugation of 7-HCG (Table 4.5), followed by the spleen with about half the activity of 
the liver. The kidney and lung displayed low activity relative to the liver, with the heart and 
intestine showing the lowest activity. The fat, as expected, showed no detectable trace of 7- 
HCG breakdown. Figure 4.7 shows the comparison of endogenous P-glucuronidase activity 
in each organ versus 7-hydroxycoumarin produced. The activity is expressed in units, where 
1 unit is that which will liberate 1.0 p.g of phenolphthalein from phenolphthalein glucuronide 
per hour at 37°C at pH 5.0 (30 min assay). The limit of detection for the 7-HC was l|xg/ml.
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Organ homogenate Average (3-Glucuronidase activity units/g 
wet mass of whole organ (n=3)
Liver 12,660
Lung 1710
Intestine 1003
Fat 0
Spleen 6200
Heart 800
Kidney 1780
Table: 4.5 /3-glucuronidase activity (units/g wet weight o f  organ) in whole organ 
homogenates as determined after analysis by capillary electrophoresis.
W hole organ homogenate
Figure 4.7 Plot showing the comparison o f  endogenous ¡3-glucuronidase activity in each 
organ (± S D ) versus 7-hydroxycoumarin produced (fig/ml) fo r  the study o f  the deconjugation  
o f  7-hydroxycoumarin-glucuronide to 7-hydroxycoumarin.
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4.3 Determination of 7-hydroxycoumarin and its glucuronide and 
sulphate conjugates in liver slice incubates by capillary zone 
electrophoresis
Fig. 1.1 shows the reaction scheme for both the glucuronide and sulphate conjugates and 
outlines the preferential pathways for each phase II metabolite. W hile glucuronidation 
(examined in section 3.2 and 4.2) is preferential, this investigation establishes the use of CE 
for the measurement of the sulphate conjugate produced by mouse liver.
4.3.1 Synthesis of 7-hydroxycoumarin sulphate
7-hydroxycoumarin-sulphate was synthesised according to the method outlined in section 
2.3.4.1. In total 216mg was synthesised. Due to its susceptibility to hydrolyse rapidly it was 
stored at -80°C  in a sealed glass vial until required for use. The com pound was used within 
one week, and was analysed by CE each day prior to use. No evidence of breakdown to 7- 
hydroxycoumarin was detected.
4.3.1.1 NMR analysis
To check the structure for correct synthesis a sample of the com pound was taken and 
analysed by nuclear magnetic resonance (section 2.3.4.2) (Figures 4.9 -  4.10). The scan 
shows the H doublet at 6.24 corresponding to position 2 on the structure (Fig 1.1), a doublet 
and a singlet at positions 4 and 8 at 7.09 and 7.11, respectively. The doublet linked with the 
carbon double bond is shown at 7.46, and the doublet associated with the oxygen (position 7) 
at 7.79.
4.3.1.2 IR analysis
A further structural study used IR for analysis of the com pound (section 2.3.4.3). The scan is 
displayed in Figure 4.11. The fingerprint region shows a lot of peaks. However, stretches at
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1725.86 indicate the carbonyl group and a stretch at 1622.41 shows presence of the carbon 
double bond. It is also possible that the -O H  stretch at 3464 (from water) has contributions 
from the sulphate group.
4.3.2 Sample preparation
4.3.2.1 Tissue slicer fabrication
In order to obtain precision cut liver slices a small instrument based on that described by 
Krumdieck et al. (1980) was made. Figure 4.8 shows the two main units, the coring tube and 
piston. Freshly obtained liver from mice was cored with the coring tube several times to fill a 
portion of the tube.
17 rru
11 m m
^  8.1 m m
F ig ure  4.8 Diagram showing main components o f  tissue slicer. The piston is shown with 
markings to ensure exact slice thickness, and below, the coring tube which contained the liver 
sample. D imensions are in millimetres.
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Figure 4.9 Nuclear magnetic resonance scan o f  7-hydroxycoumarin sulphate, complete
scan (top), expanded reigon 6 - 8  ppm  (bottom).
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Peak constant PC 
Noise
Sens, level
1.00
1496
5985
Peak Picking region 
Start(ppm/Hz)______ End(ppm/Hz) MI (%) M A X I (%)
26.55/10623.8 -13.76/-5505.3 0 . 00 100.00
Peak
Peak
Pickinq results 
Nr. Data Point Frequency PPM Intensity % Int.
1 3812 3118.42 7.7934 262930 9.6
2 3816 3110.55 7.7737 252136 9.2
3 3878 2988.48 7.4687 258712 9.4
4 3882 2980 .60 7.4490 300318 11.0
5 3949 2848 .69 7.1193 324894 11.8
6 3954 2838.84 7.0947 236872 8.6
7 3959 2829.00 7.0701 205790 7.5
8 4126 2500.20 6.2484 233190
op
9 4130 2492.32 6.2287 233552 8.5
10 4449 1864.25 4.6590 18902 0.7
11 4461 1840.62 4.6000 2742434 100.0
12 4677 1415.35 3.5372 164248 6.0
13 4758 1255.87 3.1386 233396 8.5
F igure  10 Nuclear magnetic resonance scan o f 7-hydroxycoumarin sulphate, expanded 
region (3.0 -  5.0 ppm) o f  scan (top) and peak information (below)-
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FIND PEAKS:
Spectrum: 7-OHCOUMARINSULFATE
Region. 4000.00 400.00
Absolute threshold: 59.177 
Sensitivity: 50
Position: 1240.15 Intensity. 9 788
Position: 1061 15 Intensity 13 340
Position: 1725 86 Intensity: 16 444
Position: 1622.41 Intensity: 24 644
Position: 129877 Intensity: 27 589
Position: 1741.10 Intensity: 29.103
Position: 992.10 Intensity: 29 377
Peak information:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
Position:
1250.59
637.28
1277.52
745.34
838.58 
1134.20 
1049.81 
1263.64
843.59
570.73 
707.87 
627.57
849.73 
879.19 
613.32 
781.03 
3457.94 
3462.27 
3444.79
Intensity
Intensity
Intensity:
Intensity:
Intensity:
Intensity
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
Intensity:
: 31.953
:32.111
:32.217
:33.313
:33.276
:34.780
:36.976
:42.536
:46.196
:48.613
:52.442
:53.729
:55.855
:55.914
:56.626
:56.672
:59.013
:59.072
:59.083
F igure  4.11 Infra-red spectrum o f  7-hydroxycoumarin sulphate. Scan shows -O H  peak at 
3454 cm'1, carbon oxygen double bond at 1725 c m 1 and carbon double bond at 1622 c m 1.
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The piston was used to push the liver out where it was then sliced evenly with a razor blade 
pressed against the face of the coring tube. Regular spaced markings on the piston ensured 
slices of identical thinness while the diameter of the slice was determined by the diameter of 
the coring tube. The slicing procedure was earned out with the apparatus submerged in 
Krebs-Hanseleit buffer at all times. In order to avoid any possible reaction between the 
materials used for construction o f the sheer and the liver or buffer, brass was used to 
manufacture the piston with high speed stainless steel used for the coring tube. Following 
slicing of liver and immobilisation on a flat surface, incubations were set up and as detailed 
in section 2.3.4.4.
4.3.2.2 Krebs-Henseleit buffer
Krebs-Henseleit buffer was prepared as outlined in section 2.3.4.5 and samples were prepared 
as outlined in section 2.3.4.4 using the tissue slicer detailed in section 4.3.2.1.
4.3.3 C E  Separation
The CE method applied to the analysis of in vitro glucuronidation of 7-hydroxycoumarin in 
section 4.2 was used here. Capillary type, length and electrolyte buffers selection were made 
according to the same criteria outlined in section 4.2.3.
4.3.4 Results
The method proved very satisfactory for the resolution of all three analytes. Fig 4.12 shows 
an electropherogram of a standard mixture in Krebs-Hanseleit buffer. All three analytes were 
seen to resolve within 6 minutes. The Krebs-Hanseleit buffer was also run without any of the 
analytes added and no peaks which might interfere with results were noted. Figure 4.13 
illustrates an electropherogram following an 8 hour incubation with 100|jM  7-HC in Krebs- 
Hanseleit buffer showing the production of both phase II metabolites of 7-HC, namely, 7- 
hydroxycoumarin glucuronide and sulphate.
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F ig u re  4.12 Electropherogram o f  a standard solution o f  all three analytes in Krebs- 
Hanseleit buffer. Concentrations: 60juM 7-HC, 7-HS, 40jjM  7-HCG. Conditions: 27 cm fu sed  
silica capillary; lOOmM phosphate buffer, p H  7.0; 8 s pressure injection; separation at 
17.5kV, with detection at 320 nm.
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F ig u re  4.13 Electropherogram showing the production o f  7-HCG and 7-HS after an 8- 
hour incubation with 100-jiiM 7-HC in Krebs Hanseleit buffer. Samples filtered  (0.22/Jin) 
prior to analysis. Conditions: 27  cm fu se d  silica capillary; lOOmM phosphate buffer, p H  7.0; 
8 s pressure injection; separation at 17.5kV, w ith detection at 320 nm.
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4.3.5 Inter- and Intra-assay studies
To assess the method in terms o f reproducibility and accuracy for analysis of the three 
analytes and as a method for analysis of liver slice incubations, both inter- and intra-assay 
studies were carried out using the following procedure.
Using peak heights mean (n=3) the concentrations of 7-HC, 7-HS and 7-HCG were 
calculated (calculated concentration, (iM) along with the standard deviations. These were 
then compared to the actual known value of each analyte (nominal concentration). Values for 
coefficient of variation and percentage accuracy were calculated from peak heights using the 
following formulae:
„  „ . . Standard deviation x  100
C o e f f i c i e n t  o j  v a r i a t i o n :
mean
_ calculated result x  100
P e r c e n t a g e  a c c u r a c y :
nominal result
4.3.5.1 Intra-assay performance
Intra-assay performance was assessed by analysing concentrations corresponding to the 
lower, middle and upper regions of the standard curve. The samples were analysed in 
replicates of five on the same day. Table 4.6 shows the results obtained. CV and percentage 
accuracy values are within ±14 and ±11%, respectively, with 80% of the values for both CV 
and percentage accuracy deviating within ±7%. As expected, precision and accuracy showed 
the largest deviation at the lim it o f detection of the method, most noticeable with 7-HC and 7- 
HS.
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Intra-assay performance
Concentration
Nominal Calculated S.D. % Accuracy CV (%)
7-HC 6.17 5.55 0.52 89.95 9.37
12.3 11.5 1.60 93.35 13.89
30.9 31.6 1.28 102.4 4.05
61.7 63.1 2.25 102.2 3.57
123 121 5.76 98.26 4.75
7-HCG 2.76 3.07 0.22 111.2 7.17
5.52 5.76 0.25 104.4 4.34
13.8 14.1 0.76 102.5 5.37
27.6 28.6 1.75 103.4 6.13
55.2 57.0 0.32 103.2 0.56
7-HS 4.42 5.08 0.67 101.0 13.2
8.84 8.55 0.56 96.72 6.54
22.1 21.6 0.47 97.69 2.18
44.2 44.2 0.40 102.0 0.89
88.4 89.1 2.52 100.8 2.83
T able  4.6 Intra-assay precision and accuracy results fo r  the determination o f  7-HCG  
and 7-HS conjugates o f  7-hydroxycoumarin fo r  liver slice incubates. Values calculated as 
outlined in section 4.3.5.
4.3.5.2 Inter-assay performance
Inter-assay performance was assessed by analysis of samples in a range of four different 
concentrations of each analyte in triplicate over three different days. Table 4.7 shows the 
results obtained. CV and percentage accuracy values were between ±13 and ±6%, 
respectively. As with the intra-assay performance, both precision and accuracy showed the
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highest values at the lim it o f detection of the method. A ssay specificity was assessed by 
analysis of incubates without any 7-HC added. No significant interferents were noted in any 
of the migration zones of the analytes.
Inter-assay performance
Nominal Day 1 Day 2 Day 3 Mean S.D. CV (%) % Prec.
7-HC 12.34 13.64 12.34 12.34 12.69 0.83 102.8 6.54
30.86 30.97 31.10 30.42 30.83 0.36 99.90 1.17
61.73 61.14 62.26 61.45 61.22 0.58 99.82 0.94
123.5 122.6 123.3 123.7 123.2 0.57 99.93 0.46
7-HCG 5.52 6.35 5.02 6.04 5.80 0.70 105.1 12.1
13.8 14.0 13.5 14.5 14.0 0.52 101.1 3.71
27.6 27.4 27.8 27.5 27.6 0.24 99.93 0.87
55.2 55.0 55.3 55.4 55.2 0.22 99.98 0.40
7-HS 8.84 7.91 8.08 9.11 8.37 0.67 94.68 8.00
22.1 22.4 23.5 21.9 22.6 0.80 102.2 3.54
44.2 44.1 43.3 45.6 44.3 1.19 100.3 2.68
88.4 88.1 89.3 91.6 89.7 1.78 101.4 1.98
Table 4.7 Inter-assay percentage CV and accuracy results fo r  the determination o f  7- 
HCG and 7-HS conjugates o f  7-hydroxycoumarin fo r  liver slice incubates. Values calculated  
as outlined in section 4.3.5.
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The CE method applied to the analysis of the glucuronidation of 7-HC by rabbit tissues was 
found to be very fast and reliable for the direct determination o f 7-HC and 7-HCG as in vitro 
metabolites of reactions involving UDP-glucuronyl transferase and (3-glucuronidase with 
total analysis times less 7 minutes, with injector to detector times for all analytes under four 
minutes. Minimal sample clean up was necessary thus reducing errors that may otherwise be 
introduced due to complex sample preparation steps (extraction, precipitation etc.). The 
method would also facilitate studies of promoters and inhibitors of both UDPGT and (3- 
glucuronidase enzymes.
When compared to the HPLC method used in the previous chapter, the results show good 
agreement. Differences in the measurements of 7-HCG produced per minute per milligram of 
protein for the various organs are less than 10%. The liver shows a difference of 8.69% 
(2300pmol for HPLC, 2100pmol for CE), the kidney showed a variation of 9.09% (220 pmol 
for HPLC, 200 pmol for CE), while the large intestine showed a similar amount of 7-HCG 
produced per minute per milligram of protein (7.8 pmol) following analysis by either method. 
This study shows the CE method to be as reliable as the HPLC method. The advantages of 
speed of analysis coupled with vastly reduced sample and reagent requirements for CE (and 
hence much less waste) being significant differences.
The method may be applied for analysis of both the glucuronide and sulphate phase two 
metabolites proved to be very simple and effective for the determination of all three analytes, 
with good resolution and easy sample preparation, while still keeping the run time to a 
minimum. The method offers the advantage o f speed (3 minute decrease in analysis over the 
fastest reported HPLC method) and minimal use of solvents (10 ml total solvent volume 
required for CE analysis) over pervious HPLC methods (Hiller and Cole, 1995; W alsh et al., 
1995). Its main advantage over other CE methods using LIF detection is that all three 
metabolites can be detected simultaneously (Cole et al., 1996). Although UV detection does 
not offer the level of sensitivity of laser-induced fluorescence detection (LIF) it still offers 
acceptable levels at a much lower cost. Coupled to the lower sensitivity of UV, the sensitivity 
of the method is further affected by having to detect the coumarin metabolites at 320 nm 
instead of the more sensitive 214 nm. This is due to the absorbance of endogenous species 
present in the matrix interfering with the results when the lower wavelength is used for 
detection.
4.4 Discussion
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5 MICROCHIP CAPILLARY  
ELECTROPHORESIS - DEVELOPMENT 
OF IMMUNOASSAYS FOR WARFARIN
AND PARATHION
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5.1 Introduction
5.1.1 Micro-chip based Capillary Electrophoresis
Microchip CE was first developed in the early 1990s by Harrison and M anz (Harrison et a l,
1992). This system, with electrokinetic fluid handling has received ever increasing interest 
over the past eight years (Effenhauser, 1998) and is now a rapidly advancing area where the 
most notable results have been accomplished (Harrison et a l,  1993). Glass has been 
employed as the substrate of choice for CE applications as the micromachining techniques 
are well established and the general optical, electrical and chemical properties are favourable. 
The ability to transfer a variety of surface m odification methods from conventional CE to 
planar chips is also an advantage. Glass is preferred over silicon devices for CE applications 
as these, despite being covered with insulating layers of thermal oxide and CYD nitride, have 
suffered from breakdown problems which lim it the application voltages (Harrison et a l,
1993). Hence, while silicon substrates have been very successful in other areas (free flow 
electrophoresis and liquid chromatography), in CE, where high voltages are common, they 
have very little reported use (Effenhauser, 1998).
5.1.1.1 Sample Injection on planar chips
A means for sample injection was the first functional accessory that was successfully 
integrated into a planar CE device. The geometrical design for sample injection was first 
proposed by Verheggen et al. (1988) and has dem onstrated its performance with the injection 
of microlitre sample volumes and sample plug lengths of several centimetres (Harrison et a l, 
1992; Effenhauser et al., 1993). Figure 5.1 shows the valveless design with a double “T” 
injector. Application of potential between reservoirs 1 (sample) and 4 (injection waste) 
electrokinetically pumps sample, filling a 150 ^im length which is equal to 90 pi o f the 
separation channel. This method of injection ensures that there is no electrokinetic bias in the 
sample injected as long as the potential is applied for enough time to ensure that even the 
slowest sample component has completely filled the injection volume. This is in contrast to
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electrokinetic sample injection in conventional capillaries, which is known to bias the sample 
according to the respective ionic mobilities.
F igure  5.1 Layout o f  a glass chip with integrated sample injection. The inset shows 
details o f  the geometry o f  the injection arrangement with a sample p lug  length o f  150 /Jrn and  
volume o f  90 pi. 1,3 and 5 are buffer reservoirs, 2 is the sample reservoir, and 4 is the sample 
waste.
Leakage from the injection channels into the separation channel is sometimes observed after 
application of the separation voltage. It can be avoided by more sophisticated voltage control 
protocols during sample injection and separation (Effenhauser et al., 1994).
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5.1.1.2 Electrophoretic Separations
To date a wide variety o f separations have being performed on-chip, matching those of 
conventional CE in buffer solutions (Effenhauser, 1998; Chiem and Harrison, 1997). 
Mixtures of flourescently labelled (Fluorescein isothiocyanate, F l i  C) amino acids have been 
used as model case studies (Effenhauser et a l,  1993). Separations in polymer sieving
matrices have also been reported (Effenhauser et al., 1994). Separations are carried out in the
same format on-chip as conventional CE. However, as the separation channel on a chip is 
much shorter than a capillary, lower voltages can be applied while still achieving the same 
electric fields.
5.1.2 Materials for microsystems
Miniaturised systems for performing chemical/biochemical reactions and analysis require 
cavities, channels, pumps, valves, storage containers, couplers, electrodes, windows and 
bridges (Qin et a l,  1998). The typical dimensions of these components are in the range of a 
few micrometers to several millimetres in length or width and between 100 nm and 100 pm
in depth. The materials used are both rigid and elastomeric.
R igid  materials: There is a range of substrates on which microsystems can be built,
including crystalline silicon, glass, quartz, metals and organic polymers. Rigid silicon-crystal 
structures have the advantage o f a well established technology for manufacture, including the 
ability to form two and three-dimensional shapes and facilitate batch fabrication. However, 
disadvantages include the expense of the starting material, the fact that it is brittle and opaque 
in the uv/visible regions and its surface chemistry is complicated to manipulate (Qin et a l, 
1998).
Elastomeric materials: A  new route for fabricating optical elements and optical
systems from elastomeric materials such as poly(dimethylsiloxane), PDM S, was developed 
(Qin et a l,  1998). These types of optical components and devices have characteristics that 
can be controlled by changing their shape by mechanical compression or extension. Among
Page 109 of 243
the advantages to using PDMS are durability, ability to deform reversibly, optically 
transparent down to -300  nm, and it is inexpensive. An example of its application is adaptive 
optics, which have previously been constructed from small individual rigid components that 
were moved independently to modify characteristics (Hubin, 1993).
5.1.3 Microfabrication techniques
The methods used for the manufacture o f chips for CE applications include lithographic and 
other techniques as discussed in the following sections.
5.1.3.1 Photolithography
The most common lithographic technique in use today is photolithography (Moreau, 1988). 
The method involves a substrate which is spin coated with a thin layer o f photoresist 
(photosensitive polymer), and exposed to a UV light source through a photomask. A quartz 
plate covered with patterned microstructures of an opaque material is used as the photomask 
and the pattern is transferred to the film  of photoresist. Following this the substrate (glass 
chip) is then etched, a procedure carried out by placing the substrate in a dilute, stirred 
HF/NH4F bath to form the channels. Only the surface area of the photoresist exposed to the 
UV light is rem oved allowing the desired pattern to be etched into the substrate (Fig 5.3). To 
form the closed network of channels, a cover plate is bonded to the substrate over the etched 
channels. For fused quartz substrates, gold/chromium films are necessary as an etch mask 
during HF/NH 4F etch. When examined in cross-section the channel profile is trapezoidal due 
to the isotropic etch of amorphous materials, with measurements o f from 2 0  to 1 0 0  pm 
widths at half height and depths from 5 to 20 pm (Chiem and Harrison, 1997). Holes can be 
drilled in the cover plate to produce a communication link between an attached reservoir and 
channels and can be held in place by epoxy resin or interference fit.
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5.1.3.2 Alternative microfabrication methods
Although photolithography is widely used to manufacture structures for microelectronic 
circuits, MEMS, microanalytical devices and micro-optics, it has a num ber of disadvantages. 
It is a relatively high cost technology, cannot be applied easily to curved surfaces, is 
applicable only to a small set of material and gives little control over the properties of the 
surfaces that are generated (Qin et a l,  1998). A set o f non-photolithographic techniques for 
microfabrication have been developed. These techniques are discussed in detail by other 
authors, but include microcontact printing (Kumar et a l,  1995), micromolding in capillaries 
(Kim et a l, 1995) and replica molding (Xia et a l,  1996).
5.1.4 Microchip C E  and Immunoassays
5.1.4.1 Immunoassays -  a brief introduction
Immunoassays are among the most effective means for quantification of trace analytes in 
complex solutions (Schmalzing and Nashabeth, 1997). High selectivity results from specific 
antibody/antigen interactions while high sensitivity is achieved from a combination of strong 
binding, and fluorescent, chemiluminescent, radioactive or enzyme labels. The method of 
immunoassay was developed as far back as 1959 in New York by Solomon Berson and 
Rosalyn Yalow, when they developed the radioimmunoassay technique while working on the 
metabolism of 131I-labelled insulin (Law et a l,  1996). Although there were some initial 
difficulties with the report, as the view that antibodies could be raised against small 
molecular weight material was considered controversial, the benefits of the method were 
soon recognised and the applications of the technique grew rapidly in the area of clinical 
biochemistry. Since 1984 enzyme immunoassays have become the most popular form of 
assay, with radiolabelled and fluorescent assays the other common formats in use.
The most important part o f the immunoassay is the antibody. Figure 5.2 shows the structure 
of an IgG antibody and its fragments that can be used in assays (section 5.1.4.3). The basic 
structure consists of four polypeptide chains, two identical heavy chains, linked by one or 
more disulphide bridges, and two identical light chains, each paired with a heavy chain. Both 
heavy and light chains are comprised of two regions, a variable region (contributing to the
Page 111 of 243
binding characteristics) and a constant region, which is constant for a given class of antibody. 
There are two classes, K and X, in the constant region for light chains and for the heavy chains 
there are five major variants: y, a, e, pi, and 5. These determine the five major classes of 
immunoglobulin, IgG, IgA, IgE, IgM and IgD and their biological properties (Law et 
al., 1996).
Antigen 
binding sites
Variable Constant
l<  >\<-------------------------------->1
Light Chain Heavy Chain
Disulphide bridges
T h e  b a s i c  a n t i b o d y  u n i t
Papain fragm ents
Fab Fc Pepsin fragm  ents
F(ab’) ; pFc
E n z y m e  d e r i v e d  a n t i b o d y  f r a g m e n t s
Figure 5.2 The basic antibody unit used fo r  the development o f on-chip assays fo r warfarin 
and parathion (top). Also shown are the fragments (Fab, F(ab’) 2 and pFc) enzymatically 
produced using papain and pepsin digests o f whole antibody o f which the Fab and F(ab’) 2 can 
be used fo r  immunoassays.
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A drawback of common immunoassays is that they tend to be slow and manually intensive 
and often require multiple incubation, washing and rinsing steps, which can take many hours 
to complete. In an attempt to develop more rapid and automated assay formats, microchip CE 
has being applied to this area.
5.1.4.2 Immunoassays using C E
The immunoassays that have being performed using CE can be classified as either 
competitive or non-competitive. In almost all cases reported to date, fluorescent labels have 
been used (Koutny et al., 1996; Chiem and Harrison, 1997).
Non-competitive assays: In a non-competitive assay, an excess of labelled antibody (or
antibody fragment) is added to a sample solution and is used to determine sample antigen. 
The labelled antibody, called the affinity probe, forms a complex specifically with antigen of 
interest.
The resulting equilibrium is:
Ab* + Ag Ab*Ag
W here Ab* = labelled antibody
Ab = antigen
Ab*Ag = antibody-antigen complex
Therefore, a CE-LIF analysis o f a non-competitive mixture should reveal two zones, one 
corresponding to the free Ab* and one corresponding to the Ab*Ag complex (provided there 
is excess antibody). Provided that the complex is stable on the time scale o f separation, it 
should be possible to quantify Ag - based on the amount of complex formed, and/or decrease 
in the amount of free Ab* monitored by peak heights for each species
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Competitive im m unoassays: Competitive immunoassays utilise a competition between
labelled antigen (Ag*), also called the tracer, and antigen (Ag) to bind antibody (Ab) in order 
to determine Ag in the sample. To perform  the assay, a limiting amount of antibody is mixed 
with sample containing Ag and a fixed concentration of Ag*. The resulting equilibria are:
Ag* + Ab -^-►Ag*Ab
Ag + Ab r ^ A g  Ab
After incubation, Ag* and Ag*Ab are separated and quantified. As seen from the equilibria, a 
large [Ag] will result in lower [Ag*Ab] and higher [Ag*]. Therefore the amount of analyte 
can be indirectly determined by m easuring the concentration of either bound Ag*, free Ag* 
or their ratio. This approach has the advantage over the non-competitive format as due to the 
large size of the antibody relative to the antigen, it may not be possible to achieve a 
separation between Ab* and Ab*Ag (binding of the antigen by the antibody may not produce 
a complex with significantly different migration time). In the com petitive format, this 
problem is overcome by the use of the labelled antigen (Ag*) which will generally have a 
migration time significantly differing from that of the antibody/antibody complex, and should 
also provide a sharp peak for quantitation (Schmalzing and Nashabeh, 1997).
5.1.4.3 Special issues for immunoassays by C E
Labelling: The type of label and method of labelling of drug or antibody can be a key
element in determining the success o f the assay. Fluorescent labelling is an attractive choice 
due very low limits of detection.. However, it is important that the label does not interfere 
with the Ab/Ag complex formation, and that labelling results in a homogeneous product, 
critical for the formation of narrow well defined zones upon separation. The label may also 
be used to modify the electrophoretic m obility to improve resolution by changing the overall 
charge of the product.
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Antibody: The correct choice of antibody is also of key importance. Monoclonal
antibodies are better than polyclonal antibodies for producing well-defined zones for the 
antibody-antigen complex. Is has also being reported that the use of antibody fragments, such 
as Fab, or F(ab)’2 , (Fig. 5.2) produce better results than for whole antibody due to sharper 
Ab/Ag complex peaks produced (Shimura et a l,  1994). However, results have shown that 
whole antibody or even polyclonal antibody can be used effectively (Evangelista et a l,  1994; 
Schmalzing et a l, 1995). In each case the complex peak is not useful for quantification, as it 
does not migrate in a sharp well defined zone, however adequate quantification is possible 
based on the free tracer (which migrates in a sharp zone) provided it separates well from the 
antibody-antigen complex.
Separation conditions: Adsorption of analytes and assay reagents to the capillary
surface degrades resolution and reproducibility, especially at the low concentrations 
associated with immunoassays. The migration buffer can be m anipulated in order to decrease 
adsorption (section 5.2.5). However, with immunoassays this is lim ited since the buffer must 
be compatible with the formation of an immunoaffinity com plex. Another issue that must be 
considered is speed and resolution of separation. Separation of Ab/Ag complex from free 
labelled reagent will disturb the binding equilibrium and result in dissociation of complex 
throughout the separation (Rief et a l,  1994). The magnitude of complex dissociation will 
depend on the dissociation rate of the complex and the rate of separation. It is for this reason 
that separations need to be performed as fast as possible with antibodies with slow 
dissociation rates. Figure 5.3 shows an ideal electropherogram that might be obtained from 
CE analysis following incubation of an antibody and antigen. Both UV and fluorescent 
formats were tried in the following sections.
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Figure 5.3 Model electropherograms for CE immunoassays. (1) shows the expected result 
using UV detection, in which all three species absorb, and appear in the electropherogram. 
(2) shows the expected result using fluorescence detection with a labelled antigen, only the 
free labelled antigen and conjugate (made visible by binding the labelled antigen) appear in 
the electropherogram. (3) shows the electropherogram obtained when a labelled antibody is 
used, again the conjugate is visible by means o f the label on the antibody, as is the antibody, 
but not the unlabelled antigen. These electropherograms represent the three strategies 
examined in the work presented in this chapter.
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5.2 Development of microchip based immunoassays for warfarin and 
parathion
5.2.1 Materials for microchip manufacture
Section 5.1.1 and 5.1.2 outline the criteria used in the selection of material for chip 
fabrication. Based on these considerations glass was chosen as the material of choice. For 
ease of handling it was important for the chip to be robust, and also as final assembly (drilling 
of cover plate and thermal bonding) was carried out “in-house”, a more durable chip would 
reduce the possibility of breakage. Figure 5.4 shows the layout and dimensions of the chip 
used in the assays.
5.2.2 Device fabrication
Etching of the substrate was done in the Alberta M icromachining Centre according to the 
procedure outlined in section 5.1.3. Figure 5.4 shows the channel pattern etched into the 
glass. The injection design outlined in section 5.1.1.1 was incorporated to avoid sample bias 
during injections.
F ig ure  5.4 Chip design. Dimensions are in centimetres
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A cover plate with 2mm diameter holes drilled under water using a diamond tipped drill, 
providing channel access points, was thermally bonded to a glass plate in which the channels 
were etched. This was done by hydrolysing both surfaces and contact bonding them followed 
by thermal processing at 500°C for 6 hours.
Photoresist
iz:
C r & Au
Glass
(A )
u m m  i nl  m i  i ———  Mask
(B)
(C)
(D)
(E)
(F)
Glass
(G)
F igure 5.5 Sequence o f  photolithographic fabrication: (A) Cr and.Au m asked glass plate  
coated with photoresist; (B) sample exposed to UV light through a master mask; (C) 
photoresist developed; (D) exposed metal mask etched; (E) exposed glass etched; (F) resist 
and metal stripped; (G) glass cover plate bonded to form  capillary.
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The sample introduction channel (SIC) between reservoirs 1 and 2 was designed for previous 
experiments involving periodic sampling from a flow through system. For the purpose of 
these experiments both reservoirs were filled with sample with potential applied at reservoir
1. Reservoir 3 is the sample waste while the long channel between 4 and 5 is for separation. 
The length of the separation channel was 5 cm.
5.2.3 Microchip station control and layout
Figure 5.6 shows the computer-controlled relay system used to apply and switch the 
potentials on the four device reservoirs (1 and 4 positive; 3 and 5 grounded). A 488nm argon 
ion laser (Uniphase/Ionice Model 2011) was used to excite fluorescence after focusing to a 
~40pim spot on the device channel. The fluorescence emission was collected with a 7:1 
microscope objective and directed onto a photomultiplier tube using a pinhole at the image 
plane and an optical bandpass filter (508-533nm). The emission signal was electronically 
filtered with a Krohn-Hite Model 3342 six pole Butterworth filter with a 200Hz low-pass cut­
off. Labview programs (National Instruments Corp., Austin, TX) written locally were used 
for calculations, data acquisition and instrument control.
F igure 5.6 Block diagram o f  the high voltage relay controlled system fo r  the capillary 
electrophoresis pow er supplies, with computer control and digital data acquisition o f  laser
excited (488 nm) fluorescence.
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5.2.4 Layout of chip station
F ig ure  5.7 Drawing showing overview o f  chip station and m ethod fo r  directing laser 
beam onto separation channel. M icroscope translation stage allows movement in x  and y 
planes.
F ig ure  5.8 Side view o f  chip on support w ith microscope and photom ultiplier tube (PMT) 
mounted directly above spot where laser is focused  onto the separation channel fo r  collection 
o f  fluorescence.
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5.2.5 Development of separation conditions
Protein separation in untreated fused silica capillaries requires special considerations if 
interactions between the negatively charged silanol groups on the capillary wall and 
positively charges residues in the proteins were to be avoided. There are a num ber of ways 
these interactions can be stopped or reduced to such an extent that their effect on the 
separation is negligible. These involve surface modifications of the capillary wall (Nashabeh 
et al., 1991), the use of buffer additives, (Bushy et al., 1989) and high pH buffers (Lauer and 
McManigill, 1986). Based on the fact that surface modification is a com plicated process and 
was not available to modify the chip surfaces, high pH buffers were chosen. Success with the 
use of buffer additives depends on the specific interaction of the additives with the sample, 
and in the case of immunoassays, m ight have a detrimental effect. W ith the use of high pH 
buffers electrostatic properties of the proteins can be exploited to favourable advantage. At a 
pH above its isoelectric point the protein will have a net negative charge and will be repelled 
from the wall of the capillary and chip.
5.2.5.1 Conventional CE
The use of borate buffers has been reported for separation of proteins and in immunoassays 
(including chip assays) with considerable success (Chiem and Harrison, 1997), and as the 
assay format was similar this was the buffer of choice. Concentrations varied slightly, with 
lOmM and 5mM used, pH 9.0.
5.2.5.2 Microchip CE
Borate buffers identical to those described in section 5.2.5.1 were used for microchip analysis 
of antibodies and unlabelled drug-protein conjugates. For analysis of FlTC-labelled drug- 
protein conjugates, the use of buffer additives to improve the peak shape were assessed. SDS- 
borate buffers were tried, however, SDS gave rise to a high background, so Tris-borate
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buffers (pH 8.5) were used with no increase in background. All buffers were filtered (0.22 
fim) prior to use.
5.2.6 Checking antibody reactivity
Warfarin and parathion antibodies for use in the assays were checked for reactivity using 
competitive ELISA as outlined in section 2.3.5.1. A schematic showing the different steps 
involved in the ELISA is shown in Figure 5.9. Absorbance readings obtained for the series of 
decreasing concentrations of free drug in solution, A, over Ao (absorbance obtained with no 
free drug in solution) were plotted against the log of free drug concentration in solution for 
each antibody (Fig 5.10).
Following confirmation of reactivity for both antibodies an analysis using conventional CE 
with UV detection was carried out for warfarin antibody. This was to examine binding of 
warfarin by antibody to confirm ELISA results. This examination also provided information 
on the stability of the complex under conditions applied during CE separations i.e. if any 
dissociation occurred during separation conditions (high pH buffers, pH 9.0, and high 
separation voltages, 16kV) (section 5.2.7). The results are shown in Figures 5.11 -  5.13.
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Figure 5.9 Schematic diagram for competitive ELISA used to determine antibody 
reactivity. The procedure was carried out as outlined in chapter 2, section 2.3.5.1.
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Log of free warfarin concentration (ng/ml)
Log of free parathion concentration (ng/ml)
Figure 5.10 Competitive ELISA test fo r  antibody activity. A, absorbance obtained with 
decreasing concentration o f  free  drug over Ao, absorbance with no fre e  drug, is plotted  
against log o f  free  drug concentration. Absorbance readings were recorded at 405 nm.
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5.2.7 CE analysis with UV detection
Figure 5.11 shows the electropherogram for free warfarin and Figures 5.12 and 5.13 show 
analysis of incubations of warfarin and increasing warfarin antibody concentrations (0.46, 
0.92, 1.39, 1.84 x  10'6 M). Due to some initial delays in the preparation of the parathion 
antibody it was not assayed by conventional CE here but was assayed on the chip at a later 
date. The antibody displayed a migration time difference of about 30 seconds to that of free 
warfarin (Fig 5.11).
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F igure 5.11 Analysis by CE o f  warfarin (7.39 x  1 O'5M) and anti-warfarin antibody (0.3 
pM) with UV detection at 214 nm. Conditions; untreated fu sed  silica capillary, 375/Mn OD, 
50 pm  ID; 19.3 cm to detector window, separation buffer; 5mM  borate buffer, p H  9.0; 5 s 
pressure injection with separation at 16kV and detection at 214 nm.
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Addition of antibody results in a decrease in the peak for free warfarin (Fig 5.12). However, 
an increase in migration time for the antibody/warfarin complex is also seen, as well as a 
reduction in tailing for the complex. Tailing is caused by interactions between the antibody 
and the wall of the capillary, and the binding of warfarin seems to be having an effect on 
these interactions while also increasing the migration time. Repeated analysis showed 
identical results.
Time (min) Time (min)
F igure  5.12 Addition o f  anti-warfarin antibody (0.46/lM, left, 0.92juM, right) to free  
warfarin (7.39 X  10'5M). Conditions: untreated fused  silica capillary, 375/Mn OD, 50 fM n  ID;
19.3 cm to detector window, separation buffer; 5mM  borate buffer, p H  9.0; 5 s pressure  
injection with separation at 16kV and detection at 214 nm.
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F ig ure  5.13 Addition o f  anti-warfarin antibody (1.39/uM, left, 1.84/jM, right) to free  
warfarin (7.39 x lO '5M). Conditions; untreated fu sed  silica capillary, 375/Jm OD, 50 fJm ID;
19.3 cm to detector window, separation buffer; 5mM borate buffer, p H  9.0; 5 s pressure 
injection with separation at 16kV and detection at 214 nm.
In order to apply microchip technology to the above assay, it is necessary to flourescently 
label either the antigen or antibody, as LIF detection was the only format available. W hile the 
results above are not ideal for the assay, they do indicate that the antibody is capable of 
binding the warfarin under CE conditions. Addition of labels to either reagent could change 
their migration times somewhat and perhaps provide better resolution.
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5.2.8 Labelling and analysis of antibody
5.2.8.1 Conventional CE-LIF analysis
Both anti-warfarin and anti-parathion antibodies were labelled with fluorescein 
isothiocyanate (FITC) as outlined in section 2.3.5.2 and affinity purified (2.3.5.3). Figure 
5.14 shows an electropherogram obtained from analysis of anti-warfarin antibody with laser- 
induced fluorescence detection (LIF). Anti-parathion antibody was analysed directly on chip.
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2.5
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gFigure 5.14 CE-LIF analysis o f anti-warfarin antibody (8 .7 xW  M). Conditions: lOmM 
borate buffer, pH  9.0; untreated fused silica capillary (50[Am ID, 375/Arn OD, 19.3 cm to 
detector window), 3 s pressure injection; separation at 16kV, 25°C, with excitation at 488 
nm, and emission at 520 nm.
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5.2.8.2 Micro-chip analysis of labelled antibodies
The anti-warfarin and anti-parathion antibodies were analysed by microchip CE. Figures 5.15 
and 5.16 show the electropherograms obtained. Both antibodies showed a constant migration 
time of 6 seconds (conditions as outlined in the legend). Following labelling both antibodies 
were assayed for activity by  ELISA as outlined in section 2.3.5.1. Results obtained were 
similar to those shown earlier for unlabelled antibodies, confirm ing that labelling had not 
interfered with activity of either antibody.
Time (s)
* 8Figure 5.15 Micro-chip analysis o f  F1TC labelled anti-warfarin antibody, 8.7x10' M. 
Conditions: 5mM borate buffer, p H  9.0, 10-second injection at 1.5V, separation voltage 6kV, 
with excitation at 488 nm , and emission at 520 nm.
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Time (s)
F igure  5.16 M icro-chip CE analysis o f  FITC-labelled anti-parathion antibody
(9x 10~8M). Conditions: 5m M  borate buffer, pH  9.0, 10-second injection at 1.5V, separation 
voltage 6kV, with excitation at 488 nm, and emission at 520 nm.
5.2.9 Development of immunoassay
A number of different approaches were tried for the development of the immunoassays. On 
reaction of labelled antibody (Ab*) with unlabelled antigen (Ag) (warfarin or parathion), it 
was not possible to see a separate peak corresponding to the antibody-antigen complex. If a 
complex was forming, it showed no change in migration tim e compared to that of the original 
antibody. Figure 5.17 illustrates this with repeated analysis (conventional CE) for a range of 
concentrations of added warfarin - 14, 42, 126 and 378pM  - against a constant antibody 
concentration of 8.7xlO‘8M. This is in agreement with results from UV studies shown earlier 
which also demonstrated no separation between antibody-antigen complex and free antibody.
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Figure 5.17 CE analysis following addition o f a range o f concentrations ( 14, 42, 126 
and 378/Æ ) o f warfarin to FITC-labelled warfarin antibody. No visible change seen for  
the formation o f an Ab*Ag complex. Conditions: lOmM borate buffer, pH  9.0; untreated 
fused silica capillary (50/um ID, 375/um OD, 19.3 cm to detector window), 3 s pressure 
injection; separation at 16kV, 25°C, with excitation at 488 nm, and emission at 520 nm.
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5.2.9.1 Unlabelled BSA-conjugate as antigen
The next approach was to use an unlabelled BSA conjugate of both drugs, parathion and 
warfarin, as antigen, and react this with the labelled antibody. The theory behind this step was 
that the larger molecular weight antigen (drug-protein conjugate) may produce a significant 
change in the migration time of the complex, and produce a separate peak in the 
electropherogram. This met with limited success for warfarin initially as can be seen by the 
appearance of a shoulder on the peak of the antibody corresponding to the Ab*Ag complex. 
(Figure 5.18). However, a similar strategy with the parathion conjugate yielded inconclusive 
results, and it was not possible to improve the resolution of the warfarin complex. Section 
5.1.4.2 discussed how the use of a labelled antigen could possibly provide a solution to the 
problem. As it was not possible to label parathion or warfarin directly, the labelling of the 
parathion/warfarin-BSA conjugate was investigated.
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Figure 5.18 CE analysis o f labelled anti-warfarin antibody with unlabelled BSA-warfarin as 
Ag. (B) shows the expanded region o f (A) where the complex can be seen as a shoulder on the 
antibody peak. Conditions: lOmM borate buffer, pH  9.0; untreated fused silica capillary (50/Mn 
ID, 375/um OD, 19.3 cm to detector window) 3 s pressure injection; separation at 16kV, 25°C, 
with excitation at 488 nm, and emission at 520 nm.
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5.2.10 Labelling of BSA-conjugates with FITC
The labelling of the BSA conjugates was carried out in the same manner as the labelling of 
the antibodies (section 2.3.5.5), the only change being the protein concentration for the 
warfarin conjugate was 3 .0 3 x l0 '6M, and 1.9xlO '5M  for parathion conjugate. The 
concentration of FITC used in the labelling reaction was a five-fold m olar excess of the 
relevant drug-BSA concentration.
5.2.11 Micro-chip analysis
5.2.11.1 FITC BSA-Warfarin Conjugate
Section 5.1.4.3 outlines the potential problems associated with the labelling of antibodies and 
antigens. Following labelling it was hoped that the product would exhibit a relatively narrow 
migration zone, allowing any complex formed to be completely resolved with no overlap. 
However, despite the addition of Tris to the separation buffer, on analysis it was clear that 
there was a large distribution o f labels on the conjugate -  evidenced by the width of the peak 
shown in Figure 5.19. On addition o f unlabelled anti-warfarin it is possible to see the changes 
as the complex is form ed (Fig 5.20) showing at -35  seconds.
Time (s)
F igure  5.19 Micro-chip analysis o f  FITC-labelled BSA-Warfarin Conjugate, 1 .0 4 x l0 '7M. 
Conditions: 50 mM Tris/Borate buffer, p H  8.5, 10 s injection at 1.7kV, separation voltage 6kV, 
excitation at 488 nm, emission at 520 nm.
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F igure  5.20 Micro-chip analysis follow ing addition o f  unlabelled anti-warfarin antibody to
labelled BSA-warfarin conjugate, fin a l concentrations; warfarin antibody 9.26x10' M, BSA- 
warfarin conjugate 1.04x10' M. Conditions: Tris/Borate buffer, pH  8.5, injection voltage 
1.7kV fo r  10 seconds, separation voltage 6kV  with excitation at 488 nm, and emission at 520
5.2.11.2 FITC BSA-Parathion conjugate
On analysis it became clear that there was a wide distribution of large numbers of labels on 
the BSA-parathion conjugate as evidenced by the width of the peak shown in Figure. 5.21 (as 
obtained following analysis of the BSA-warfarin conjugate) However, on addition of 
unlabelled parathion antibody it is possible to see the conformational changes as the complex 
is formed (Fig 5.22). The antibody-antigen complex shows a migration time between that of 
the antigen and free antibody as expected (about 42 seconds). This effect was reproducible, 
like the warfarin assay, using the BSA-warfarin conjugate, but the separation did not provide 
complete resolution of both species It was not possible to obtain results that could be used to 
quantify either species due to this heterogeneity causing the overlap in peaks for both species.
Page 134 of 243
Time (s)
yF igure  5.21 Micro-chip analysis o f  FITC-BSA-Parathion, at a concentration o f  3x10' M. 
Conditions: Tris/borate buffer, 50mM, p H  8.5, injection 2.7kV 5 seconds, separation voltage 
7.3kV with excitation at 488 nm, and emission at 520 nm.
Time (s)
F igure  5.22 Micro-chip analysis fo llow ing addition o f  anti-parathion antibody to labelled — 
BSA-parathion conjugate (final concentrations, BSA-parathion conjugate: 1.04x10' M,
oantibody: 8.7x10' M ) with the complex showing after -4 0  seconds. Conditions: Tris/Borate 
buffer, 50mM, p H  8.5, injection 2 .7kV  5 seconds, separation voltage 7.3kV with excitation at 
488 nm, and emission at 520 nm.
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5.3 Discussion
The development of immunoassays using a labelled drug instead of a labelled antibody, or as 
in this case, a labelled drug conjugate, w ould be more effective than the use of a labelled 
drug-protein conjugate for obtaining complete resolution between all species involved 
(antigen, antibody and antigen-antibody complex). However, except for a few cases where it 
is deemed clinically worthwhile to manufacture such a labelled drug, the vast majority of 
drugs cannot be assayed in this manner. The research described investigated a number of 
different approaches in developing CE-based immunoassays for both parathion and warfarin 
using polyclonal antibodies without having to label the free drug. The reasoning for this was 
the difficulty in attaching a fluorescent label to the free form of the drug, as compared to the 
relative ease of labelling a drug-protein conjugate, and also the ease of producing polyclonal 
compared monoclonals antibodies. The first approach, using a labelled antibody with two 
different types o f antigen (unlabelled free drug, and unlabelled drug-protein conjugates) was 
not successful as it was not possible to achieve a separation of antibody/antigen complex 
from free antibody. The second approach, using an unlabelled polyclonal antibody and a 
labelled drug conjugate was more successful, although it was still not possible to achieve 
complete resolution.
The results, while not satisfactory for the development of an immunoassay, are in agreement 
with those reported in the literature. Schmalzing et al. (1995) investigated the possibility of 
using polyclonal antibodies for a serum cortisol immunoassay. They discovered that the use 
of a polyclonal antibody gave a much broader complex signal, similar to that seen here for 
both the labelled drug-protein conjugates (antigen) and antibody-antigen complex and 
concluded it was not possible to obtain any quantitative data from this signal. However, for a 
later microchip assay, cortisol (free drug) was available labelled at a single location with a 
fluorescent tag, and this provided the investigators with a clear, sharp, and well resolved 
signal which could be used for quantitation as opposed to measuring the signal corresponding 
to the antibody-antigen complex. For this assay migration time for the labelled cortisol was 
under 20 seconds. In the cases presented here, the use of a heterogeneous polyclonal, in 
combination with a labelled protein conjugate (itself very heterogeneous in nature due to 
multiple labelling at numerous sites on the protein) did not allow the antibody-antigen 
complex to fully resolve from the free labelled drug-protein conjugate.
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The research also shows that the conditions applied on-chip allowed a stable complex to  form 
and not to dissociate during the separation. Separation o f complex from  free labelled antigen 
will disturb the binding equilibrium and result in dissociation o f complex throughout the 
separation. This is a problem associated with CE immunoassays, as outlined in section 
5.1.5.3. However, the extent to which any dissociation was occurring was not investigated, 
due to time restrictions. It is also difficult, to quantitate what contribution, if any, to the 
broadening of the signal for both free labelled drug-protein and complex came from 
adsorption (interactions between the glass surface o f the channel of the chip). Use of high pH 
buffer (9.0) to help avoid adsorption and provide a sharp peak for the labelled antibody (Fig. 
5.7) indicated that interactions were possibly minimal and that the broad nature of the signals 
was due almost entirely to the heterogeneity of both species.
Despite not achieving optimal results, the use of micro-chip CE demonstrated the speed at 
which it is possible to achieve separations with this system. The migration time for the 
antibody was 6 seconds, a large decrease in time over conventional CE, which takes over a 
minute. Other reports in the literature for immunoassays also report very fast analysis times. 
Chiem and Harrison (1997) reported total analysis times under 45 seconds for a theophylline 
micro-chip CE immunoassay, further demonstrating micro CE to be a m ajor improvement in 
terms of total analysis time.
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6 ANALYSIS OF LIPOSOMES USING CE  
WITH POST COLUMN LIF DETECTION^ ^ ^ ^ ^ ^ — 5
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6.1 Introduction
The analysis o f cellular components has become more of a focus in the scientific community 
in recent years, so much so that there are now individual companies being set up to deal 
specifically with organelle analysis and research. One such company is MitoKor, based in 
San Diego, California. MitoKor began in 1991, as Applied Genetics. The company is based 
around observed similarities in the pathology and history of diseases o f the very young and 
very old. This was traced to energetic deficiencies and ultimately to mitochondria. This is 
perhaps the organelle with the highest profile at the moment, because of its proposed 
involvement in diseases like Parkinson’s disease and Alzheimer’s disease (section 7.1.6).
Classical methods have to date focused mostly on the analysis of whole cell populations and 
their organelles with the use of techniques like flow cytometry and fluorescent microscopy 
(section 1.4.2) with very little done on individual organelles. However, if we are to gain a 
more complete understanding of what is happening on a subcellular level, instrumentation 
and methods capable of analysing organelles on a more thorough individual level must be 
developed. Analysis based on a population of cells tells us nothing of w hat’s happening on an 
individual cellular level. As this thesis looks at the development and application of 
chromatographic methods of analysis it was investigated if capillary electrophoresis could be 
applied successfully to the analysis o f subcellular particles. In order to do this a model was 
needed, i.e. something that would mimic the properties (size, membrane composition) of an 
organelle.
An ideal solution was found in the choice of liposomes. These were chosen as a model for 
organelles, for several reasons, (i) They are easy to manufacture, (ii) Membrane bound 
vesicles can be produced with a membrane composition that mimics that of an organelle, (iii) 
The size of liposomes can be controlled depending on the method o f production. Another 
important factor was that they could also be loaded with a fluorescent dye for their detection, 
which would be similar to the fluorescent probes available for the different organelles. A 
challenge also presented itself in that there are to date no reported methods capable of 
analysing individual liposomes. Several researchers have reported on the analysis of 
liposomes using capillary electrophoresis (Roberts et a l,  1996; Tsukagoshi et al., 1998; 
Radko and Chrambach, 1999), however in every case the electropherogram was characterised 
by broad gaussian profiles for the liposom e peaks, representative of the entire population of 
liposomes. The exciting discoveries detailed during research carried out in the University of
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Minnesota represents a new departure from current thinking regarding liposome analysis 
using capillary electrophoresis.
The work presented here describes liposomes and their selection as models for organelle 
analysis using capillary electrophoresis (section 6.1.1). A description of an ‘in-house’ 
constructed capillary electrophoresis instrument is given (6.1.2). The procedure to set up this 
instrument and its use in the analysis of individual liposomes as a model for analysis of 
individual organelles (section 6.2.1) is given.
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6.1.1 Liposomes as models for organelle analysis
Liposomes are colloidal particles form ed when a lipid bilayer membrane, composed from 
self-assembled lipid molecules encapsulates part o f an aqueous phase in which they are 
dispersed, or as A. D. Bangham (1981) so eloquently put it “ ’smectic mesophases’, layer 
lattices of alternating, closed bim olecular lipid sheets intercalated by aqueous spaces”. The 
formation arises due to the properties of the phospholipid molecules, a polar head and double 
hydrophobic tail, and the energetically favourable association of the hydrophobic portion of 
the molecules to reduce interaction with the aqueous solvent. Liposomes are characterised by 
their lipid composition, particle size distribution, number of lamellae (number of ‘layers’) and 
inner outer aqueous phases. All of these properties dictate their stability and interaction 
characteristics (Chapman, 1984). M orphologically liposomes are distinguished between large 
(L), small (S), uni (U), oligo (O), and multilamellar (ML) vesicles (Lasic and 
Papahadjopoulos 1998). Figure 6.1 shows the structure of a single lamellar liposome. Other 
combinations of liposomes exist including multivesicular liposom es in which smaller 
liposomes are entrapped within a larger liposome. In terms o f interaction properties 
liposomes are distinguished between sterically stabilised types, in which they are relatively 
inert and do not interact with their environment, conventional liposomes which are 
characterised by a nonspecific reactivity towards the mileu and polymorphic liposomes which 
are reactive towards various agents (Lasic and Papahadjopoulos, 1998).
6.1.1.1 Liposome preparation
W hile the common perception of liposom e appearance is that of a spherical shape composed 
of differing numbers of layers, in fact there are many shapes possible, ranging from elliptical 
shapes to long tubules, varying in dimensions from several hundred angstroms to several 
microns. The method of preparation determines the size of liposomes obtained.
Large M ultim em brane Liposom es: These are the type of liposomes made for the work 
described in this chapter. The spacing between the membrane is determined by a balance 
between van der W aals’ forces of attraction and electrostatic and hydration forces of
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repulsion arising between adjacent membranes (Chapmann, 1984). Altering the lipid 
composition or adding other charged molecules allows these distances to be varied. Large 
multimembrane liposomes are usually made by the method or a variation on the method 
described by Bangham et al. in 1965. This involves dissolving the appropriate lipids in an 
organic solvent which is then evaporated leaving a dried film of lipid on the surface of the 
flask. Addition of an aqueous solution containing the water-soluble solute to be trapped 
inside the liposomes and swirling/vortexing gently to release the lipids from the flask surface. 
The solution is then allowed to equilibrate for several hours before use. Any remaining solute 
in the external aqueous phase is rem oved by repeated centrifugation and washing. A feature 
of large multimembrane liposomes is that they respond to osmotic gradients by shrinking or 
swelling.
Sm all single m em brane liposomes: These liposomes range in diameter from 200 to
500 angstroms and are constructed of a single bilipid layer surrounding an aqueous 
compartment (Huang, 1969). These liposomes differ from the large multimembrane 
liposomes in that they are osmotically insensitive, a disproportionate amount of lipid is 
located in the outer leaflet of the membrane (about 70%), and the small radius of curvature 
imposes strains on the packing of the lipid molecule (Chapmann, 1984). There are a number 
of methods which can be used to prepare small single membrane liposomes. The most 
common method is ultrasonic dispersion, in which an ultrasonic probe can be placed directly 
into a suspension of large liposomes or by suspending the flask of lipid dispersion in an 
ultrasonic bath. Narrow-bore needles can also used to inject an ethanolic solution of lipids 
into a rapidly stirred aqueous solution, forming small unilam ellar vesicles. This method 
eliminates aerosols, but is dependent on the lipids being soluble in ethanol. Another method 
involves dissolving the lipids in detergent followed by its removal by dialysis.
Large single m em brane liposomes: Large liposomes ranging in size from 500
angstroms to several microns have been prepared by Reeves and Dowben, (1970). The 
method involved slowly hydrating a thin layer of phospholipid in distilled water or an 
aqueous solution of nonelectrolyte to form the vesicles. The use of “ether injection” to 
produce a large “unimembrane” liposome was described by Deam er and Bangham (1976). In
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this method, an ether solution of lipid is injected into warm aqueous medium and the 
liposomes formed are osmotically active and mostly unimembrane.
F ig u re  6.1 Structure o f  a single lamellar liposome
In the early 1960’s there was a lot of emphasis on the study o f the properties of lipid-water 
systems as model biomembrane structures (Chapman, 1984). The ability to alter the 
membrane composition of the liposome to mimic specific organelles (Table 6.1) makes the 
liposome an ideal model for organelle analysis. As separations in CE are influenced by 
electrostatic charge, which is conferred on the organelle due to the membrane composition, 
liposomes would also exhibit similar properties. Liposomes with a similar phospholipid 
composition would also be expected to interact with the walls of the capillary in a similar
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manner to organelles. The capillary electrophoresis instrument used for analysis of liposomes 
is introduced in section 6.1.2.
6.1.2 Capillary electrophoresis instrument
The instrument used for analysis involves a different structure to commercially available CE 
instruments (Figures 6.2 and 6.3) and is constructed from the following parts:
>  Argon-Ion Laser and power supply. (Figure 6.2 (A)).
>  Spellman power supply for controlling the injections and separations. (Figure 6.2 
(A)).
>  Detector box with high numerical aperture lens for collection o f fluorescence and 
photomultiplier tubes (x2) with power supply. (Figure 6.2 (B)).
>  M icroscope body for aligning capillary end tip with laser beam (instrument 
alignment. (Figure 6.2 (B)).
>  Carousel for holding samples and separation buffers (Figure 6.3 (A)).
>  Sheath flow cuvette (containing capillary end) (Figure 6.3 (B) and Figure 6.4).
>  Sheath flow container (Figure 6.2 (A)) and waste reservoir to flush away sample 
exiting capillary. (Figure 6.3 (B)).
All components involved in the optics of the instrum ent (laser beam, cuvette and detector 
box) were on translation stages, which allowed movem ent in up to three planes for alignment.
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(B)
Figure 6.2 Pictorial (A) and plan (B) o f CE instrument used
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C a r o u s e l
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Figure 6.3 View o f  injection (A) and detection (B) mechanism o f  instrument
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6.1.2.1 Laser
The laser used for liposome analysis was a continuous-wave argon ion. A m ajor advantage of 
using continuous-wave as apposed to pulsed wave is the fact that they possess high spatial 
coherence, which enables the beam to be focused to a spot a few pirn’s in diameter, whereas 
pulsed lasers tend to have poor spatial coherence and are difficult to focus to a small spot 
(Wu, 1989). The argon ion laser used has a wavelength of 488 nm and was ideal for use with 
the fluorescent probes, most of which have their absorbance maxima at or near 490 nm. 
Detection at 520 nm or so also avoids overlap with the water Raman bands, o f which there 
are two, one at 1650 cm '1 and another stretching from 3100 to 3700 cm '1 (Wu, 1989). Having 
a fluorescence emission at 520 nm ensures detection where the Raman signal is relatively 
weak. Laser power used for experiments was 12mW, as this was the optimum power for 
excitation given the time the sample was exposed to the beam with the flow rates used, and to 
avoid saturation and photodegradation.
6.1.2.2 Laser focusing
To focus the laser beam an inexpensive high quality microscope objective was used. This 
type of lens is well corrected for aberrations, and is easy to use. In the case of narrow bore 
capillaries used (20 pirn’s ID), it was necessary, on occasion, to focus the beam tightly, 
sometimes to less than 10 |xm’s, to match exactly the width of sample stream exiting the 
capillary and to minimise the detector volume.
6.1.2.3 Spectral filters
In order to selectively detect at a desired wavelength, two spectral filters were used. The first 
was used to block laser scatter from particles at 488 nm, (used for all applications), and the 
second interchangeable bandpass filter was applied for the different wavelengths of the 
dyes/labels. A 535 D F 35 nm filter was used for wavelengths corresponding to 
FITC/Fluorescein emissions and a 630 DF 35 nm  filter was used for FQ-labelled samples 
(chapter 7).
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6.1.2.4 Instrument construction and alignment
The plan of the instrument is shown in Figure 6.2 (B). The laser beam is deflected through an 
angle of 90° with a mirror and passed through a pinhole before being focused at the end of the 
capillary in the cuvette (Figure 6.4). For most applications it was necessary to align a focused 
laser beam spot that matches exactly the width the sample stream exiting the capillary. In 
some cases, it was necessary to slightly de-focus the beam for larger particles exiting the 
capillary to ensure all are exposed to the laser for excitation.
Capillary
160um
-►I ]<-
250(im
F igure  6.4 Diagram o f  the sheath flo w  cuvette showing dimensions and working position  
o f capillary and laser beam fo r  post column LIF  detection.
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The most common detection form at detects fluorescence through the capillary wall, however 
there are large background signal contributions from this form at (light scatter generated at the 
air-column and column-sample interfaces, signal degraded by capillary wall aberrations). For 
signal collection here, the capillary is placed into a 250 pm 2 square flow chamber (Fig 6.4) 
with the laser beam focused at the tip of the capillary. As the sample exits the capillary it is 
suiTounded by the sheath buffer flow, of the same composition as the separation buffer, thus 
preventing any scatter at the interface. The size and shape o f the sample area excited by the 
laser beam can be optimised by altering the flow rate of the sheath flow (accomplished by 
raising or lowering the reservoir).
6.1.2.5 Collection optics
The fluorescence emitted from the sample is collected using a high numerical aperture (N.A.) 
lens (0.65). A limiting factor in the choice of the lens is that a relatively high working 
distance is required as the fluorescence must be imaged from the centre of the cuvette, a 
distance of over 2mm and there are few lenses available with both high working distance and 
high N.A. A pinhole is placed in the image plane of the lens to eliminate light from scattering 
entering the detector as this would contribute to a high background signal.
6.1.2.6 Instrument alignment
Alignment is carried out in two steps. Rough alignment was achieved with the naked eye 
using a low concentration o f fluorophore in the run buffer (10 '10M  fluorescein) followed by 
precise optimising of signal output using the computer. Rough alignment is carried out by 
keeping the detector box fixed (photom ultiplier tube and collection optic) and aligning all 
other components with respect to the light collection optic. The microscope body placed 
opposite the collection optic is used to align the cuvette. To prevent any potential hazard 
when the laser beam is on, the microscope eyepiece is fitted with a high efficiency coloured 
glass filter to block any scattered laser light. A  pinhole is placed in the image plane of the of 
the collection optic to eliminate scattered light and isolate the illuminated region. Rough
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alignment is then com pleted with the use of an LED placed after the pinhole but before the 
photomultiplier tube (multi-alkali), so that when it is switched on, light travels back in the 
reverse direction of fluorescence projecting the image of the pinhole through the collection 
optic. The microscope is then focused on the light to produce a sharp image of the pinhole. 
The position o f the cuvette is adjusted (and hence the position of the fluorescent spot) in 
conjunction with the laser beam, until the fluorescent spot and pinhole image are exactly 
superimposed. The instrum ent is now roughly aligned. The shroud is placed around the 
cuvette and collection optic and the eyepiece of the microscope covered. Switching on the 
photomultiplier tubes allows the signal output from the flourophore in the run buffer to be 
detected and monitored on screen. Carefully moving the x, y and z translation stages of the 
cuvette and moving the detector box in the x/y plane until maximum signal output is achieved 
completes the alignment of the instrument. Alignment was carried out each day prior to 
instrument use.
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6.2 Single liposome analysis by capillary electrophoresis with laser 
induced fluorescent detection
Liposomes with a lipid composition similar to that of the mitochondrial membrane (Table 
6.1) were made as outlined in section 2.3.6.1. The preparations were monitored by 
fluorescence microscopy for uptake of fluorescein and size. For detection, liposomes were 
filled with 10‘6M fluorescein in lOmM borate (pH 9.3) and were visualised with a FETC cube 
and a 60x, N. A. 1.3 oil immersion lens. The fluorescence intensity was observed to decrease 
rapidly as fluorescein photobleaches and liposomes were not detectable after 30 seconds of 
illumination with the fluorescent source. Due to their susceptibility to photobleaching, 
liposomes were stored in the dark at 4°C prior to analysis by capillary electrophoresis.
Phospholipid R atio  to ta l lipid by w eight
Cholesterol 3
Phosphatidylethanolamine 35
Phosphatidylserine 2
Phosphotidylcholine 39
T able 6.1 Composition o f  liposomes sim ilar to the outer mitochondrial membrane made 
fo r  analysis by capillary electrophoresis
6.2.1 Detector characterisation and optimisation
It was necessary to for the detector performance to be characterized before analysis of 
individual liposomes. There were a number o f factors to be determined. It was of prime 
importance to establish if particles exiting the capillary were being exposed to the laser beam 
for identical lengths of time, and if so, was all o f the emitted light being collected by the 
detector. Ideally for particles of identical diam eter and containing the same amount of 
fluorescent dye, the signal output from the detector should be the same. In order to 
investigate this, a model was needed which would fulfil the requirements of constant size and
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fluorescence intensity when equally excited. For this reason fluorescent beads were chosen as 
they had a constant size (6 pirn’s diameter) and the variation in fluorescein content was given 
by the manufacturer to be 5% CV as determined by flow cytometry.
6.2.1.1 Bead experiments to determine detector variation
The detector sensitivity and limit of detection for fluorescein (used as fluorescent marker) 
were determined. The values obtained were a LOD of 4.1516 x  10'21 moles with a sensitivity 
of 1.5605 x  1012 V/mole. Fluorescent beads with uniform fluorescent intensity and size were 
used to estimate the variation coefficient of the detector response to individual events. Due to 
the electrophoretic mobility of these beads (0.33 cm m in’1) it was feasible to use an electric 
field (200V/cm) to make them migrate. A continuous electrophoretic-propelled flow of the 
bead suspension (0.85 beads/nl) allowed for the detection of individual events (Figure 6.5) as 
beads reached the post-column laser-induced fluorescence detector. Peak height variation of 
individual peaks had contributions from the variation of fluorescein content in the beads and 
variations due to the detector design. Beads follow slightly different trajectories as they leave 
the capillary and enter the sheath flow regime (as monitored with a CCD camera attached to 
the observation microscope). Each trajectory exposed the eluting particle to different 
fluorescent excitation regimes. The bead trajectory could be controlled by increasing or 
decreasing the speed of the sheath flow, and using trial and error coupled with monitoring of 
events with a CCD camera, a setting was achieved for sheath flow speed at which the beads 
were uniformly exposed to the laser beam.
Neglecting variations attributed to their intensity measurement, the additional contribution 
due to the detector design was estimated to be 10.6%. This value was obtained by statistical 
analysis of electropherograms obtained from  repeated continuous injections of beads (Fig. 
6.5). Taller peaks were not taken into account to estimate the CV since they corresponded to 
beads sticking together or simultaneous elution of two or more beads (monitored by CCD 
camera). A low electric field (200 V/cm) was maintained to minim ize taller peaks. At higher 
electric fields the number of events corresponding to agglomerated beads may have resulted 
from polarization of the surface charge of the beads and cohesion among them due to 
different polarities.
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F igure 6.5 Electropherogram showing peaks corresponding to fluorescent beads (8.5 x  
10s/ml). Conditions; continuous injection at 200V cm 1 ; separation buffer: 250mM  sucrose, 
lOtnM HEPES, p H  7.50. Average peak height (single event): 3.78 fluorescent units; standard 
deviation: 0.39; coefficient o f  variation: 10.8%. PM T at 800V with data acquisition at 50Hz. 
Excitation was at 488nm with detection at 535DF35nm.
Having established a detector configuration that would accurately measure the fluorescence 
emitted from a particle based on its size and content of fluorescent agent, the liposomes 
prepared were analysed.
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6.2.2 Analysis of liposomes
As shown for fluorescent beads, post-column laser-induced fluorescence is an appropriate 
system for detection of single events. Using capillaries coated as outlined in section 2.3.6.2 
Figure 6.6 shows the electropherogram resulting from an electrokinetic injection of a 
liposome preparation (prepared as outlined in section 2.3.6.1). This electropherogram shows 
that Gaussian profiles used to describe the migration o f a large sample o f charged species (i.e. 
molecular ions) cannot describe the migration of a sample containing a small number of 
liposomes. Peaks of various heights corresponding to the migration of individual liposomes 
are localised in a migration zone. Figure 6.6 illustrates three electropherogram overlays, 
showing the expected dilution effect from high numbers of liposomes and a run of unlabelled 
liposomes.
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F igure  6.6 Analysis o f  liposomes by capillary electrophoresis. Conditions: separation 
buffer; 250mM  sucrose, lOmM HEPES, p H  7.50, coated fu sed  silica capillary, 50pan ID, 
150¡Am OD 5 s injection at SOVcm1, separation at 200V'em1. PM T at 800V with data 
acquisition at 50Hz. Excitation was at 488nm with detection at 535DF35nm.
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Liposome-liposomc interaction also decreased as expected when the liposome density was 
varied (Figure 6.6). A dilution of liposome samples showed an increase in electrophoretic 
mobility and disappearance of intense events in the intensity distribution. This is probably 
due to polarisation of the surface charge (similar to the fluorescent beads) and cohesion 
between the liposomes due to the different polarities. M easurement of peak height and 
electrophoretic mobility for each event using a specially written software programme allowed 
for determination of statistical parameters.
Time (s)
F igure  6.7 Electropherogram o f  liposomes used fo r  calculation o f  statistical parameters, 
peak height distribution, mobility distribution, size distribution and membrane charge 
distribution. Conditions; separation buffer; 250mM  sucrose, lOmM HEPES, pH  7.50, coated  
fused  silica capillary, 50jJm ID, 150/urn OD 5 s injection at 50Vcm'1, separation at 200Vcm'1. 
PM T at 800V with data acquisition at 50Hz. Excitation was at 488nm with detection at 
535DF35nm.
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6.2.3 Analysis of results
A programme written for Igor Pro™ wavemetries data analysis package was used to calculate 
the peak height (Figure 6.8) and mobility values for the liposomes. Appendix A gives the full 
programme used for the calculations. The programme, named PickPeaks, when used with 
Igor Pro allowed for the representation of the current and signal plots from the instrument and 
adjusted the waves to correct for the background. M obility values for the liposomes in Figure 
6.7 were calculated using the standard formula (1) and the distribution is shown in Figure 6.9.
2
^ v k  ( 1 )
Where: ju = mobility
L  = length to detector 
V  = separation voltage 
tm = migration time
Peak height (V)
F igure  6.8 Peak height distribution based on the liposome peaks detected in Figure 6.7, 
calculated using PickPeak analysis programm e in IgorPro graphics package.
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F igure  6.9 M obility distribution based on the standard formula o f  mobility and the 
migration time fo r  each peak in Figure 6.7, calculated using PickPeak analysis programme 
in IgorPro graphics package.
that they are spherical and that their volume can be estimated from the total amount of 
fluorescein entrapped in the liposome. In order to calculate the amount o f fluorescein, the 
detector response, (transfer function) to a known injection of fluorescein solution must be 
calculated. Calculation of the ratio of signal area (Volts-sec) to the total amount of 
fluorescein (moles) is called the transfer function. The number of moles injected is calculated 
using the formula:
Calculation o f  liposome radius: For calculation of the liposome radius, it is assumed
moles = Vinj x c (2)
where
Vinj = injection volume
c = concentration (molarity)
Vcap = volume o f  capillary
tinj = injection time
Vinj = injection voltage
V Ce  = separation voltage
(3)
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The value obtained for “i” was 3.4 x  1018 V/mole. Calculation of the amount of fluorescein 
inside a liposome requires measurement of the signal area for each liposome. Since each 
profile resembles a triangle with constant base (sec), and variable height (Volts), the base can 
be included in the transfer function, and its area is calculated by:
~  Base X  height (4)
In order to calculate the radius of the liposomes the form ula shown below was derived:
r _  J y  ^ (s ig n a l) (5)
V 4 1000n
W here: r — radius o f  liposome
1
t X C
Signal = signal from  detector 
71 = 3.14
c = concentration (molesA) o f
fluorecsein used to label 
liposomes, 
t = transfer function o f  detector
The value of the factor inside the radical is expressed in “litres” , however, changing to cubic
18metres (1000 litres in one cubic meter) gives a factor value of 4.68 x  10' , and gives the 
desired output value in m3. Figure 6.10 shows the size distribution for the liposomes in Figure 
6.7. This value is calculated by assuming the liposomes are spheres of radius r, that they are 
filled with 10'6 M  fluorescein, concentration c, and that the transfer function (t) of the 
detector is 3.4 x  1018 V/mole. The output of the calculation is in meters.
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Radius (m)
F igure  6.10 Size distribution fo r  the liposomes in Figure 6.7, calculated using PickPeak  
analysis programme in IgorPro graphics package.
M e m b r a n e  c h a r g e  d e n s i t y :  To calculate the membrane charge density o f each individual 
liposome the basic formula o f electrophoresis was used:
M = i2 —  : Ï  <6 >(oX Trxvii cos i ty x r )
Where: q = charge (coloumbs)
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From  the previous calculations we know (a and r. Viscosity is 0.01002 poises (dynas-
2 3sec/cm ), and combining all the constants gives a value of 8.35 x  10' .
8 .35x10 
( O  signal
Where: P  = density
tm ~migration time 
signal = signal from detector
Figure 6.11 shows the membrane charge density distribution calculated for the liposomes in 
Figure 6.7, with the corresponding numbers (counts) of liposomes.
Charge density (C/m2)
F ig u re  6.11 Membrane charge density distribution o f  liposomes in Figure 6.7, calculated  
using PickPeak analysis programm e in IgorPro graphics package.
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6.3 Discussion
Liposome technology is now well advanced and the physico-chemical properties as well as 
the fundamental physical and chemical concepts which underly liposome structure, stability 
and interaction are well established (Lasic and Needham, 1995). They have been used in 
drug/gene delivery systems for some time (Lasic and Papahadjopoulos, 1998). There are 
several companies now manufacturing and supplying equipm ent for liposome production as 
well as equipment for their characterisation due to the increased use of liposomes in the 
medical area. Among the different types of methods available for characterisation are 
extrusion, homogenisation, detergent dialysis, particle size analysis and zeta potential 
(Woodle and Papahadjopoulos, 1989). Many different methods must be undertaken to fully 
characterise liposomes. To try and improve this situation several researchers analysed 
liposomes using capillary electrophoresis. Roberts et a l,  (1996) published results on 
liposome behaviour in capillary electrophoresis. In their research, the peak resulting from the 
population of liposomes was of a broad gaussian nature. Their observations were all based on 
the entire population of liposomes. It was concluded that there was an overall negative charge 
on the liposomes. However, the method did not allow for estimation of the charge or its 
distribution within the liposome population. This is also the case with the other methods 
reported to date (Tsukagoshi et al., 1998; Radko and Chrambach, 1999). However, the 
method developed here provides information on the charge of individual liposomes. In 
studies on the size of the liposomes calculations were made using laser light-scattering 
particle size distribution and the peak was compared to that from CE analysis. The CE 
method alone does not provide any information on size (Roberts et a l,  1996). In the method 
reported in this thesis, liposomes are represented by an individual peak that allows the 
calculation of statistical parameters, including size, on an individual basis for each liposome. 
This represents a very significant advance in liposome analysis.
Since liposomes have such extensive use in both commercial skin care products and the 
medical industry, the need for a method to characterise fully liposome preparations is vital for 
quality control. The method described in this chapter is a major improvement over other 
current methods attempting to achieve this goal as it gives all the required parameters in the 
one analysis step. The rational behind for developing this method for liposome analysis was 
to provide a model for the analysis of cell organelles (also membrane bound vesicles) due to 
the ability of liposomes to accurately mimic the membrane characteristics and properties of
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cells and membrane bound subcellular particles . The results show conclusively that the 
method and instrument are capable of producing excellent results regarding the analysis of 
small biological particles.
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7 ANALYSIS OF MITOCHONDRIA USING
C E WITH POST COLUMN LIF
DETECTION
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7.1 Introduction
An introduction to cell organelles was given in section 1.4.1 and in section 1.4.2 an 
examination of the methods used to analyse various organelles, including mitochondria was 
described. The work presented in this chapter focuses on the analysis of mitochondria using 
capillary electrophoresis and is based on the method development presented in chapter 6 for 
the analysis of liposomes as models for organelle analysis.
7.1.1 The Mitochondrion
M itochondria are small membrane-bound particles found in the cytoplasm of all eukaryotic 
cells of higher plants and animals. They have a characteristic shape, size, structure and 
staining properties. The basic structural pattern is an outer membrane enclosing an inner 
membrane which has ‘tube-like’ invaginations (cristae) into an inner compartment known as 
the matrix. The degree of cristae development present in mitochondria varies with different 
cell types. For example, mitochondria from kidney, heart and skeletal muscle have extensive 
arrangements o f cristae, while mitochondria of fibroblasts and nerve axons have relatively 
few cristae arrangements. M itochondria play a critical role in the generation o f metabolic 
energy, in the form of ATP, derived from the breakdown of fatty acids and carbohydrates, in 
a process known as oxidative phosphorylation (Cooper, 1996).
7.1.2 Origin of mitochondria
Early observations of mitochondria using the light microscope suggested a similarity with 
bacteria. A comparison between the properties of isolated mitochondria and bacteria revealed 
many similarities, both structurally and enzymatically. A detailed table of similarities is 
provided by Tyler, (1992) and give rise to the two main theories about the origin of 
mitochondria. The one that is commonly accepted is the endosymbiotic theory, which 
postulates that m itochondria arose from the invasion of aerobic or anaerobic photosynthetic 
bacteria into ancestral protokaryotic cells. The second theory postulates their existence by 
compartmentalisation within an ancestral prokaryotic cell (Tyler, 1992).
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7.1.3 Functions of the Mitochondrion
The various functions of the mitochondrion are carried out in different locations within it. 
Each mitochondrion is surrounded by a double membrane system, consisting of the inner and 
outer membrane. These are separated by the intermembrane space. The numerous folds or 
cristae of the inner membrane extend into the matrix. Each o f these components play a 
separate functional role, with the matrix and inner membrane representing the major working 
areas. The mitochondrial genetic system is contained within the matrix, as well as the 
enzymes responsible for the central reactions of oxidative metabolism following from the 
breakdown of glucose to pyruvate in the cytosol and its subsequent transport into 
mitochondria. The inner membrane plays its role in the production of ATP via energy derived 
from electron transfer reactions involving NADH and FAD H2. These reactions are used to 
create a potential energy difference across the membrane which drives the reactions 
necessary for ATP production (Reid and Leech, 1980).
7 .1.4 Mitochondrial Genetics
Mitochondria contain their own genetic system, which, if the most widely accepted theory 
about the evolution of m itochondria is correct, has descended from the genome of the original 
endosymbiotic bacteria that evolved into eukaryotic organelles. The mitochondrial genome is 
still similar today to that of a bacterial genome, in that it is circular in nature and present in 
multiple copies per organelle. There is a wide diversity in the size of the mitochondrial 
genome, ranging from 16kb pairs in the humane mitochondrial genome to approximately 
80kb pairs in yeast. Like any other DNA, mitochondria] DNA can be altered by mutations, 
which can prove deleterious to both organelle and organism. Since almost all of the 
mitochondria of fertilised eggs are contributed by the oocyte, rather than the sperm, 
mutations in the mitochondrial DNA are transmitted via the mother.
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7.1.5 Intracellular distribution
Although mitochondria are present in all eukaryotic cells, they are not present in a number of 
fungi and over a thousand species of protozoa. M any of the species of protozoa living in the 
absence of oxygen have hydrogenosomes instead of m itochondria and these are thought to be 
derived from mitochondria. Several colourless algae and aquatic moulds also contain no 
mitochondria (Tyler, 1992). At one extreme 487,000 m itochondria have been found in the 
giant amoeba cell, and up to 150,000 in the oocytes o f some sea urchin eggs (Afzelius, 1957), 
while at the other, in rat liver, the tissue used most frequently as a source of isolated 
mitochondria, the num ber per cell ranges from 500 to 2500. M itochondria also differ in size. 
Examination of rat liver cells revealed considerable differences in the size of the 
mitochondria, despite the identical average size of the cells (Tyler, 1992).
7.1.6 Mitochondrial life cycle
Despite more than one theory on how new m itochondria come to exist, only one theory has 
withstood the test of time and study. Is it now believed that m itochondria grow and divide to 
keep pace with cell growth and division. To date the knowledge of the fundamental process 
involved in this is still incomplete, however, it is understood that growth and division 
involves the synthesis of a large variety of proteins, lipids, nucleic acids and other 
components (e.g. enzyme cofactors). The majority of these com ponents are synthesised 
outside the organelle in the external cytoplasm, and transported inside for assembly at 
specific sites prior to mitochondrial division. Conclusive evidence for this mechanism was 
produced in 1963, during experiments with Neurospora crassa  cells (Luck, 1963). Division 
takes place in two main stages. The first is the division of the mitochondrial DNA, followed 
by the division of all other mitochondrial components (mitochondriokinesis). It is known for 
these two processes to occur at the same time, but in most cases, the DNA division is 
completed first. The process of division involves the formation of a constriction across the 
middle of the major axis of the mitochondrion, which gradually deepens and separates the 
organelle into two roughly equal parts.
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7.1.7 Mitochondria and Disease
It is now known that many diseases originate from  within the cell, and hence the question as 
to the location where it all begins to go wrong needs to be answered. Based on what we know 
about mitochondria, and our understanding of its energy producing operations, it is not 
surprising that mitochondria should be the first part of the cell to wear out. Respiration is a 
potentially dangerous process, involving the transfer of electrons from one carrier molecule 
to another. The electrons’ destination is molecular oxygen; in the final reaction the electrons 
are used to reduce it to water. However, if there is a block in the electron transport chain, or if 
one component is more active than the next component, the stray electrons can damage the 
mitochondrion and in doing so can cause damage to other cellular components. Generally the 
electrons help form reactive oxygen species (ROS), which can damage proteins, DNA, and 
membranes. Damage to the membranes can short-circuit the charge gradient needed for ATP 
production, and release pro-apoptotic molecules like cytochrome c that can trigger 
programmed cell death. Oxidative damage to mitochondrial DNA is linked with Huntington’s 
disease (Polidori et al., 1999). In Parkinson’s disease, which represents a genetically 
heterogeneous group of disorders, a relatively large group of patients are known to possess a 
functional defect of mitochondrial complex I (the first component of the respiratory chain, 
located in the inner mitochondrial membrane) (Graeber et al., 1999). M itochondria are also 
involved in defects such as mitochondrial myopathy" (indicating muscle involvement) or 
"mitochondrial encephalomyopathy" (indicating brain and muscle involvement). The 
mitochondrial encephalomyopathies and myopathies are typically caused by defects in the 
respiratory chain or the electron transport chain (Hesterlee, 1999).
Due to the role of mitochondria in the development of these diseases, methods capable of 
analysing both the size and activity o f individual mitochondria, as well as the proteins 
expressed by the mitochondrial genome, may provide valuable contributions to our 
understanding of the various diseases. This chapter examines both approaches to the analysis 
of mitochondria, and develops methods for both mass and activity m easurements using 
capillary electrophoresis, as well as investigating the use of capillary gel electrophoresis for 
analysis of the mitochondrial proteome.
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7.2 Analysis of mitochondria by capillary electrophoresis with post 
column laser-induced fluorescence detection
7.2.1 Analysis of whole cells by fluorescent microscopy
For investigations involving the mitochondrion, there are a num ber of fluorescent probes 
available today. Among the most commonly used are nonyl acridine orange, (NAO), 
rhodamine 123 (R hl23), and 5,5’,6 ,6 -te trach lo ro -l,r,3 ,3 ’-tetraethylbenzimidazolyl-
carbocyanine iodide, (JC-1). NAO is used for the determination of mitochondrial mass, as it 
binds the lipid cardiolipin found in the mitochondrial membrane in a 2:1 ratio, and its uptake 
is independent of mitochondrial activity. Rhodamine 123 is a cell-permeable, cationic, 
fluorescent dye that is readily taken up by active mitochondria without inducing cytotoxic 
effects. As its uptake is dependent on membrane potential it may be used to measure the 
activity of mitochondria. The green fluorescent JC-1, 5 ,5’,6,6’-tetrach loro-l,r,3 ,3  - 
tetraethylbenzimidazolylcarbocyanine iodide, is also dependent on membrane potential and 
exists as a monomer at low concentrations or at low membrane potential. However, at higher 
concentrations (aqueous solutions above 0.1 /iM) or higher potentials, JC-1 forms red 
fluorescent "J-aggregates" that exhibit a broad excitation spectrum and an emission 
maximum at about 590 nm. Chinese ham ster ovary cells (Figure 7.1) were stained with the 
above dyes and examined by fluorescence microscopy. Figures 7.2 -  7.4 show photographs 
taken of the cells at different magnifications, 20x and 60x, stained with lOpiM NAO, JC-1, 
and lpiM R hl23.
7.2.1.1 Nonyl acridine orange staining of Chinese hamster ovary cells
Chinese ham ster ovary cells were stained with the dye nonyl acridine orange (NAO) as 
outlined in section 2.3.7.1. NAO binds to the cardiolipin content of the mitochondrial 
membrane, and is well retained in the mitochondria over reasonable time periods (days). It is 
toxic at high concentrations and binds to all mitochondria, regardless of their energetic state. 
A sample of the cells were placed on a slide and examined by both light and fluorescent
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microscopy at various magnifications. Figure 7.1 shows CHO cells examined by light 
microscopy prior to labelling and photographed at 20x magnification. For fluorescence, the 
cells were viewed through a fluorescein longpass optical filter.
F ig ure  7.1 Fluorescent m icroscopy analysis o f  unlabelled Chinese hamster ovary cells, 
photographed under 20 xm agnification .
7.2.1.2 Rhodamine 123 and 5,5’,6 ,6 ’-tetrachloro-1,1’,3 ,3 ’ tetraethylbenzimidazolyl- 
carbocyanine iodide (JC-1) staining of Chinese hamster ovary cells
Staining with Rhodamine 123 (R hl23) (Figure 7.3) and 5 ,5’,6,6’-te trach lo ro -l,r,3 ,3 - 
tetraethyl-benzimidazolylcarbocyanine iodide (JC-1) (Figure 7.4), were carried out in the 
same way as for NAO. Both o f these dyes are used for investigations on mitochondrial 
membrane potential. It is possible to see clearly the live cells and dead cells. As Rhodamine 
123 depends on an active mitochondrial membrane potential for its uptake, it will stain only 
live cells, and hence cells w ith active mitochondria. This effect is less clear with those cells 
stained with JC-1.
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(A)
(B)
F igure 7.2 Chinese hamster ovary cells stained with lOfiM Nonyl acridine orange and  
viewed using a fluorescent microscope. (A) 20 x  magnification and (B) 60 x  magnification.
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(B)
F igure  7.3 Chinese hamster ovary cells stained with l f jM  Rhodamine 123 and viewed  
using a fluorescent microscope. (A) 20x  magnification and (B) 60 x  magnification. Both 
dead and live cells can be seen.
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(B)
F igure  7.4 Chinese hamster ovary cells stained with lOfjM JC-1 and viewed using a 
fluorescent microscope. (A) 20x  magnification and (B) 60 x  magnification.
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7.2.2 Analysis of whole cells by capillary electrophoresis
W hole hybridoma cells were stained according to the procedure for Chinese ham ster ovary 
cells using NAO stain, and were analysed by capillary electrophoresis. Figure 7.5 shows the 
results when whole hybridoma cells were analysed by capillary electrophoresis using 
uncoated capillaries with hydrodynamic and electrokinetic injections.
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F ig ure  7.5 Analysis o f  whole hybridoma cells by capillary electrophoresis. (A) 30 s 
electrokinetic injection at 2 4 .8 V cm I, separation at lOOVcm1, (B) continuous hydrodynamic 
injection. Conditions; uncoated fu sed  silica capillary, (40.2cm), separation buffer; 250mM  
Sucrose, lOmM HEPES, pH  7.5, 0 .3x106 cells/ml, PM T 800V w ith data acquisition at 50Hz. 
Excitation was at 488nm with detection at 535DF35nm.
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Hydrodynamic injection showed a higher and more intense num ber of peaks, this could be 
due to the electric field having a damaging effect on individual cells, thus reducing the signal.
7.2.3 Analysis of isolated mitochondria by capillary electrophoresis
M itochondria were isolated from Chinese hamster ovary cells as outlined in section 2.3.7.3 
and 2.3.7.4 and stained with the relevant dye (NAO or Rhodam ine 123). Figure 7.6 shows the 
tissue homogeniser used for disruption of cells and overlays o f the different fractions of 
Percoll and M etrizamide for ultracentrifugation following homogenisation. The development 
of mitochondria isolation is detailed in section 7.2.3.1.
16 ml Ultracentrifuge tube
Tissue homogeniser (1 ml) 
(0.1 mm clearance)
PNS • 
6% Percoll (v/v) •
17% M etrizamide (w/v) 
35% M etrizamide (w/v) ■
p = 1.0406
p = 1.1079  
p = 1.1907
F igure  7.6 Potter Elvehjem tissue homogeniser used to disrupt cells fo r  isolation o f  
mitochondria, and gradient profile used fo r  ultracentrifugation o f  postnuclear supernatant 
(PNS) follow ing cell homogenisation and removal o f  nuclear fraction.
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7.2.3.1 Development of procedure for isolation of mitochondria
In order to obtain isolated mitochondria, from tissue culture cells, in fractions suitably pure 
for further studies, the use of density gradient ultracentrifugation was employed. This method 
was developed by M adden and Storrie (1987) specifically for the preparation of isolated 
mitochondria from tissue culture cells (CHO’s) and was used for the work presented in this 
chapter. Figure 7.7 shows a flow diagram of the method following staining of the cells for 5 
minutes at room temperature with 10'6M  NAO or Rhodamine.
(1)
Cell disruption
Centrifuge to 
remove nuclear 
material (1300g 
for 5 min) (2)
Rem ove post 
nuclear  
supernatant 
(PNS), add to top 
o f  ultracentrifuge  
tube
Ultracentrifuge 
(50,000g fo r  15 m in)
Remove desired fraction  
with blunt ended needle
(3 )
(5 )
F igure 7.7 Flow diagram showing sequence o f  events fo r  isolation o f  mitochondrial 
fraction fo r  analysis by capillary electrophoresis with post column laser-induced 
fluorescence.
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7.2.3.2 Mass measurements using Nonyl Acridine Orange
Uncoated capillaries: For mass measurements, m itochondria were isolated from
Chinese hamster ovary cells and stained with nonyl acridine orange as outlined in sections
2.3.7.3 and 2.3.7.4. The fractions were analysed by CE using uncoated fused silica 
capillaries. Figure 7.8 shows the results obtained. Each peak represents a single 
mitochondrion and the height is proportional to the amount of dye bound to cardiolipin in the 
membrane and, hence, the size of the mitochondrion. Unlabelled mitochondria were also 
analysed to determine if there was any contribution to peak height from scattering (produced 
when the laser beam strikes a particle/mitochondrion, either labelled or unlabelled). In the 
blank run, while there are some small peaks, when set against the same scale as the labelled 
mitochondria electropherogram (Fig. 7.8), the unlabelled mitochondria contribute very little 
to peak number or height. The absence of a defined window of migration for the 
mitochondria may indicate a problem of mitochondria continuously interacting with the wall 
of the capillary throughout the separation. This may be due to interactions between the 
proteins in the mitochondrial membrane and the capillary wall. This assumption can be made 
based on the fact that the interactions between proteins and the walls of narrow bore 
capillaries are well documented. Blank injections consisting only of buffer were made 
between sample injections, and any peaks observed in the electropherogram would support 
the conclusions that m itochondria are adhering to the walls of the capillary. Results obtained 
showed this to be the case, as mitochondria (peaks) were observed in the electropherograms 
of these blank runs.
The use of the surfactant, digitonin, to try and eliminate these interactions was investigated. 
Digitonin was chosen over other surfactants (e.g. SDS) because at low concentrations it does 
not disrupt lipid membranes, a feature of most surfactants. Concentrations of 0.01, 0.05 and 
0.1% (w/v) digitonin were tried. However, results were inconclusive with no reproducibility 
found between repeated injections of the same sample. At all concentrations of digitonin 
used, there was an accompanying large rise in background, increasing as the digitonin 
concentration increased. A blank run showed mitochondria eluting from the capillary walls, 
although in reduced numbers, presumably due to the presence of the digitonin having some 
effect on sticking. From these results it was clear that the use of coated capillaries to try and 
eliminate sticking completely would have to be investigated.
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F igure  7.8 Analysis o f  isolated mitochondria from  Chinese hamster ovary cells. 
Separation conditions; uncoated fu sed  silica capillary; buffer: 250mM  Sucrose, lOrnM 
HEPES, p H  7.5; 5  s injection at SOVcm1, separation at 200V cm 1, PM T 1000V, data 
acquisition at 50Hz. M itochondria were stained with 10'6M  NAO  (upper trace) and analysed 
unlabelled (lower trace).
Coated capillaries: A num ber of capillaries were coated as described in section 2.3.6.2 to
attempt to circumvent the problems associated with uncoated capillaries. The results were an 
improvement with a defined window of migration for the m itochondria (Figure 7.9). Section
7.2.3.3 discusses the advantages of using both coated and uncoated capillaries for analysis of 
mitochondria.
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F igure  7.9 CE separation o f  nonyl acridine orange-stained mitochondria (final 
concentration 10'6M) using AAP coated capillaries. Conditions: buffer; 250mM  sucrose, 
lOmM HEPES, p H  7.5, 5 s injection at 5 2V cm 1, separation at 200 V cm 1, PM T 1000V, data 
acquisition at 50Hz. Excitation was at 488nm with detection a t 535DF35nm.
7.2.3.3 Analysis of results from uncoated capillaries
A comparison of electropherograms of mitochondria obtained from both uncoated and coated 
capillaries is shown in Figure 7.10. When the data is analysed using PickPeaks software 
analysis, stained mitochondria had mobilities dispersed within a range of 2 x  10'4 cm 2 V 's"1 
(90% of all peaks), while the use of a coated capillary dem onstrated 90% of all mitochondrial 
mobility dispersed within a range of 3.6 x  10'4 c m W 1 (Figure 7.10). This mobility 
dispersion can be used to spread mitochondria elution to obtain analysis o f single 
mitochondria with coated capillaries, while uncoated capillaries can be used to obtain a 
narrow mobility window.
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F igure  7.10 Comparison o f  electropherograms o f  mitochondria analysed using uncoated 
and coated capillaries. Conditions: buffer; 250m M  sucrose, lOmM HEPES, p H  7.5, 5 s 
injection at 52Vcm'1, separation at 200Vcm'1, PM T 1000V, data acquisition a t 50Hz. 
Excitation was at 488nm with detection at 535DF35nm.
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7.2.3.4 Analysis of mitochondrial activity using Rhodamine 123
Rhodamine 123-stained mitochondria were isolated as outlined in section 23.1 .3  and 
analysed by CE to investigate the feasibility of carrying out activity measurements in the 
same manner as for mass measurements, using the dye NAO. Some preliminary results were 
obtained and Figure 7.11 shows an electropherogram of mitochondria stained with the 
activity dye, Rhodamine 123 and analysed using an uncoated capillary. The uptake of R hl23  
is dependent on membrane potential, and hence each peak represents a single active 
mitochondrion. The peak height is an indication of the amount of dye present inside, thus 
giving an indication of its level of activity. A large background rise/peak can be seen at the 
start of the separation after about 4.1 minutes (250 seconds). This was though to have arisen 
from dye leaking from the m itochondria due to a loss in membrane potential. This could have 
occurred due to the electric field applied during the separation possibly disrupting the 
mitochondrial membrane. Another possibility may be the fact that there were no protease 
inhibitors present in the isolation medium at this time which could also have resulted in 
enzymatic damage to the mitochondria from the time of cell disruption and isolation allowing 
dye to leak from the mitochondria. No results were obtained for coated capillaries. However, 
this initial investigation shows that the method may be applicable to activity measurements 
for individual mitochondria, although further investigations are required.
7.2.4 Comparison of different separation voltages for analysis of 
mitochondria
The effect of the separation voltage on the mobility and separation o f the mitochondria was 
investigated by comparison of two voltages, 200 and 300 Vcm 1 to see if the mobility 
behaviour is consistent for each separation voltage applied. The results were analysed and 
histograms for mobility were calculated. Figure 7.12 shows the electropherograms obtained 
for separations at 200 and 300 Vcm"1. Both samples were analysed consecutively from the 
same fraction, and show that the separation voltage is inversely proportional to migration 
time (increasing the separation voltage results in a decrease in migration time). The 
calculated mobilities for both electropherograms along with the average mean, range and 
mode are shown in Table 7.1.
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Possible Rh 123 dye leaking
Time (s)
F igure  7.11 Electropherogram showing Rhodamine 123-stained mitochondria. 
Conditions: fu sed  silica capillary (uncoated), buffer; 250mM  sucrose, lOmM  HEPES, p H  
7.5; 5  s injection at 52Vcm'J ; separation at 200Vcrrî1 ; P M T1000V , data acquisition at 50Hz. 
Excitation was at 488nm with detection at 535DF35nm.
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F igure 7.12 Electropherograms obtained fo r  analysis o f  the same fraction  o f  mitochondria 
by CE using two different separation voltages, 200 and 300 Vcm'1. Conditions: buffer; 
250mM sucrose, lOmM HEPES, p H  7.5, 5 s injection at 52Vcm'1, separation at 200/300 
Vcm'1, PM T 1000V, data acquisition at 50Hz. Excitation was at 488nm with detection at 
535DF35nm.
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M obility Separation Voltage (V  cm '1)
200 300
Average 2.23 x  10'4 1.44 x  10'4
Median 1.50 x 10'4 1.41 x  10'4
Range 3.72 x 10'3 8.35 x  10'4
Mode 1.50 x 10 4 1.25 x  10’4
Table  7.1 Calculated mobilities fo r  electropherograms shown in Figure 7.12.
It was expected that the mobility distribution should be the same for both voltage separations, 
as mobility is independent of capillary length, migration time and applied voltage. However, 
this was not the case. Figures 7.13 and 7.14 illustrates the two mobility histograms calculated 
from the electropherograms in Figure 7.12. Large numbers of mitochondria have low 
mobility at the higher separation voltage, as well as a greater num ber of m ore intense events. 
This may be due to higher electric fields causing polarisation of mitochondria resulting in 
agglomeration. These agglomerated mitochondria take longer to migrate through the capillary 
and hence this results in lower mobility values. This is in agreement with the results obtained 
in chapter 6 (section 6.2.1) for the bead experiments when high electric fields resulted in bead 
agglomeration. In the case of the liposomes, dilutions of the sample resulted in an increase in 
electrophoretic mobility and disappearance of intense events in the intensity distribution.
M obility (cm2/Volts/sec) x 10"6 
F igure  7.13 Histogram o f  mobility distribution fo r  analysis o f  m itochondria at 200 Vcm'1.
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F igure  7.14 Histogram o f  mobility distribution fo r  analysis o f  m itochondria at 300 V cm 1.
7 .2 .5  Analysis of sample injection reproducibility
The volume of sample injected into the capillary is varied by changing the injection voltage 
and the time it is applied to the sample vial. Figure 7.15 shows two electropherograms (A) 
and (B) obtained from identical injections, with a third identical injection from the same 
sample (C) shown in Figure 7.17. All three electropherograms should contain the same 
number of peaks, however following analysis by PickPeaks, the samples were found to have 
72, 78, and 127 peaks, respectively. Investigation for error in the injection volume by 
integration of the area beneath the injection trace in the current plot revealed identical 
volumes had being injected. It is possible that there may have been ‘carry-over’ from one 
injection to the next, despite the use of coated capillaries to try and eliminate the problem of 
mitochondria adhering to the capillary wall. Analysis of the peak height distribution for all 
three electropherograms shows the most frequent peak height of about 0.02 volts, with a local 
maximum at about 0.07 volts in each case (Figures 7.16 and 7.17). A 10 second injection of 
the same sample expected to have a higher number of peaks, showed only 92 events. 
However, histogram analysis revealed identical features to samples injected for 5 seconds,
with the most frequent peak height at 0.02 volts with a local maxim um  at 0.07 volts (Figure 
7.18).
Time (s)
Time (s)
F igure 7.15 Electropherograms obtained from  identical injections o f  the same sample.
Conditions: buffer; 250mM  sucrose, lOmM  HEPES, pH  7.5, 5 s injection at SOVcm1', 
separation at 200/300 V cm 1, PM T1000V, data acquisition at 50Hz. Excitation was at 488nm  
with detection at 535DF35nm. Histogram analysis o f  these electropherograms is shown in 
Figure 7.16.
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Fluorescence (Volts)
F igure  7.16 Peak height distribution histograms fo r  electropherograms (A) and (B) in 
Figure 7.15. The most frequent peak height at 0.02 volts with a local maximum at 0.07 volts 
can be seen fo r  both injections.
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F ig ure  7.17 Electropherogram obtained from  the third 5 second injection (C) with 
histogram analysis illustrating most frequent peak height at 0.02 volts with a local maximum  
at 0.07 volts. Conditions fo r  separation: buffer; 250mM  sucrose, lOmM HEPES, p H  7.5, 5 s 
injection at 5 0 V cm !, separation at 200/300 V cm 1, PM T 1000V, data acquisition at 50Hz- 
Excitation was at 488nm with detection at 535DF35nm
Page 187 of 243
1.0 -1
o>
oo
g
sao
3
0.8  -
0.6  -
0.4
E 0.2
0.0 1
500
Jk 1 k
(A)
1000 1500
Time (s)
2000
I<u
0
1
3z1— 1búO
Fluorescence (Volts)
F igure  7.18 CE electropherogram o f  a 10 s injection o f  m itochondria (A), with histogram  
analysis (B) showing most frequent peak height at about 0.02 volts with a local maximum at 
about 0.07 volts, identical to that observed fo r  5 second injections. Conditions fo r  CE  
separation: buffer; 250mM  sucrose, lOmM HEPES, p H  7.5, 5 s injection at SOVcm1, 
separation at 200/300 Vcm'1, PM T1000V, data acquisition at 50Hz. Excitation was at 488nm  
with detection at 535DF35nm.
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More investigations are necessary in order to fully explain the inconsistency in the numbers 
of peaks in the three electropherograms corresponding to identical sample injections. 
However, it may be possible that there was a lack of hom ogeneity in the sample, although 
this is unlikely as the sample is collected from the 17% m etrizam ide/35%  metrizamide (w/v) 
(M17/M35%) interface, and the density of this is greater or equal to that of the mitochondria. 
Therefore it is unlikely that any sample settling would occur. The other possibility is that 
there may be some alterations to the capillary wall with each injection and this may have an 
effect on the numbers eluting, possibly retaining some m itochondria during the separation. 
This might explain why the numbers increased from the first to third 5 second sample 
injection. However, the similarities o f peak height distributions suggest that organelle 
analysis could be carried out even with the variations in the num ber of peaks for identical 
injections.
7.2.6 Analysis of mitochondria from different fractions following 
ultracentrifugation
As outlined in section 7.2.3.1, m itochondria were separated on the basis of their density, with 
the 17/35% (w/v) interface corresponding to a mitochondrial fraction with no or minimal 
contamination from other organelles. According to M adden and Storrie (1987) who 
developed the method, the 6% percoll/17% metrizamide (w/v) (P6/M 17%) interface, which is 
less dense, is expected to contain a higher num ber o f m itochondria than the 17/35% interface. 
However, this fraction will be contaminated with other organelles of similar density. Analysis 
of a sample taken from the (P6/M17%) interface stained with NAO, show peak height 
histograms with distinctly different features than those obtained from analysis of the 
M17/M35% interface (Figure 7.19). Injection and separation conditions for both were 
identical. The fact that the histograms display different profiles is an indication that the 
mitochondria in each fraction have different size profiles. This is as expected as the 
separation is based on density, and mitochondria with higher protein content (and perhaps 
differing size) would be expected to separate from m itochondria with less protein content in 
the membrane. A higher num ber o f peaks in the P6/M 17% sample was also observed and this 
agrees with the reports made regarding the numbers of m itochondria located at each interface. 
The apparent higher peak values from the P6/M 17%  fraction may also have a contribution 
from agglomeration of mitochondria due to the electric field as described earlier.
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F igure  7.19 Peak height histogram analysis o f  electropherograms obtained from  analysis 
o f samples taken from  the both the P6/M17% interface and the M17/M35% interface. The 
different profiles o f  each fraction can be seen corresponding to the different size profiles o f  
the mitochondria, with the P6/M 17%  sample containing many more mitochondria than the 
17/35% sample.
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7.2.7 Analysis of stability of prepared fractions
With the preparation of isolated mitochondria from tissue culture cells there may be a 
problem following the homogenisation process whereby lysosomes, containing many 
proteases and other potentially harmful enzymes to isolated m itochondria, are also disrupted, 
releasing enzymes into the homogenate. To circumvent this ultracentrifugation was 
performed immediately following disruption of the cell. However, as there were no inhibitors 
added to the homogenate, fractions from the M17/M35% interface, stained with NAO, were 
analysed three times over a time period of eight hours while stored at room temperature, thus 
allowing for the possibility of any protease enzymes present in the sample to digest or 
damage the mitochondria. The effect of this would be no peaks or a reduced num ber in the 
electropherograms and a different mobility distribution for any peaks present. However, 
analysis of peak mobility showed sim ilar trends in all samples (Figures 7.20 and 7.21). Peak 
numbers for analysis at 0, 4 and 8 hours were 90, 40 and 95, respectively, corresponding to 
histograms (A), (B) and (C).
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F ig ure  7.20 Peak height histogram analysis o f  stability o f  mitochondrial fractions  
prepared by density gradient ultracentrifugation without protease inhibitors added.
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F igure  7.21 M obility histogram analysis o f  mitochondrial fractions prepared by density 
gradient ultracentrifugation w ithout protease inhibitors added.
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A similar number of peaks (95) in the final electropherogram after 8 hours, compared to the 
first injection (90), supports the conclusion that the samples are stable and that the 
mitochondria are not being digested by enzymes released during homogenisation. The 
mobility histogram distributions are also similar further supporting the idea of intact 
mitochondria. It also suggests that the ultracentrifugation procedure of isolation for the 
mitochondria is separating them from potentially harmful enzymes released during cell 
disruption. This would agree with the theory as it is expected that during ultracentrifugation, 
the heavier and more dense mitochondria will move towards the bottom of the centrifuge 
tube, and away from free enzymes that may also be present in the post-nuclear supernatant. 
These enzymes will remain suspended at the top of the 6% percoll (v/v) medium, and, 
provided care is taken during removal of the fraction containing mitochondria, should not 
contaminate the sample.
The methods described so far demonstrate the use of CE in the analysis of whole 
mitochondria. As outlined in section 7.1.7, however, many disease states of the 
mitochondrion involve mutations in the genome, and hence in the expression of proteins. As 
discussed in the introduction (section 1.4.4), the new area of proteomics analyses the proteins 
expressed by the genome of an organism or cell, or as in the case presented here, the 
mitochondrial genome. Section 7.3 presents initial investigations into analysis of the 
mitochondrial proteome using capillary electrophoresis. Various strategies are examined, 
including the use of coated capillaries, and capillary gel electrophoresis.
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7.3 Mitochondrial proteome analysis using capillary electrophoresis
For the analysis of the mitochondrial proteome by capillary electrophoresis, two approaches 
were investigated. The use of coated capillaries was initially examined, followed by capillary 
gel electrophoresis. In each case, two sets of fluorescently labelled protein molecular weight 
markers were analysed; one set labelled with FITC and the other labelled with 3,(2-furoyl) 
quinoline-2-carboxaldehyde, FQ.
7.3.1 Use of coated capillaries for protein analysis
Due to the problems associated with proteins adhering to the walls o f capillaries, the use of 
coated capillaries for protein separations has become increasingly common (section 4.1.3.3). 
Here the use of coated capillaries (as used in section 7.2.3.1) was investigated for the 
separation of six different molecular weight markers (Table 7.2).
7.3.1.1 Analysis of molecular weight markers
FITC-labelled markers were purchased and diluted with water to give the desired 
concentration prior to analysis, while FQ labelling of markers was carried out as described in 
section 2.3.8.1. Figure 7.22 (FITC-labelled) and Figure 7.23 (FQ-labelled) show the 
electropherograms obtained for each set o f labelled markers. The separation shows 
incomplete resolution of the individual proteins in both cases, although there are 5 partially 
visible peaks for the FITC-labelled markers, none are completely resolved from each other. 
The FQ-labelled markers showed less resolution, with only three clear peaks, and again, none 
completely resolved from each other. Investigating the effect of different electric fields (from 
200 to 700V cm '1) and changes in the injection volume showed no improvements on the 
results. A possible explanation for incomplete resolution of the molecular weight markers can 
be found in the fact that capillary zone electrophoresis (as performed here) separates 
components based on mass to charge ratios, and not molecular weight. These markers are 
manufactured for polyacrylamide gel electrophoresis (SDS-PAGE), which separates based on 
m olecular weight using a sieving matrix. However, due to the nature o f the separation process
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in CE, differences in the num ber of labels on the proteins can have a detrimental effect on the 
separation, producing broad bands for each protein, causing overlap to occur, and hence poor 
resolution, despite the use o f a low concentration of SDS in the buffer. The fact that the FQ- 
labelled markers show less resolution would agree with this theory, as these were labelled 
‘in-house’ with no control on the number of labels attaching to the different proteins. Its also 
possible for proteins of different molecular weight to have similar mass to charge ratios, thus 
having similar mobilities and hence two proteins may elute as a single peak, preventing 
identification.
P ro te in Source M olecular w eight (Da)
Myosin Rabbit muscle 205,000
ß-Galactosidase E. coli 116,000
Albumin Bovine Serum 66,000
Alcohol Dehydrogenase Horse Liver 39,000
Carbonic Anhydrase Bovine Erythrocyte 29,000
Trypsin Inhibitor Soybean 20,100
T able 7.2 Protein molecular weight markers analysed by CE.
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F igure  7.22 Analysis o f  FITC-labelled molecular weight markers using coated capillaries. 
Conditions: AAP coated capillary; buffer: 2.5mM  borate, 5mM  SDS, p H  9.3; 5 s injection at 
lOOVcm1 ; separation at 2 00 V cm I. Excitation was at 488 nm with detection at 535nmDF35nm.
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The electropherogram obtained for the FQ-labelled molecular weight markers illustrates the 
overlap of the different proteins as they elute. Contained within the electropherogram are the 
six markers, but it is not possible to resolve them completely as discussed. Despite not 
achieving complete resolution for the molecular weight markers, it was decided to analyse a 
mitochondrial protein extract using the coated capillaries.
6 
5 
4
'o
8 3
§
Ö 2 
1
0
Time (s)
F igure 7.23 Electropherogram showing separation achieved fo r  FQ-labelled molecular 
weight markers using coated capillaries. Conditions: A AP  coated capillary; buffer: 2.5mM  
borate, 5mM SDS, p H  9.3; 5 s injection at lOOVcm1; separation at lOO Vcm 1. Excitation was 
at 488 nm with detection at 635 nm DF35 nm.
7.3.1.2 CE analysis of mitochondrial protein extract using coated capillaries
Protein was extracted from isolated mitochondria as outlined in section 2.3.8.3 and labelled 
with FQ according to the procedure detailed in section 2.3.8.1. The resulting sample was 
analysed by CE and the results are shown in Figure 7.24. While the peaks are resolved from
0 200 400 600 800 1000
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each other, there are very few, and are at a very low concentration (electropherogram 
expanded for clarity). The best resolution and peak shape was obtained with an applied 
electric field o f 700Vcm"1. Based on the observations with the molecular FITC- and FQ- 
labelled molecular weight markers, it is possible that the many proteins contained within the 
mitochondrial membrane are not resolving using the coated capillaries, accounting for the 
very few peaks.
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F igure  7.24 Electropherogram obtained from  the analysis o f  extracted FQ-labelled  
mitochondrial protein. Conditions: coated capillary; buffer: 2.5m M  borate, 5mM  SDS, p H  
9.3; 30 s injection at lOOVcm1; separation at VOOVcm1. Excitation was at 488 nm with 
detection at 635 nm DF35 nm.
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7.3.2 Capillary gel electrophoresis
As outlined in section 4.1.4.2, capillary gel electrophoresis offers many advantages for 
analysis of proteins over traditional SDS-PAGE methods, including the application of high 
voltages resulting in faster analysis times coupled with the ability of quantitative as well as 
qualitative detection. Here the use of different molecular weight dextrans was investigated to 
allow the separation to be tailored to the molecular weight markers.
7.3.2.1 Analysis of molecular weight marker standards
A number of different weights of dextrans were tried, with a molecular weight of 185,000Da 
giving the best resolution for the markers (Figure 7.25), although the FQ labelled markers did 
not resolve as well as the FTTC-labelled markers. Best results were achieved with electric 
fields of 400V cm '1. Analysis of FITC-labelled m olecular weight markers showed more peaks 
than expected. A possible explanation for this may again be due to the fact that these markers 
are manufactured for SDS-PAGE work, and therefore may not be of very high purity. For 
SDS-PAGE this will not present a problem as only the larger peaks (numbered 1-6, Figure 
7.25) would be detected. Its also possible that the smaller peaks observed in the 
electropherogram only appear with the greater resolving power o f capillary gel 
electrophoresis (due to higher electric fields) which on a SDS-PAGE gel would appear 
combined with the peak closest, resulting in only six bands on the gel as expected.
In the electropherogram for the FQ-labelled markers, slightly less resolution is observed, 
again, this could be due to the fact that labelling was carried out ‘in-house’ with no controls 
over the labelling process. On the smaller m olecular weight proteins, a large num ber of 
labels could significantly change the overall molecular weight, possibly affecting the 
migration time and, in conjunction with different numbers of labels, produce a spread on the 
peak, similar to that observed for analysis using coated capillaries.
Analysis of individual molecular weight markers would help in optimising the separation at 
this point, and would provide information on the ability of the gel to separate smaller 
molecular weight proteins. Table 7.3 shows the individual molecular weight markers, labelled 
with FQ, which were analysed by capillary gel electrophoresis.
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F igure  7.25 Separation o f  FITC- (top) and FQ-labelled (bottom) molecular weight 
markers by capillary gel electrophoresis. Conditions: 5% dextran, 6.7m M  SDS, lOmM  
HEPES, pH  7.5, sheath flo w  buffer: lOmM  HEPES, 6.7mM  SDS, p H  7.50. Sample denatured 
fo r  5  min at 95°C prior to analysis. Excitation was at 488 nm with detection at 635 nm DF35 
nm (FQ-labelled markers), and 535 nm D F  35 nm (FITC-labelled markers).
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Molecular weights for these individual markers ranged from  66,000 for albumin, bovine 
serum, to 14,200 for a-Lactalbum in, bovine milk. Results are shown in Figure 7.26. W hile it 
is expected that the high molecular weight dextran (185,000) will not provide optimum 
separation for the smaller molecular weight proteins, exactly what separation would be 
achieved was investigated.
P ro tein Source M olecular W eight (Da)
Albumin, Bovine Serum 66,000
Ovalbumin Egg 45,000
Glyceraldehyde-3-Phosphate
Dehydrogenase
Rabbit Muscle 36,000
Carbonic Anhydrase Bovine Erythrocytes 29,000
Trypsinogen Bovine Pancreas 24,000
Trypsin Inhibitor Soybean 20,100
a-Lactalbumin Bovine milk 14,200
Table  7.3 Individual molecular weight markers FQ labelled and analysed separately
Analysis of the individual m olecular weight markers showed inconsistencies in the migration 
times of the proteins according to their molecular weight. The most probable cause o f this is 
the sieving gel used was not optimised for proteins in the smaller molecular weight range 
(14-66kDa). As the separation gel was optimised for the higher molecular weight proteins 
shown in Table 7.2, this is as expected. A trial run with an extract of mitochondrial protein 
would be required to first determine the molecular weight range of the proteins before the 
correct molecular weight sieving matrix could be determined. This was carried out with an 
extract of protein from isolated mitochondria prepared as before. The result is shown in 
Figure 7.27.
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F igure  7.26 Capillary gel electrophoresis o f  individually FQ-labelled protein molecular 
weight markers. Conditions: capillary filled  with 5% dextran (M W  185,000), 6.7mM  SDS, 
lOmM HEPES, p H  7.50; sheath flo w  buffer: lOmM  HEPES, 6.7mM  SDS, p H  7.50; 10 s 
injection at SOVcm1, separation at 400V cm I. Sample denatured fo r  5 min at 95°C prior to 
analysis. Excitation was at 488 nm with detection at 635 nm DF35 nm.
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7.3.2.2 Capillary gel electrophoresis of mitochondrial protein extract
Mitochondrial protein was extracted and labelled with FQ as before. Analysis by gel 
electrophoresis revealed that while peaks corresponding to mitochondrial protein can be seen, 
resolution was very poor (Figure 7.27). Analysis of relative migration times for both 
individual and the mixture of molecular weight markers reveal inconsistencies between the 
migration times and relative molecular weights.
While separation in CGE is primarily based on m olecular weight, it is expected that a 
difference in the num ber of labels would not have a significant effect on the peak shape and 
migration time for the larger molecular weight proteins (due to the molecular weight of the 
label being so small relative to that of the protein), however, this may not be the case for the 
smaller molecular weight proteins as discussed. From  comparison of relative migration times 
from the electropherogram obtained for the mitochondrial protein extract, with those from the 
individually labelled molecular weight markers, (Figure 7.26), it indicates that the molecular 
weights of the proteins present are mostly below 36,000 Da. This would allow for 
heterogeneity in the labelling of the smaller molecular weight proteins to affect the 
resolution. The results obtained indicate that a higher m olecular weight sieving matrix may 
give better resolution. These investigations are being carried out.
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F igure 7.27 Capillary gel electrophoresis o f  FQ-labelled mitochondrial protein extract. 
Conditions: Capillary fd le d  with 5% dextran, (M W  185,000), 6.7mM  SDS, lOmM IIEPES, 
pH  7.50. Sheath flow  buffer; lOmM IIEPES, 6.7mM SDS, pH  7.50; 30 s injection at 5 0 V cm ' ; 
separation at 400V cm 1. Sample denatured fo r  5 min at 95°C prior to analysis. . Excitation 
was at 488 nm with detection at 635 nm DF35 nm.
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7.4 Discussion
Chapter 6 illustrated the capillary electrophoresis system employed to be an ideal system for 
analysis of subcellular particles with the analysis of both polystyrene beads and liposomes 
filled with a fluorescent dye. This chapter examined the application of this method to the 
analysis of mitochondria following isolation from Chinese ham ster ovary cells. M itochondria 
play an important role in the the cell providing the energy necessary for life and as discussed 
in section 7.1.7, also play a critical role in health. There are various methods today used for 
analysis of the mitochondrion and other organelles (section 1.4.2), but the use of capillary 
electrophoresis has only recently being applied to this area. A  review on the methods and 
their relative success is given by Radko and Chrambach, (1999). They reported the use of CE 
for analysis of lipoprotein particles, classified as high (HDL, 7-13 nm diameter), intermediate 
(IDL, 25-35 nm in diameter), low (LDL, 18-25 nm diameter) and very low (VLDL, 30-80 
nm) density lipoproteins using cITP, with the particles separation into 14 well defined zones. 
However similar to the liposomes analysed by CE (Roberts et al., 1996) (discussed in the 
same review and chapter 6), there is no information on single particles.
To the date of publication, (February 1999) the authors reported that the sole subcellular 
particles of some biological relevance analysed by CE were rat liver microsomes, the 
membrane vesicles form ed from isolated rough endoplasmic reticulum  in aqueous solutions, 
with a mean diameter of 150 nm. However, the microsomes, isolated by a similar technique 
to that used here (density gradient centrifugation) exhibited a broad but single peak in CZE 
using 150 pm diameter fused silica capillaries internally coated with linear polyacrylamide, 
similar to that reported by Roberts et al. for the liposomes. The results reported here represent 
the first successful demonstration of the use of capillary electrophoresis for analysis of 
individual mitochondria. Sim ilar to the results reported in chapter 6 for liposomes, the 
mitochondrion is visualised as a single peak. Results with the use o f NAO demonstrate the 
applicability of using this as a means o f accurately measuring the size o f mitochondria, while 
initial results presented with Rhodam ine 123 demonstrate that the method can be used to 
measure the activity of a single mitochondrion.
The design o f the instruments allows for detection o f more than one fluorescent probe at the 
same time. This allows the exciting possibility of measuring both the mass and activity of a 
single mitochondrion in a single measurement. This would be done with the use of the dye 
JC-1, as its uptake is dependent on the membrane potential, in conjunction with NAO. As JC-
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1 emits fluorescence at a higher wavelength (590 nm) on the formation o f red aggregates, due 
to high mitochondrial membrane potential, collection of emitted fluorescence from both dyes 
(by use of a dichromatic beam splitter to separate the emissions) would allow mass/activity 
ratios to be measured for individual mitochondria.
The initial results presented on the analysis of the mitochondrial proteome demonstrate the 
use of the chromatographic method of CE for an almost entire analysis of a single organelle 
from a cell. The area of proteomics is rapidly expanding today (section 1.4.4) with projects 
like the human genome continuing to rely on analysis of both structure and function of genes 
and gene products (proteins), with detection o f changes between normal and diseased states 
being of paramount importance. In 1990 the US National Cancer Institute (NCI) launched a 
separate programme to screen more than 60,000 compounds against a panel of 60 human 
cancer cell lines for determination of potential target molecules and modulators for activity 
(Patton, 1999). As the mitochondrion is known to be involved in several diseases (section 
7.1.7), analysis of the proteome will also provide important information regarding the 
expression of proteins during the different stages in the life cycle. In conjunction with the 
methods for analysis of the mitochondrial mass and activity, correlation’s can be made 
between results obtained from these measurements and the type and numbers of proteins 
expressed by the mitochondrial genome at a given time.
Page 205 of 243
8 CONCLUSIONS
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The purpose of this research was to examine chromatographic methods of analysis and their 
use in biotechnology, concentrating on HPLC and CE. The w ork focused on the analysis of 
coumarin metabolism, development of micro-chip based CE immunoassays for a coumarin 
derivative, warfarin, and an insecticide, parathion, and the use CE in the analysis of 
subcellular particles. For analysis of subcellular particles liposomes were chosen as the model 
for the development of the method, and having successfully achieved this, analysis of 
mitochondria was carried out using a very sensitive unique post-column LIF detection 
arrangement.
HPLC was used to examine the metabolism of the m ajor human phase I metabolite of 
coumarin, 7-hydroxycoumarin, in rabbit tissues. The purpose of the examination was to gain 
more information regarding the metabolic pathways present in rabbit for the phase I 
metabolite of coumarin. The method was based on a previous HPLC method by Killard et al.
(1996) with significant improvements made in terms of total run time. This was achieved by 
altering the gradient elution profile to achieve reductions in the retention time for all 
components (up to 8 minutes in the case of the internal standard, 4-hydroxycoumarin). The 
presence of the UDPGT enzyme system responsible for the glucuronidation of 7- 
hydroxycoumarin and the rate o f metabolism for 7-hydroxycoumarin for each of these tissues 
was determined.
Following on from these conclusions with HPLC, another study using capillary 
electrophoresis was carried out on rabbit tissue samples. CE with UV detection examined in 
greater detail the metabolism o f 7-hydroxycoumarin, with a study on the breakdown of 7- 
hydroxycoumarin glucuronide by the enzyme (3-glucuronidase. The results of this study 
provides information on the various organs where glucuronidation occurs in the rabbit, the 
rates at which it does so, and also details the organs in which breakdown of the glucuronide 
occurs along with the various rates. From  this combined information it is possible to predict 
where futile cycling (section 1.2.4.3) of the glucuronide may occur.
CE was also applied to analysis of another 7-hydroxycoumarin conjugate, 7- 
hydroxycoumarin sulphate, via the sulphation pathway. The study examined mouse liver for 
production of both the glucuronide and the sulphate conjugates. The methodology applied 
was identical to that used for the glucuronide conjugation and de-conjugation studies of 
various rabbit tissues, and demonstrated excellent inter- and intra-assay coefficients of
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variation for the detection of all three components (7-hydroxycoumarin, 7-hydroxycoumarin 
sulphate, 7-hydroxycoumarin glucuronide)
M icrochip capillary electrophoresis was used to investigate novel approaches towards CE- 
based immunoassays. After detailed investigations, the use of a labelled drug-protein 
conjugate and unlabelled antibody for both parathion and warfarin proved the most 
promising. However, problems arising from the heterogeneity of reagents used in the assays 
having a detrimental effect on the resolution of both the free drug-protein conjugate and 
antibody/drug-protein complex, did not allow any accurate quantitation measurements to be 
made. These observations are in agreement with those reported in the literature (Schmalzing 
and Nashabeh, 1997) where the use of a polyclonal antibody in an assay for cortisol provided 
an antibody/antigen complex too broad for quantitation. The authors investigated the 
differences between using Fab fragments, monoclonal or polyclonal antibodies, with the Fab 
fragment providing the best resolution and peak shape for the antibody/antigen complex. 
From the results shown, it is concluded that the use of a drug labelled at a single location 
would provide the ideal solution in this case. However, as this is not possible for all drugs, a 
homogenous labelled drug protein conjugate in conjunction with a monoclonal antibody or a 
Fab fragment prepared from a papain digest of whole monoclonal antibody may also provide 
enough resolution for quantitation.
In the application of CE to the analysis of subcellular particles, the results obtained for 
analysis of liposomes as a basis for organelle analysis, demonstrate very well a new level of 
information available for the first time using CE. The unique design of the CE instrument 
allowed for detection of single events corresponding to individual liposomes. Never before 
has this level of detail on an individual liposome basis being reported for CE. W hile the 
method sets out to define the parameters for analysis of cellular organelles, it has 
demonstrated its use as an excellent method for the complete characterisation of liposomes 
which may be manufactured for use in the medical industry. The method demonstrates 
detection of single events corresponding to individual mitochondria when applied to the 
analysis o f mitochondria, following purification from Chinese hamster ovary cells. This also 
represents the first reported analysis of mitochondria by CE. The ability to stain mitochondria 
with various dyes (NAO, R hl23  and JC-1) will allow measurements on mass and activity of 
individual mitochondria to be made using this method.
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M itochondrial proteome analysis on solvent extracted mitochondrial protein by capillary gel 
electrophoresis with the same instrument showed initial results, with proteins in the 
molecular weight range around 35,000Da confirmed to be present in the mitochondrial 
membrane. The results however, illustrated that the gel needed to be optimised towards the 
smaller m olecular weight proteins, and not the larger (66,000 -  205,000 Da) molecular 
weights as was the case here, before any meaningful conclusions can be made. Unfortunately, 
as the research visit to the University of M innesota was at an end, there was no time to 
complete this work.
In summary, capillary electrophoresis along with HPLC, has shown themselves to be 
extremely versatile tools for analysis in analytical biotechnology, with the above examples of 
drug molecules, cells and subcellular particles representing two extremes of size experienced 
by the analytical scientist. The work required an intimate understanding of the theory of 
chromatography and the problems and obstacles encountered when working with both small 
molecules and large particles. In addition, the work has made a significant contribution to the 
understanding o f phase II metabolism of coumarin and provided results on a new level of 
detail and precision for analysis of both liposomes and mitochondria using CE, thus allowing 
for analysis of all organelles by capillary electrophoresis.
Page 209 of 243
Page 210 o f 243
Afzelius, B. A., (1957) Electron M icroscopy of Sea Urchin Eggs. Slmqvist and Wiksell, 
Upsalla, Sweden.
A lberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K. and W atson, J. D., (1989) Intracellular 
sorting and the maintenance of cellular compartments, In “M olecular Biology of the Cell (2nd 
edition), Garland Publishing Inc., New York, U SA , pp 405-479.
A tam na, I. Z., Issaq, H. J., M uschik, M. and Janini, G. M., (1991) Optimisation of resolution 
in CZE: combined effect of applied voltage and buffer concentration. J. Chromatogr., 588: 
315.
B angham , A. D., (1981) In: “Liposomes: from physical structure to therapeutic 
applications”, Knight, C. G., (Ed), Elsevier, Amsterdam, New York.
B angham , A. D., Standish, M. M. and W atkins, J. C., (1965) Diffusion of univalent ions 
across the lamellae o f swollen phospholipids. J. Mol. Biol., 13: 238-241.
van den Berg, A. and Lammerick, T. S. J., (1998) M icro Total Analysis Systems: 
Microfluidic aspects, Integration Concept and Applications, In “M icrosystem Technology in 
Chemistry and Lifesciences”, M anz, A., Becker, H., (Eds), Springer-Verlag, New York, 
Heidelberg, Berlin, pp. 21-49.
van  d er B ery, A. and Gerveld, P., (1995) M icro Total Analysis Systems, K luwer Academic 
Publishers, Dordrecht, Netherlands.
B iblingm eyer, B. A., (1992) Overview of m odem  liquid chromatography, In “Practical 
HPLC: M ethodology and Applications” , John W iley and Sons, New York, USA. pp. 1-27.
Page 211 of 243
B ogan, D. P., Keating, G. J., Reinartz, H., Duffy, C. F., Smyth, M. R. and O ’Kennedy, R.,
(1997) Analysis of coumarins, In “Coumarins - Biology, Applications and M ode of Action” . 
O ’Kennedy, R and Thornes R.D. (Eds), John W iley and Sons Ltd., Chichester, England, pp  
267-302.
Bogan, D.P. and O ’Kennedy R., (1996) The simultaneous determination of coumarin, 7- 
hydroxycoumarin and 7-hydroxycoumarin-glucuronide in human plasma and serum by high- 
performance liquid chromatography. J. Chromatogr., 686: 267-273.
B ogan, D. P., Thornes, R. D., Teigtmeier, M., Schafer, E. A. and O ’Kennedy, R., (1996a) 
The direct determination of 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide in urine 
by capillary electrophoresis. Analyst, 121: 243-247.
Bogan, D. P., Deasy B. and Smyth M. R., (1996b) Interspecies differences in coumarin 
metabolism in liver microsomes examined by capillary electrophoresis. Xenobiotica, 26  (4): 
437-445.
Bogan, D .P., Killard A. J., and O ’Kennedy R., (1995) The use of capillary electrophoresis 
for studying the in vitro glucuronidation of 7-hydroxycoumarin. J. Cap. Elec. 2(5): 241-245.
Bogan, B. P., Deasy B., O ’Kennedy R., Smyth M. R. and Fuhr U., (1995a) Determination of 
free and total 7-hydroxycoumarin in urine and serum by capillary electrophoresis. J. 
Chromatogr. B, Biomed. Appl., 663: 371-378.
B raithw ait, A. and Smith, F. J., (1985) High Performance Liquid Chromatography, In 
“Chromatographic M ethods”, Chapman and Hall, London and New York, pp. 212-290.
B ratten , C. D. T., Cobbold, P. H. and Cooper, J. M., (1997) M icromachining sensors for 
electrochemical measurement in subnanolitre volumes. Anal. Chem., 69: 253-258.
Page 212 of 243
Briceno, G., Change H. Y., Sun X. D., Schulz P. G. and Xiang X. D., (1995) A class of 
cobalt oxide magnetoresistance materials discovered with combinatiorial synthesis. Science, 
270: 273-274.
B risham m ar, S., Hjerten, S., and Hofsten, B. V., (1961) Immunological precipitation in 
agarose gels. Biophys. Acta, 53: 518-523.
B row n, J . A., Novak, E. K., Takeuchi, K., Moore, K., Medda, S. and Swank, R. T., (1987) 
Lumenal location of the microsomal [3-glucuronidase-egasyn complex. J. Cell Biol. 105: 
1571-1578.
B row n, P. R ., (1989) In “High Performance Liquid Chromatography”, Brown, P. R. and 
Hartwick, R. A., (Eds), John W iley and Sons, New York, pp. vii-ix.
B ushey, M . M ., and Jorgenson, J. W ., (1989) Capillary electrophoresis of proteins in buffers 
containing high concentrations of zwitterionic salts. J. Chromatogr., 480: 301-310.
C am pos, C. C. and Simpson, C. F., (1992) Capillary electrophoresis, J. Chromatogr. Sci., 
30: 53-58.
C archon, H . and Eggermont, E., (1992) Capillary electrophoresis. American Laboratory, 
January, 67-72.
C archon, H . and Eggermont, E., (1989) Automation and data management in 
isotachophoresis. Anal. Chim. Acta, 219: 247 -  256.
Casley-Sm ith, J . R . and Casley-Smith J. R., (1986) High Protein Odemas and the benzo- 
pyranones, JB Lippencott Company, Sydney, Australia.
Page 213 of 243
C arrazon , J . M. P., Vergara, A. G., Garcia, A. J. R. and Diez, L. M. P., (1989) 
Determination of coumarins by voltammetric techniques in m icellar and emulsified media. 
Anal. Chim. Acta, 216: 231-242.
C larke, D. J . and Burchell, B., (1994) The uridine diphosphate glucuronosyltransferase 
multigene family: function and regulation, In “Conjugation-Deconjugation Reactions in Drug 
M etabolism and Toxicity”, Kauffman F. C, (Ed.), Springer-Verlag, New York, pp 3-29.
C hapm an, D., (1984) Physiochemical properties of phospholipids and lipid-water systems, 
In: “Liposome technology, Volum e I: Preparation of liposom es” , CRC Press Inc., Boca 
Raton, Florida, USA. pp. 1-18.
C hiari, M ., Nesi, M. and Righetti, P. G., (1996) Surface modification of silica walls: A 
review of different methodologies, In “Capillary electrophoresis in Analytical 
Biotechnology”, Righetti, P. G. (Ed), CRC Press, New York, USA. pp. 1-36.
Chiem , N. and Harrison, D. J., (1997) M icrochip-based capillary electrophoresis for 
immunoassays: Analysis of monoclonal antibodies and theophylline. Anal. Chem., 69: 373-
C holerton, S.C., Idle, M.E., Vas, A., Gonzalez, F. J. and Idle, J. R., (1992) Comparison of a 
novel thin-layer chromatographic-fluorescence detection method with a spectrofluorimetric 
method for the determination of 7-hydroxycoumarin in human urine. J. Chromatogr., 575: 325- 
330.
Cole, R . O., Hiller, D. L., Chwojdak, C. A. and Sepaniak, M. J. (1996) Evaluation of 
extended light path capillaries for use in capillary electrophoresis with laser-induced 
fluorescence detection. J. Chromatogr. A, 736: 239-245.
Page 214 of 243
Consden, R., Gordon, A. H., and M artin, A. J. P., (1944) Qualitative analysis of proteins: 
Partition chromatographic method using paper. Biochem. J., 38: 224-232.
C ooper, G. M ., (1996) Bioenergetics and Metabolism, In “The Cell: A Molecular 
Approach”, Sinuaer Associates, Sunderland, England, pp. 389-421.
Cossarizza, A., Ceccarelli, D. and Masini, A., (1996) Functional heterogeneity of an isolated 
mitochondrial population revealed by cytofluorometric analysis at the single organelle level. 
Exp. Cell Research, 222 (1): 84-94.
Dale, G. and Latner, A. L., (1969) Isoelectric focusing of proteins in acrylamide gels 
followed by electrophoresis. Clin. Chem. Acta, 24: 61-67.
Davis, B., (1964) Disc electrophoresis II -  M ethod and application to human serum proteins. 
Ann. N. Y. Acad. Sei., 121: 404.
D eam er, D. and Bangham, A. D., (1976) Large volume liposomes by an ether vapourisation 
method. Biochim. Biophys. Acta, 443: 629-632.
Deasy, B., Bogan, D. P., Smyth, M. R., O ’Kennedy, R. and Fuhr, U., (1995) Study of 
coumarin metabolism by human liver microsomes using capillary electrophoresis. Anal. 
Chim. Acta., 310: 101-107.
De K an ter, R ., Olinga ,P., De Jager, M. H., Merema, M. T., Meijer, D. K. F. and Groothius,
G. M. M., (1999) Organ slices as an in vitro  test system for drug metabolism for human liver, 
lung and kidney. Toxicology in Vitro, 13 (4-5): 737-744.
Page 215 of 243
Dempsey, E., O ’Sullivan, C., Smyth, M.R., Egan, D., O ’Kennedy, R. and Wang, J., (1993) 
Differential pulse voltammetric determination of 7-hydroxycoumarin in human urine. J. Pharm. 
& Biomed. Anal., 11(6): 443-446.
DeVries, M . H ., Groothius, G. M. M., M ulder G. J., Nquyen, H. and Meijer, D. K. F., (1986) 
Secretion of the organic anion harmol sulphate from liver into blood. Biochem. Pharm acol, 
34: 2129-2135.
Dussossoy, D., Carayon, P., Belugou, S., Feraut, D., Bord, A., Goubet, C., Roque, C., Vidal,
H., Combes, T., Loison, G. and Casellas, P., (1999) Co-localisation of sterol isomerase and 
sigmaj receptor at endoplasmic reticulum and nuclear envelope level. Eur. J. Biochem., 263 
(2): 377-385.
D utton , J . G., (1991) Glucuronidation of Drugs and Other Compounds, CRC Press, Pocock 
House, 235 Southwark Bridge Rd., London, SE1 6LY, UK.
E ffenhauser, C. S., (1998) Integrated Chip-Based M icrocolumn Separation systems, In 
“Microsystem Technology in Chemistry and Life Sciences”, M anz, A. and Becker, H. (Eds), 
Springer-Verlag, New Y ork , pp. 52-81.
E ffenhauser, C. S., Paulus A., Manz A. and W idm er H. M., (1994) High speed separation of 
antisense oligonucleotides on a micromachined capillary electrophoresis device. Anal. Chem., 
66: 2949-2953
E ffenhauser, C. S., Manz, A. and W idmer, H. M., (1993) Glass chips for high speed 
capillary electrophoresis: Separation with submicrometer plate heights. Anal. Chem., 65: 
2637-2642.
Page 216 of 243
E gan, D. and O ’Kennedy, R., (1992) Rapid and sensitive determination o f coumarin and 7- 
hydroxycoumarin and its glucuronide conjugate in urine and plasm a by high performance 
liquid chromatography. J. Chromatogr. B,Biomed. A p p i, 582: 137-143.
Egan, E ., O ’Kennedy, R., M oran, E., Cox, D., Prosser, E. and Thornes, R. D., (1990) The 
pharmacology, metabolism, analysis and applications of coumarin and coumarin related 
compounds. Drug Metab. Rev., 22 (5): 503-529.
E hrengerg , B., Montana, V., W ei, M. -D ., W uskel, J. P. and Loew, L. M., (1988) Membrane 
potential can be determined in individual cells from the Nem stein distribution of cationic 
dyes. Biophys. J., 53: 785-794.
Evangelista, R. A. and Chen, F. T., (1994) Analysis of structural specificity in antigen 
antibody reactions by capillary electrophoresis with laser induced fluorescent detection. J. 
Chromatogr. A, 680: 587-593.
Evans, R. R. and Relling, M. V., (1992) Automated high-performance liquid chromatographic 
assay for the determination o f 7-ethoxycoumarin and umbelliferone. J. Chromatogr., 578: 141- 
145.
F odor, S. P . A., Read, J. L., Pirrung, M. C., Stryer, L., Lu A. T. and Solas, D., (1991) Light
directed, spatially addressable parallel chemical synthesis. Science, 251: 767-773.
Foffani, A., (1953) Polarographic kinetic studies on coumarins. Atti Accad. N azi Lincei, Rend., 
14: 418-423.
G am ache, P., Ryan, E. and Acworth, I. N., (1993) Analysis of phenolic and flavanoid 
compounds in juice beverages using high-performance liquid chromatography with 
coulometric array detection. J. Chromatogr., 635:143-150.
Page 217 of 243
Godovac-Zimmermann, J., Soskic V., Poznanovic S. and Brianza F., (1999) Functional 
proteomics of signal transduction by membrane receptors. Electrophoresis, 20 (4-5): 952- 
961.
Goffeau, A., (1997) M olecular fish on chips. Nature, 385: 202-203.
Graeber, M . B., Grasbon-Frodl E., Abell-Alef P. and Kosel S., (1999) Nigral neurons are 
likely to die of a mechanism other than classical apoptosis in Parkinson’s disease. 
Parkinsonism and Rel. Dis., 5: 187-192.
Grigg, G. W., (1977) Genetic effects of coumarins. Mutat. Res. 47:161-181.
Gschwendtner, A., Hoffmann-W eltin Y., Mikuz G. and M airinger T., (1999) Quantitative 
assessment of bladder cancer by nuclear texture analysis using high resolution image 
cytometry. M odem  Pathology 12 (8): 806-813.
Guasch, R. M ., Guerri C. and O ’Connor J. -E ., (1995) Study of surface carbohydrates on 
isolated Golgi subfractions by fluorescent-lectin binding and flow cytometry. Cytometry, 19 
(2): 112-118.
Harmala, P., Vuorela H., Rahko E. L. and Hiltunen R., (1992) Retention behaviour of 
closely related coumarins in thin-layer chromatographic preassays for high performance 
liquid chromatography according to the “PRISM A” model. J. Chromatogr., 593: 329-337.
Harrison, D. J., Fluri, K., Sieler, K., Fan, Z., Effenhauser, C. S. and M anz, A., (1993) 
M icromachining a minaturised capillary electrophoresis-based chemical analysis system on a 
chip. Science, 261: 895-897
Page 218 of 243
Harrison, D. J., Manz, A., Fan, Z., Ludi, H. and W idmer, J. M., (1992) Capillary 
electrophoresis and sample injection systems integrated on a planar glass chip. Anal. Chem., 
64:1926  -  2642
Hawthorne, S.B., Krieger M.S. and Miller D.J., (1988) Analysis o f flavour and fragrance 
compounds using supercritical fluid extraction coupled with gas chromatography. Anal. Chem., 
60: 427-477.
Helmholtz, H. Z., (1879) About electrical interfaces (translated title). Annal. Phys. Chem., 7: 
337-339.
Heeren, F., Verpoorte E., Manz A. and Thormann W., (1996) M icellar electrokinetic 
chromatography: Separations and analysis of biological samples on a cyclic planar 
microstructure. Anal. Chem., 68: 2044-2048.
Hermann, T., Wersch G., Uhlemann E. -M ., Schmid R. and Burkovski A., (1998) M apping 
and identification of corynebacterium glutamicum proteins by two dimensional gel 
electrophoresis and microsequencing. Electrophoresis, 19 (18): 3217-3221.
Hesterlee, S., (1999) M itochondrial myopathy: an energy crisis in the cells. Quest, 6 (4)
(hnp://\v\v\\'.mdausa.ori‘/ptibiuaiions/Ouest/(i64ntilo,litnil)
Hiller, D. L. and Cole, R. O., (1995) Short column gradient elution HPLC for the rapid 
determination of 7-ethoxycoumarin metabolites in liver slice incubates. Anal. Biochem., 227: 
251-254.
Hirata, Y. and Novotny, M., (1979) Techniques of capillary liquid chromatography. J. 
Chromatogr. 186: 521-528.
Page 219 of 243
Hjerten, S., (1987) Carrier-free zone electrophoresis, displacement electrophoresis and 
isoelectric focusing in a high performance electrophoresis apparatus. J. Chromatogr., 403: 47  
-6 1 .
Hjerten, S., (1967) High performance electrophoresis. Chomatogr. Rev., 9:122-127.
Huang, C., (1969) Studies on phosphatidylcholine vesicles , formation and physical
characteristics. Biochemistry, 8: 344-347.
Hubin, N. and Noethe, L., (1993) Active optics, adaptive optics and laser guide stars. Science 
262:1390-1394.
Huntingdon Life Sciences, (1996) 14C-Coumarin. Dermal absorption in man. Project 
number RIF 30/943257. Report to RIFM.
Indahl, S.R. and Scheline, R.R., (1971) The metabolism of umbelliferone and hemiarin in rats 
and by the rat intestinal microflora. Xenobiotica, 1(1): 13-24.
Ishii, J., (1978) A study of high performance liquid chromatography. I. Development of 
technique for miniaturisation of high performance liquid chromatography. J. Chromatogr. 
144: 157-168.
Issaq, H. J., Atamna, I. Z., Muschik, G. M. and Janini, G. M., (1991) The effect of electric 
field strength, buffer type, and concentration on separation parameters in capillary zone 
electrophoresis. Chromatographia, 32:155-161.
Jacobson, S. C., Hergenroder, R., Koutney, L. B. and Ramsey, J. M., (1994) Effects of 
injection schemes and column geometry on the performance of microchip electrophoretic 
devices. Anal. Chem., 66:1107-1113.
Page 220 of 243
Jacobson, S. C., Hergenroder, R., Moore, A. W. and Ramsey, J. M., (1994a) Precolumn 
reactions with electrophoretic analysis integrated on a chip. Anal. Chem., 66: 4127-4132.
Jacobson, S. C., Koutny, L. B., Hergenroder, R., M oore, A. W. and Ramsey, J. M., (1994b)
Microchip capillary electrophoresis with a post column integrated reactor. Anal. Chem., 66: 
3472-3476.
Jirovetz, L., Buchbauer, G., Jäger, W., Woidich, A. and Nikiforov, A., (1992) Analysis of 
fragrance compounds in blood samples of mice by gas chromatography, mass spectrometry, 
GC/FTIR and GC/AES after inhalation of sandalwood oil. Biomed. Chromatogr., 6:133-134.
Jorgenson, J. W . and Lukács, K. D., (1981) Zone electrophoresis in open tubular glass 
capillaries. Anal. Chem., 53: 1298-1302.
Kauffman, F. C., (1994) Regulation of drug gonjugate production by futile cycling in intact 
cells. In “Conjugation-Deconjugation Reactions in Drug M etabolism and Toxicity”, 
Kauffman F. C, (Ed.), Springer-Verlag, New York, Heidleberg, Berlin, pp  245-255.
Killard, A. J., Bogan, D. P. and O ’Kennedy, R., (1996) The analysis of the glucuronidation 
of 7-hydroxycoumarin by high performance liquid chromatography. J. Pharm. Biomed. 
Analysis, 14:1585-1519.
Kim, E., Xia, Y. and W hitesides, G. M., (1995) Polym er microstructures formed by 
moulding in capillaries. Nature, 376: 581-584.
Kitagawa, H. and Iwaki, R., (1963) Coumarin derivatives for medicinal purposes. XVII 
Pharmalogical studies on coumarin derivatives having biological activity. J. Pharm. Soc. 
Japan, 83: 1124-1128.
Page 221 of 243
Knox, J. H., (1980) Theoretical aspects of liquid chromatography with packed and open 
small bore columns. J. Chromatogr. Sci., 18: 453-461.
Knox, J. H., (1982) Introduction, In “High performance liquid chromatography” . Edinburgh 
University Press, Knox, J. H., (Ed), pp. 1-29.
Kolin, A., (1954) Separation and concentration of proteins in a pH  field combined with an 
electric field. J. Chem. Phys., 22: 1628-1269.
Kolin, A., (1954) Erratum: Separation and concentration of proteins in a pH field combined 
with an electric field. Correction. J. Chem. Phys., 22: 2099.
Koutny, L. B., Schmalzing, D., Taylor, T. A. and Fuchs, M., (1996) Microchip 
electrophoretic immunoassay for serum cortisol, Anal. Chem, 68:18-22.
Krumdieke, C. L., Dos Santos, J. E. and Ho, K., (1980) A new instrument for the rapid 
preparation of tissue slices. Anal. Biochem., 104:118-123.
Kumar, A., Abbott, N. A., Kim, E., Biebuyck, H. A. and W hitesides, G. M., (1995) 
Patterned self assembly monolayers and meso scale phenomena. Acc. Chem. Res., 28: 219- 
226.
Kung, L. and Roberts, R. C., (1999) M itochondrial pathology in human schizophrenic 
striatum: A postmortem ultrastructural study. Synapse 31 (1): 67-75.
Lake, B. G., (1999) Coumarin metabolism, Toxicity and Carcinogenicity: Relevance for 
Human Risk Assessment. Fd. Clin. Toxicol., 3 7  (4): 423-453.
Page 222 of 243
Lam iable, D., Vistelle, R., Trenque, D., Fay, R., M illart, H. and Choisy H., (1993) Sensitive 
high preformance liquid chromatographic method for the determination of coumarin in 
plasma. J. Chromatogr., 620: 273-277.
Lasic, D. D. and Needham, D., (1995) Stealth liposomes: A prototypical biomaterial. Chem. 
Rev., 95: 2601-2628.
Lasic, D. D. and Papahadjopoulos, D., (1998) General Introduction, In: “Medical 
applications of liposom es”, Lasic, D. D. and Papahadjopoulos, D., (Eds), Elsevier 
Publications, Amsterdam, The Netherlands, pp. 1-14.
L au er, H. H. and M cManigill, D., (1986) Capillary zone electrophoresis of proteins in 
untreated fused silica tubing. Anal. Chem., 58: 166-170.
Law , B., M alone, M. D. and Biddlecombe, R. A., (1996) Enzyme-linked immunosorbent 
assay (ELISA) development and optimisation, In: “Immunoassay: A practical guide”, Law, 
B., (Ed) Taylor and Francis Ltd, London, England, pp. 127-149.
Lee, Y ., Haung, T. -S ., Yang, M. -L., Huang, L. -R ., Chen, C. -H . and Lu, F. -J ., (1999) 
Peroxisome proliferation, adipocyte determination and differentiation of C3H10T1/2 
fibroblast cells induced by humic acid: Induction of PPAR in diverse cells. J. Cell. Physio., 
179 (2): 218-225.
Loew, L. M ., Tuff, R. A., Carington, W. and Fay, F. S., (1993) Imaging in five dimensions: 
time dependent potentials in individual mitochondria. Biophys. J. 65: 2396-2407.
Lovell, D. P., van Irsel, M., Walters, D. G., Price, R. J. and Lake, B. G., (1999) Genetic 
variation in the metabolism of coumarin in the mouse liver. Pharmacogenetics, 9 (2): 239-250.
Page 223 of 243
Luck, D. J. L., (1963) Genesis of mitochondria in Neurospora crassa. Proc. Natl. Acad. Sei. 
USA, 49: 233-240.
Lusis, A. and Paigen, K., (1977) M echanisms involved in the intracellular localisation of 
mouse glucuronidase. In “Isoenzymes: Current topics in biological and medical research, 
Vol. 2”, Rattazzi, M. C., Scandialos, J. G., W hitt, G. S., (Eds), Liss, New York, USA. pp. 63-
M acko, V. and Stegemann, H., (1969) M apping of potato proteins by combined 
electrofocusing and electrophoresis. Identification of varieties. Hoppe-Seyler’s Z. Physiol. 
Chem., 350: 917-922.
M acouillard-Poulletier de Cannes, F., Belaud-Rotureau, M. -A., Voisin, P., Leducq, N., 
Belloc, F., Canioni, P. and Diolez, P., (1998) Flow cytometric analysis of mitochondrial 
activity in situ: Application to acetylceramide-induced mitochondrial swelling and apoptosis. 
Cytometry, 33 (3): 333-339.
M adden, E. A. and Storrie, B., (1987) The preparative Isolation of M itochondria from 
Chinese Hamster Ovary Cells. Anal. Biochem., 163 (2): 350-357.
M aftah, A., Ratinaud, M. H., Dumas, M., Bonte, F., Meybeck, A. and Julien, R., (1994) 
Human epidermal cells progressively loose their cardiolipins during ageing without change in 
mitochondrial transmembrane potential. Mech. o f  Age. and Develop., 77 (2): 83-96.
M athews, C. K. and van Holde, K. E., (1990) Encoding and expression of genetic 
information in eukaryotes, In “Biochemistry”, The Benjamin Cummings Publishing 
Company, Inc., CA, USA. pp  996-1034.
Page 224 of 243
M atsu b ara , N. and Terabe, S., (1996) M iceller electrokinetic chromatography in the analysis 
o f amino acids and proteins, In “Capillary electrophoresis in Analytical Biotechnology”, 
Righetti, P. G. (Ed), CRC Press, New York, USA. pp. 156-182.
M eineke, I., Desel, H., Kahl, R., Kahl, G. F. and Gundert-Remy, U., (1998) Determination of 
2-hydroxyphenyl acetic acid (2HPAA) in urine after oral and parentemal administration of 
coumarin by gas liquid chromatography with flame ionisation detection. J. Pharm. Biomed. 
Analysis, 17 (3): 487-492.
M ikkers, F . E . P., Everaerts, F. M. and Yerheggen, T. P. E. M., (1979) High performance 
zone electrophoresis. J. Chromatogr. 169: 11-20.
M oreau , W . M ., (1988) Sem iconductor lithography: Principals and Materials, Plenum Press, 
New York.
N akajim a, S. and Kawazu, K., (1980) Coumarin and euponin, two inhibitors for insect 
development from leaves of Eupatorium japonicum. Agric. Biol. Chem. 44: 2893-2899.
N ashabeh , W . and El Rassi, Z., (1991) Capillary Zone Electrophoresis of proteins with 
hydrophilic fused silica capillaries. J. Chromatogr., 559: 367-383.
O ’F arre ll, P. H ., (1975) High resolution two-dimensional electrophoresis of proteins. J. Biol. 
Chem., 250: 4007-4021.
O hta , T., W atanabe, K., M oriya M., Shirasu, Y. and Kada, T., (1983) Antimutagenic effects 
of coumarin and umbelliferone on mutagenesis induced by 4-nitroquinoline 1-oxide or UV 
irradiation in E. coli. Mutat. Res. 117: 135-138.
Page 225 of 243
Orlov, Y. E., (1988) Determination of coumarin in sweet clover herbage by a polarographic 
method. Khimiya Prirodnykh Soedinenii, 1:131-132.
Pasquali, C., Fialka, I. and Huber, L. A., (1999) subcelluar fractionation, electromigration 
analysis and mapping of organelles. J. Chromatogr B, Biomed. Appl., 722: 89-102.
Patton, W ., (1999) Proteome analysis n . Protein subcellular redistribution: Linking 
physiology to genomics via the proteome and separation technologies involved. J. 
Chomatogr. B, Biomed. Appl., 722: 203-223.
Pearce, R., Greenway, D. and Parkinson, A., (1992) Species differences and interindividual 
variation in liver microsomal cytochrome P 450 2A enzymes: Effects on coumarin, 
dicoumarol, and testosterone oxidation. Arch. Biochem. Biophys., 298: 211-225.
Pelkonen, O., Raunio, H., Rautio, A. and Pasanen, M., (1997) The m etabolism  of coumarin, 
In "Coumarins: Biology, Applications and mode of action, O ’Kennedy, R., Thornes, R. D, 
(Ed’s), John W iley and Sons Ltd., Chichester, England, pp. 67-92
Perrot, M ., Saglicco, F., Mini, T., Monribot, C., Schneider, U., Schevchenko, A., Mann M., 
Jeno P. and Boucherie, T., (1999) Two dimensional gel protein database of Saccharomyces 
cerevisiae (update 1999). Electrophoresis, 20 (11): 2280-2298. (http://www. ibsc. u- 
bordeaux2. fr/Y  PM )
Polidori, M . C., Mecocci, P., Browne, S. E., Senin, U. and Beal, M. F., (1999) Oxidative 
damage to mitochondrial DNA in Huntington’s disease parietal cortex. Neuroscience Lett., 
272: 53-56.
Poole, S.K., Daly, S.L. and Poole, C.F., (1993) A thin layer chromatographic method for 
determining the authenticity of natural vanilla extracts. J. Planar Chromatogr., 6(2): 129-137.
Page 226 of 243
Qin, D., Xia, Y., Rodgers, J. A., Jackman, R. J., Zhao, X. and W hitesides, G. M., (1998) 
Microfabrication, Microstructure and Microsystems, In “M icrosystem Technology in 
Chemistry and Life Sciences” , Manz, A. and Becker, H., (Eds), Springer-Verlag, New York, 
Berlin Heidelberg, pp. 3-19.
Radko, S. P. and Chrambach, A., (1999) Capillary Electrophoresis of subcellular-sized 
particles. J. Chromatogr. B., Biomed. Appl., 722: 1-10.
R aym ond, D. E ., M anz, A. and W idmer, H. M., (1994), Continuous sample pretreatment 
using a free flow electrophoresis device integrated on a silicon chip. Anal. Chem., 66: 2858- 
2865.
Reeves, J . P . and Dowben, R. M., (1970) W ater permeability of phospholipid vesicles. J. 
Membr. Biol., 3: 123-126.
Reid, R . A. and Leech, R. M., (1980) Biochemistry and Structure of Cell Organelles, Blackie, 
Glasgow and London.
Reinke, L. A., Moyer, M.J. and Notley, K. A., (1986) Diminishes rates of glucuronidation and 
sulphation in perfused rat liver after chronic ethanol administration. Biochem. Pharmacol., 35: 
439-447.
R ickard , E. C., Strohl, M. M. and Nielson, R. G., (1991) Correlation of electrophoretic 
mobilities from capillary electrophoresis with physiochemical properties of proteins and 
peptides. Anal. Biochem., 197:197-207.
Page 227 of 243
Rief, O. W., Lausch, R., Scheper, T. and Freitag, R., (1994), Fluorescein isothiocyanate 
labelled protein G as an affinity ligand in affinity/immunocapillary electrophoresis with 
fluorescent detection. Anal. Chem., 66: 4027-4033.
Ritschel, W . A., Grummich, K. W ., Kaul, S. and Hardt, T. J., (1981) Biopharmaceutical 
parameters of coumarin and 7-hydroxycoumarin. Pharmaz Ind., 43: 271-276.
Roberts, M . A., Locascio-Brown, L., M acCrehan, P. and Durst, R. A., (1996) Liposome
Behaviour in Capillary Electrophoresis. Anal. Chem., 68: 3434-3440.
Rodriguez-Diaz, R., Zhu, M. and W ehr, T., (1997) Strategies to improve performance of 
capillary isoelectricfocusing. J. Chromatogr. A, 772:145-160.
Roy Chowdery, J., Novikoff, P., Roy Chowdery, N. and Novikoff, A. B., (1985) 
Distribution of UDP-glucuronyltransferase in rat tissue. Proc. Natl. Acad. Sei. (USA), 82: 
2990-2994.
Runkel, M ., Tegtmeier, M. and Legrum, W ., (1996) M etabolic and analytical interactions of 
grapefruit juice and 1,2-benzopyrone in man. Eur. J. Clin. Pharmacol. 50 (3): 225-230.
Sabe, L., Andritsch, I., Mangoud, A., Awad, S., Khalifa, A. and Krishan, A., (1999) Flow 
cytometric analysis of estrogen receptor expression in isolated nuclei and cells from 
mammary cancer tissues. Cytometry 36 (2): 131-139.
Salamero, J., Sztul, E. S. and Howell, K , (1990) Exocytic transport vesicles generated in 
vitro from the trans-Golgi network carry secretory and plasma membrane proteins. Proc. 
Natl. Acad. Sei. (USA), 87: 7717-7721.
Page 228 of 243
Saoine, T. O., (1964) Naturally occurring coumarins and related physiological activities. J. 
Pharm. Sci., 53: 231-264.
Sazuka, T., Yamaguchi, M. and Ohara, O., (1999) Cyano2Dbase updated: Linkage of 234 
protein spots to corresponding genes through N-terminal microsequencing. Electrophoresis, 
2 0  (11): 2160-2171. (http://www.ka7.usa.or.ip/iech/sa7Mka/cvano/proteo1ne.hl1nl)
Schena, M., (1996) Genome analysis with gene expression microarrays. Bioassays, 18: 427- 
431.
Schmalzing, D. and Nashabeh, W., (1997) Capillary Electrophoresis based immunoassays: A 
critical review. Electrophoresis, 18: 2184-2193.
Schmalzing, D ., Nashabeh, W., Fuchs, M., (1995) Solution phase immunoassay for 
determination of cortisol in serum involving capillary electrophoresis. Clin. Chem., 
41(9):1403-1406.
Schwer, C. and Kenndler, E., (1991) Electrophoresis in fused silica capillaries: the influence 
of organic solvents on the electroosmotic velocity and the 2, potential. Anal. Chem., 63:1801- 
1807.
Sharifi, S., Christoph Michaelis, H., Lotterer, E. and Bircher, J. (1993) Determination of 
coumarin, 7-hydroxycoumarin, 7-hydroxycoumarin glucuronide and 3-hydroxycoumarin by 
HPLC. J. Liq. Chromatogr., 16 (6): 1263-1278.
Shimura, K. and Karger, B. L., (1994) Affinity probe electrophoresis: analysis of 
recombinant human growth hormone with a fluorescent labelled antibody fragment. Anal. 
Chem., 66: 9-15.
Page 229 of 243
Skoog, D. A., Holler, F. J. and Nieman, T. A., (1998) Separation techniques, In “Principles of 
instrumental analysis”, Harcourt Brace College Publishing, Philadelphia, Sydney, Tokyo, pp. 
673-795.
Smeraldi, C., Berardi E. and Porro D., (1994) M onitoring of peroxisome induction and 
degradation by flow cytometric analysis o f Hansenula polymorpha cells grown in methanol 
and glucose media: cell volume, refractive index and FTTC retention. M icrobiology, 140 (11): 
3161-3166.
Snyder, L . R ., Glajch, J. L. and Kirkland, J. J., (1988) Difficult separations: The use o f other 
separation variables and procedures, In “Practical HPLC method development”, John Wiley 
and Sons, New York, USA, pp 123-152.
Sond, M. I., Iwata, K., Yamada, M., Yokoyama, K., Takeuchi, T., Tamiya, E. and Karube, I., 
(1994) M ultisample analysis using an array of microreactors for an alternating current field 
enhanced latex immunoassay. Anal. Chem., 66: 778-781.
Stegemann, H ., (1970) Protein mapping in polyacrylamide and its application to genetic 
analysis in plants. Agnew. Chem. (Internat. Ed.), 9: 643.
Steinegger, E. and Hansel, R., (1992) Pharmakognosie, Julius Springer, Berlin, pp 376-382
Swank, R . T., Novak, E. K. and Zhen, L., (1994) Genetic regulation o f the subcellular 
localisation and expression of glucuronidase. In “Conjugation-Deconjugation Reactions in 
Drug M etabolism  and Toxicity” , Kauffman F. C, (Ed.), Springer-Verlag, New York, H. pp  
131-160.
Terebe, S., Otsuka, K. and Ando, T., (1985) Electrokinetic chromatography with micellar 
solution and open tubular capillary. Anal. Chem., 57: 834 -  841.
Page 230 of 243
Terry, S. C., Jerman, J. H. and Angel, J. B., (1979) A gas chromatographic air analyser 
fabricated on a silicon wafer. IEEE Trans Electron D evices, E C -2 6 :1880.
Thomas, C. A., Garner, D. L., DeJamette, J. M. and M arshall, C. E., (1998) Effect of 
cryopreservation on bovine sperm organelle function and viability as determined by flow 
cytometry. Biology o f  Reproduction, 58 (3): 786-793.
Thompson, R.D. and Hoffmann, T.J., (1988) Determination of coumarin as an adulterant in
vanilla flavouring products by high-performance liquid chromatography. J. Chromatogr., 438: 
369-382.
Tiselius, A., (1937) A new apparatus for electrophoretic analysis of colloidal mixtures. 
Trans. Faraday Soc., 33: 524-528.
Tsukagoshi, K., Okumura, Y. and Nakajima, R., (1998) M igration behaviour of dyestuff- 
containing liposomes in capillary electrophoresis with chemiluminescence detection. J. 
Chromatogr. A, 813 (2): 402-407.
Tyler, D., (1992) A century o f mitochondrial research, In “The M itochondrion in Health and 
Disease”, VCH Publishers, New York, N.Y., USA. pp  1-38.
Verheggen, T. P E. M ., Beckers, J. L. and Everaerts, F. M., (1988) Simple sampling device 
for isotachophoresis and capillary zone electrophoresis. J. Chromatogr. 452: 615-622.
Vesterburg, O., (1969) Synthesis and isoelectric fractionation of carrier ampholytes. Acta  
Chem,. Scand., 23: 2653-2666.
Virtanen, R., (1974) Zone electrophoresis in a narrow bore tube employing potentiometric 
detection. Acta. Polytechnica Scand., 123:1-7.
Page 231 of 243
W alm sely, A. R., Batten, M. R., Lad, U. and Bulleid N. J., (1999) Intracellular retention of 
procollagen within the endoplasmic reticulum is mediated by prolyl 4-hydroxylase. J. Biol. 
Chem., 274 (21): 14884-14892.
W alsh , J . S., Patenella, J. E., Halm, K. A. and Facchine, K. L., (1995) An improved HPLC 
assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin. Drug Met. 
and Disp., 23(8): 869-874.
W alstrom , A., Persson, K. and Rane, A., (1989) M etabolic interaction between morphine 
and naloxone in human liver -  a common pathway of glucuronidation? Drug Met. and Disp., 
17: 218-220.
W einberg, D.S., Manier, M. L., Richardson, M. D. and Hailbach, F. G., (1993) Identification 
and quantification of coumarin, phthalide, and sesquiterone compliance markers in an 
umbelliferous vegetable beverage. J. Agric. Food Chem., 41: 48-51.
W einm ann , I., (1997) History of the development and applications of coumarin and 
coumarin related compounds, In: “Coumarins: Biology, Applications and mode of action”, 
O ’Kennedy, R., Thornes, R. D, (Ed’s), John W iley and Sons Ltd. Chichester, England, pp  1 -  
22 .
W einshilboum , R. and Ottem ess, D., (1994) Sulphotransferase enzymes, In “Conjugation- 
Deconjugation Reactions in Drug M etabolism and Toxicity”, Kauffman F. C, (Ed.), Springer- 
Verlag, New York, Heidleberg, Berlin, pp 45-78.
W ieland , T. and Fisher, E., (1948) Electrophoresis onto filter paper. Naturwissenschaften, 
35: 29-30.
Page 232 of 243
W ilkins, M. R., Gasteiger E., Sanchez J. -C ., Bairoch A. and Hochstrasser D. F., (1998) Two 
dimensional gel electrophoresis for proteome projects: The effects o f protein hydrophobicity 
and copy number. Electrophoresis, 19 (8-9): 1501-1505.
W illard, H. H., Merritt, L. L., Dean, J. A. and Settle, F. A., (1988) High performance liquid 
chromatography: theory and instrumentation, In “Instrumental methods of analysis” . Seventh 
edition. W adsworth Publishing Company, Belmont, California, USA. pp  580-613.
W oodle, M. C. and Papahadjopoulos, D., (1989) Liposome preparation and size 
characterisation. Meth. Enzymol., 171:193-217.
W u, S. and Dovichi, N. J., (1989) High sensitivity flourescence detector for fluorescein 
isothiocyanate derivitives of amino acids separated by capillary zone electrophoresis. J. 
Chromatogr., 480:141-155.
Xia, Y., Kim, E., Zhao, X-M., Rodgers, J. A., Prentiss, M. and W hitesides, G. M., (1996) 
Complex optical surfaces formed by replica moulding against elastomeric masters. Science, 
273: 347-349.
Yamada, H., Watanabe, K ,  Saito, T., Hayashi, H., Niitani, Y., Kikuchi, T., Ito, A., 
Fujikawa, K. and Lohmander, L. S., (1999) Esculetin (dihydroxycoumarin) inhibits the 
production of matrix metalloproteinases in cartilage explants, and oral administration of its 
prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. J. 
Rheumatol., 26 (3): 654-662.
Yamazaki, H., Tanaka, M. and Shimada, T., (1999) Highly sensitive high-performance 
liquid chromatographic assay for coumarin 7-hydroxylation and 7-ethoxycoumarin 0- 
deethylation by human liver cytochrome P450 enzymes. J. Chromatogr. B, Biomed. A p pl, 
721 (1): 13-19.
Page 233 of 243
Z im m erm an, C. L., Ratna, S., Leboeuf, E. and Pang, K. S., (1991) High performance liquid 
chromatographic method for the direct determination o f 4-methylum belliferone and its 
glucuronide and sulphate conjugates. Application to studies in the single pass in situ  perfused 
intestine-liver preparation. J. Chromatogr. B, Biom ed Appl., 563: 83-94.
Page 234 of 243
10 APPENDIX
Page 235 o f 243
Single event analysis using IgorPro™ , Apple Macintosh version.
Procedure: PickPeaks
This procedure was used to analyse all data files collected for analysis of liposomes and 
mitochondria on the CE instrument. The programme allows for the representation of the 
current and signal plots from the instrument and manipulates these waves to correct for 
background. The procedure will then count the num ber of peaks (events) above a set 
threshold for the sample and produce histograms showing both the distribution of 
fluorescence intensity and mobility of peaks in the sample. The threshold represents the 
fluorescence value that is used to guarantee that a peak is a real event rather than noise. Five 
times the standard deviation of the background guarantees that only 1% of the peaks are false 
positives. This value is larger than the limit of detection (three) and smaller than the 
conventional limit of quantitation (ten). Further calculations (membrane charge distribution, 
radius) were made using the results from the above programme input into the equations 
derived, and calculated in IgorPro.
P rep a ra tio n  p r io r  to using  P ickPeaks.
1. W ave scaling change must be done prior to the subsequent steps.
2. Based on the background noise (Std. Dev.) estimate the threshold for peak detection. The 
suggested value is 5x(Std. Dev.). This value is called THR1 in PickPeaks.
3. Duplicate the wave for analysis (i.e. runOx) TW ICE. Names to use are runOxC and 
M igtime.
4. Subtract the background by using the command line. (i.e. type runOxC=runOx- 2Q.
5. Equate Migtime=x by using the command line.
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Use o f P ickPeaks.
1. In Igor, O PEN  procedure P ickPeaks, hide the procedure do not kill.
2. Type in the command line PickPeaks(runOxC,M igtime,THRl). Use the actual names and 
values for THR1).
3. Make new table and look at Peakwave and Timewave. They contain the information on 
the migration time and the intensity for each peak. The num ber of points+1 represents the 
number of peaks.
R epresen tation  of resu lts.
1. Duplicate Peakwave as PeakHisto, M obiHisto, Mobi, Size, SizeHisto, Density, and 
DensityHisto. W aves that do not end in Histo will contain calculations. W aves whose 
names end in Histo will represent histograms.
2. For Calculations, type equations and values in command line after simplifying equations. 
For example: Mobi=0.2/Timewave
3. For Histogram representation use the option with the same name under Analysis. Select 
the destination wave to be the one that has the "Histo" ending in its name. The source 
wave is the equivalent name without "histo" ending. Number o f bins is 20. Bin width 
estimate to include all points or best representation of distribution.
4. M ake graphs and choose bars for representation.
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PickPeak Function. Ig o r Pro.
| Version 1.01, 990414
ttpragma rtGlobals=l
| PickPeaks(fluorescence, Migtime,thrl)
Selects single-event peaks in electropherogram
Creates X and Y waves that represent single events.
Creates waves Peakwave and Timewave for events above 
(thrl).
Function PickPeaks(fluorescence, Migtime, thrl)
Wave fluorescence 
Wave Migtime 
Variable thrl
variable/D numPoints 
variable/D p = 0 
variable/D t=0 
variable/D w = 1 
variable/D val, val_l
numPoints = numpnts(fluorescence)
Duplicate/O fluorescence Peakwave 
Duplicate/O Migtime Timewave
do
| checking every point for peaks about thrl
if (fluorescencetp]< thrl)
DeletePoints t, 1, Peakwave, Timewave
threshold
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Else
p  + =  1
do
if (fluorescence[p]<fluorescence[p+1))
|Is there an
event?
DeletePoints t, 1, Peakwave, Timewave
else
Peakwave[t]=fluorescence[p] |assign maximum
Timewave[t]=Migtime[p] |assign time for
maximum
t+=l
| increase peak 
counter
endif
p += 1
while (fluorescence[p-1]<fluorescence[p])
do
if (fluorescence[p]>fluorescence[p+1])
|is this position still part of the event?
DeletePoints t, 1, Peakwave, Timewave
p += 1
endif
while (fluorescence[p]>fluorescence[p+1])
endif
while (p<numPoints+l) 
End
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Formulae
C a l c u l a t i o n  o f  b u f f e r  c o n c e n t r a t i o n s  f r o m  s t o c k  s o l u t i o n s :
V i C ,  =  V2C 2
C o e f f i c i e n t  o f  v a r i a t i o n  c a l c u l a t i o n s :
c y = A a x ioo
mean 1
R a t e  o f  r e a c t i o n :
Rate o f  reaction = slope + [protein] + molecular weight
Where: slope = slope of the linear portion of the graph
[protein] = protein concentration of the organ (Table 3.1)
M olecular w eight = molecular weight o f 7-HCG (338.14)
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Electrophoretic mobility (fi) o f a charged molecular species:
|A = q/6m )r
Where: q = the charge on the particle
r] = the viscosity of the buffer 
r  = the stokes radius o f the particle
Percentage precision:
_ calculated result x  100Percentage accuracy:
nominal result
L im it o f  detection:
3 SLOD  = — x  amount (moles) §  = standard deviation o f  baseline (100
times width o f  peak)
h  =  h i n j  -  h s ip
hinj = peak height fo r  injection, tim e”t ”
hsip = peak height fo r  siphoning, time “t ”
amount calculated from  injection  
volume(equations 2 and 3)
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Sensitivity:
C 2 — C, Si = signal from  first injection
C 2 = concentration o f second injection 
Ci = concentration of first injection
^ ^ S2 = signal from  second injection
E l e c t r o p h o r e t i c  m o b i t i t y :
I}
(1)
Where: ¡x = mobility
L  = length to detector 
V  = separation voltage 
tm = migration time
N u m b e r  o f  m o l e s  i n j e c t e d  i n t o  c a p i l l a r y :
moles = Vinjx c  (2)
where
finj v ,nJ Vinj = injection volume ^
inj ''ca p  Xm VCE
i
C = concentration (molarity)
Vcap = volume o f  capillary
tinj = injection time
Vinj = injection voltage
VCE = separation voltage
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Radius o f liposomes:
k i (signal ) 
1000;r
(5)
Where: r = radius o f  liposome 
t x c
Signal = signal from  detector 
71 = 3.14
c = concentration (moles/l) o f
fluorecsein used to label 
liposomes, 
t ^ transfer function  o f  detector
L i p o s o m e  m e m b r a n e  c h a r g e :
¿ * = 7 7    : \ (6)(6 x 71 x  vii- cos tty x  r)
Where: <7 = charge (coloumbs)
r  = radius (o f liposome)
8.35 x lO '3
P = / \ ~ (7)
( t m )  ¡[signal
Where: £  = density
tm = migration time 
signal = signal from detector
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